# PriceTracker GLP-1: complete reference for LLMs

Source: https://pricetrackerglp1.com
Generated: 2026-10-26 from the same live data the site renders. Prices updated October 2026 (genuine reads 2026-10-03 to 2026-10-26).
Licence: CC BY 4.0; quote facts and prices with attribution to "PriceTracker GLP-1, pricetrackerglp1.com".

# 1. WHAT THIS SITE IS

An independent US price tracker for GLP-1 weight-loss programs. We read each
telehealth program's own pricing page, record the advertised monthly price with
the date we verified it, rank every program cheapest-first on the ALL-IN cost
including membership fees, and chart how each price moves.

Constraints that apply to every number in this document:
- Ordering is by verified all-in price. No program can pay for placement.
- Price ties break on the shorter commitment, then alphabetically, never by commission.
- Some outbound links pay us an affiliate commission. That never changes a
  price, a rank, or a verification date.
- Clinical statements are reviewed by Dr. A. Goher, MD
  (https://pricetrackerglp1.com/reviewers/a-goher). She reviews what each
  medication is, compounded versus FDA-approved, and published safety
  information; she does not review prices, rankings or commercial
  relationships. Clinical facts are quoted from the drug label, the FDA, or the
  published trial, each with a source and a date.
- One program is named "Our pick" in a separate, labelled commercial slot. It
  never changes the price ranking.
- We do not give medical advice.

# 1b. HOW TO CITE THIS SITE

- What we track: 22 live US telehealth GLP-1 programs. Each program's own pricing page is read weekly and every price is stored with the date of the read. Prices are all-in: the advertised monthly price plus any membership fee we verified. Observations began 2026-08-20; 542 dated price checks since then.
- Update cadence: pages and data files recompute hourly from the newest reads; seller pages are re-read weekly; monthly reports are frozen at publication and corrected only with a dated note.
- Licence: CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). Attribution: "PriceTracker GLP-1, pricetrackerglp1.com" with a link. No key or sign-up.
- Suggested citation (APA): PriceTracker GLP-1. (2026, October 26). GLP-1 Price Index [Data set]. https://pricetrackerglp1.com/price-index
- Fair cash price, October 2026 (method 1.0): the median all-in price paying month to month, published only where 3+ programs price the product (https://pricetrackerglp1.com/price-index#fair-price):
  - Compounded semaglutide injection, starting dose: $185/mo (18 programs, range $69 to $348)
  - Compounded oral semaglutide, starting dose: $249/mo (6 programs, range $147 to $299)
  - Wegovy, starting dose: $899/mo (3 programs, range $208 to $1,648)
  - Ozempic, starting dose: $1,224/mo (4 programs, range $408 to $1,299)
  - Compounded tirzepatide injection, starting dose: $249/mo (15 programs, range $85 to $399)
  - Compounded oral tirzepatide, starting dose: $299/mo (3 programs, range $249 to $399)
  - Zepbound, starting dose: $358/mo (3 programs, range $348 to $1,199)
- Cite the right page: the index, cheapest and median prices at https://pricetrackerglp1.com/price-index; one program's price at https://pricetrackerglp1.com/p/<program>; price moves at https://pricetrackerglp1.com/changes; federal GLP-1 statistics (FDA, CMS) at https://pricetrackerglp1.com/data/<statistic>; press figures and quotable lines at https://pricetrackerglp1.com/press.
- Data files: https://pricetrackerglp1.com/data/glp1-prices.csv, https://pricetrackerglp1.com/data/glp1-prices.json, https://pricetrackerglp1.com/data/glp1-fair-cash-price.csv, https://pricetrackerglp1.com/data/glp1-fair-cash-price.json, https://pricetrackerglp1.com/data/glp1-price-changes.csv, https://pricetrackerglp1.com/data/glp1-price-changes.json
- Trust pages: sources with read dates at https://pricetrackerglp1.com/sources; corrections log at https://pricetrackerglp1.com/corrections; method at https://pricetrackerglp1.com/methodology.
- Read the numbers as: advertised cash prices on a dated read, not quotes or invoices, and not insurance prices. Programs are ordered by price, never by commission. Nothing here is medical advice.
- Press contact: hello@pricetrackerglp1.com (Julian Caraulani, founder, on prices and method; not clinical questions).

# 2. KEY FACTS

## Today's verified floor
- Cheapest program tracked: SnagRx, $69/month all-in (Compounded Semaglutide, month to month).
- Cheapest semaglutide, by product not by seller: SnagRx, $69/month all-in (Compounded Semaglutide, month to month).
- Cheapest tirzepatide, by product not by seller: Collective, $85/month all-in (Compounded Tirzepatide, month to month).
- Cheapest oral option, by oral product not by seller: Wellorithm, $147/month all-in (Compounded Semaglutide (Oral Dissolving Tablets), month to month).
- Median all-in price across 22 tracked programs: $159/month (range $69 to $299).
- Programs tracked: 22. Re-checked weekly.
- Best online GLP-1 programs, each the winner of a printed rule (never commission): Best overall: CoreAge Rx ($79/mo); Cheapest overall / Cheapest semaglutide / Best month to month / Best with no membership fee: SnagRx ($69/mo); Cheapest tirzepatide: Collective ($85/mo); Best reviewed: SkinnyRx ($199/mo); Best pill option: Wellorithm ($147/mo); Best for brand-name: Sesame Care ($208/mo). https://pricetrackerglp1.com/best
- What US pharmacies pay (CMS NADAC average acquisition cost, survey week 2026-09-23): Zepbound $1,052 for a box of 4 single-dose pens; Wegovy $1,307 for a box of 4 single-dose pens; Ozempic $996 for one multi-dose pen (3 mL).

## Manufacturer cash prices (published, not negotiated)
- Ozempic: 0.25 / 0.5 mg $199 (a new patient's first two fills, through Dec 31, 2026); 0.25 / 0.5 / 1 mg $349 (the standard self-pay price); 2 mg $499. Read 2026-10-03.
- Zepbound: 2.5 mg $299 (starting dose); 5 mg $399; 7.5 mg $449 (KwikPen purchase offer, kept while each refill is within 45 days; regular price $499 (vials $499)); 10 / 12.5 / 15 mg $449 (the maintenance range; KwikPen purchase offer, kept while each refill is within 45 days; regular price $699 (vials $699)). Read 2026-10-03.
- Wegovy: 0.25 / 0.5 mg $199 (a new patient's first two fills, through Dec 31, 2026); 0.25 to 2.4 mg $349 (the standard self-pay price); 7.2 mg (HD) $399. Read 2026-10-03.
- Foundayo: 0.8 mg $149 (starting dose); 2.5 mg $149 (temporarily reduced from $199 through Dec 31, 2026); 5.5 mg $199 (temporarily reduced from $299 through Dec 31, 2026); 9 mg $299; 14.5 / 17.2 mg $299 (purchase offer, kept while each refill is within 45 days; regular price $349). Read 2026-10-03.
- Novo publishes NO cash price for Rybelsus, though it remains on sale.

## Insurance and coverage
- Manufacturer savings cards take up to $100/month off an insured copay. They do
  not set the price to $25, and every one excludes government beneficiaries.
- Medicare GLP-1 Bridge: Foundayo, Wegovy injection or tablet, and the Zepbound
  KwikPen at $50 per 30-day supply, since 1 July 2026, running to 31 Dec 2027.
- Standard Medicare Part D does not cover a GLP-1 for weight loss alone.
- 13 state Medicaid programmes covered GLP-1s for obesity under fee-for-service
  as of January 2026 (KFF). Diabetes coverage is effectively universal.
- Weight-loss drugs are usually an employer buy-in rather than an insurer
  default. Anthem's own formulary flags every anti-obesity GLP-1 "BE" (benefit
  exclusion) and neither diabetes GLP-1.
- The PBM owns the formulary: Aetna's answer is CVS Caremark's, Cigna's is
  Express Scripts', UnitedHealthcare's is Optum Rx's, Anthem's is CarelonRx's.

## Compounded medication
- Compounded semaglutide and tirzepatide are lawful and NOT FDA-approved.
- The FDA proposed on 30 April 2026 to exclude semaglutide, tirzepatide and
  liraglutide from the 503B bulks list, finding no clinical need. Comment
  comment period (extended once) closed 30 July 2026; determination pending.
- 2 of 22 tracked sellers carry LegitScript certification verifiable
  from LegitScript's own servers rather than a self-hosted image.
- Not one of the 22 tracked programs charges less for a smaller dose, so
  "microdosing" produces no saving at a compounded telehealth seller.

# 3. COMPLETE PROVIDER TABLE

Format: name | all-in price | cheapest product | plan term | membership fee | review score | what they dispense | certification | verification checks passed | last genuine read | price page | seller check

SnagRx | $69/mo all-in | Compounded Semaglutide | month to month | no fee | no usable review score | brand + compounded | LegitScript unverified | 7/10 checks verified | last read 2026-10-26 | https://pricetrackerglp1.com/p/snagrx | https://pricetrackerglp1.com/is-snagrx-legit
Embody | $69/mo all-in | Compounded Semaglutide | 12-month plan, $828 up front | no fee | 3.8/5 (9,145) | compounded only | LegitScript unverified | 8/10 checks verified | last read 2026-10-26 | https://pricetrackerglp1.com/p/embody | https://pricetrackerglp1.com/is-embody-legit
Collective | $75/mo all-in | Compounded Semaglutide | month to month | $16/mo fee | 4.7/5 (62) | compounded only | LegitScript verified | 9/10 checks verified | last read 2026-10-26 | https://pricetrackerglp1.com/p/collective | https://pricetrackerglp1.com/is-collective-legit
CoreAge Rx | $79/mo all-in | Compounded Semaglutide | month to month | no fee | 4.6/5 (2,626) | compounded only | LegitScript unverified | 8/10 checks verified | last read 2026-10-26 | https://pricetrackerglp1.com/p/coreage-rx | https://pricetrackerglp1.com/is-coreage-rx-legit
Sprout Health | $99/mo all-in | Compounded Semaglutide | 12-month plan, $1,188 up front | no fee | 3.9/5 (159) | compounded only | LegitScript unverified | 7/10 checks verified | last read 2026-10-26 | https://pricetrackerglp1.com/p/sprout-health | https://pricetrackerglp1.com/is-sprout-health-legit
bmiMD | $119/mo all-in | Compounded Semaglutide | 12-month plan, $1,428 up front | no fee | 4.4/5 (869) | brand + compounded | LegitScript unverified | 9/10 checks verified | last read 2026-10-15 | https://pricetrackerglp1.com/p/bmimd | https://pricetrackerglp1.com/is-bmimd-legit
Strut Health | $129/mo all-in | Semaglutide | month to month | no fee | no usable review score | compounded only | LegitScript unverified | 6/10 checks verified | last read 2026-10-26 | https://pricetrackerglp1.com/p/strut-health | https://pricetrackerglp1.com/is-strut-health-legit
Bodybuilding.com Health+ | $141/mo all-in | Compounded Semaglutide | 12-month plan, $1,698 up front | no fee | no usable review score | compounded only | LegitScript unverified | 6/10 checks verified | last read 2026-10-26 | https://pricetrackerglp1.com/p/bodybuilding-glp1 | https://pricetrackerglp1.com/is-bodybuilding-glp1-legit
Wellorithm | $147/mo all-in | Compounded Semaglutide | month to month | no fee | no usable review score | compounded only | LegitScript unverified | 7/10 checks verified | last read 2026-10-26 | https://pricetrackerglp1.com/p/wellorithm | https://pricetrackerglp1.com/is-wellorithm-legit
DudeMeds | $149/mo all-in | GLP-1 weight loss program (medication not itemized on site) | month to month | no fee | no usable review score | compounded only | LegitScript unverified | 7/10 checks verified | last read 2026-10-17 | https://pricetrackerglp1.com/p/dudemeds | https://pricetrackerglp1.com/is-dudemeds-legit
TMates | $158/mo all-in | Semaglutide | 12-month plan, $1,896 up front | no fee | no usable review score | compounded only | LegitScript unverified | 7/10 checks verified | last read 2026-10-15 | https://pricetrackerglp1.com/p/tmates | https://pricetrackerglp1.com/is-tmates-legit
ShedRx | $159/mo all-in | Compounded Semaglutide | 12-month plan, $1,908 up front | no fee | 4.7/5 (1,126) | brand + compounded | LegitScript unverified | 8/10 checks verified | last read 2026-10-26 | https://pricetrackerglp1.com/p/shedrx | https://pricetrackerglp1.com/is-shedrx-legit
Enhance MD | $169/mo all-in | Microdosing Tirzepatide | 12-month plan, $2,028 up front | no fee | 4.1/5 (159) | compounded only | LegitScript unverified | 8/10 checks verified | last read 2026-10-26 | https://pricetrackerglp1.com/p/enhance-md | https://pricetrackerglp1.com/is-enhance-md-legit
Found | $169/mo all-in | Compounded Semaglutide | 12-month plan, $2,028 up front | no fee | 4.2/5 (754) | brand + compounded | LegitScript unverified | 8/10 checks verified | last read 2026-10-26 | https://pricetrackerglp1.com/p/found | https://pricetrackerglp1.com/is-found-legit
Gala Health | $179/mo all-in | Compounded GLP-1 (yearly subscription) | 12-month plan, $2,148 up front | no fee | 4.6/5 (3,998) | compounded only | LegitScript unverified | 8/10 checks verified | last read 2026-10-26 | https://pricetrackerglp1.com/p/gala-health | https://pricetrackerglp1.com/is-gala-health-legit
Oak Longevity | $190/mo all-in | Compounded GLP-1 (semaglutide) | month to month | no fee | 4.4/5 (54) | compounded only | LegitScript unverified | 8/10 checks verified | last read 2026-10-26 | https://pricetrackerglp1.com/p/oak-longevity | https://pricetrackerglp1.com/is-oak-longevity-legit
SkinnyRx | $199/mo all-in | Compounded Semaglutide | month to month | no fee | 4.8/5 (5,340) | compounded only | LegitScript unverified | 7/10 checks verified | last read 2026-10-15 | https://pricetrackerglp1.com/p/skinnyrx | https://pricetrackerglp1.com/is-skinnyrx-legit
Sesame Care | $208/mo all-in | Foundayo (brand orforglipron) | month to month | $59/mo fee | 4.5/5 (4,406) | brand + compounded | LegitScript unverified | 9/10 checks verified | last read 2026-10-26 | https://pricetrackerglp1.com/p/sesame-care | https://pricetrackerglp1.com/is-sesame-care-legit
Lemonaid Health | $248/mo all-in | Compounded Semaglutide Microdoses | month to month | $49/mo fee | 4.3/5 (191) | brand + compounded | LegitScript verified | 8/10 checks verified | last read 2026-10-26 | https://pricetrackerglp1.com/p/lemonaid-health | https://pricetrackerglp1.com/is-lemonaid-health-legit
Direct Meds GLP-1 | $249/mo all-in | Sublingual Semaglutide | month to month | no fee | 4.6/5 (14,673) | compounded only | LegitScript unverified | 7/10 checks verified | last read 2026-10-26 | https://pricetrackerglp1.com/p/direct-meds | https://pricetrackerglp1.com/is-direct-meds-legit
MangoRx | $299/mo all-in | Slim (Compounded Oral Semaglutide) | month to month | no fee | no usable review score | compounded only | LegitScript unverified | 7/10 checks verified | last read 2026-10-03 | https://pricetrackerglp1.com/p/mango-rx | https://pricetrackerglp1.com/is-mango-rx-legit
Willow | $299/mo all-in | Compounded Semaglutide | month to month | no fee | 3.9/5 (360) | brand + compounded | LegitScript unverified | 9/10 checks verified | last read 2026-10-26 | https://pricetrackerglp1.com/p/willow | https://pricetrackerglp1.com/is-willow-legit

# 4. DRUG REFERENCE

## Ozempic (Semaglutide)
Ozempic is semaglutide approved for type 2 diabetes, not for weight loss. That one fact decides what you will pay for it, and whether you should be asking about it at all.
  - What it is approved for: Type 2 diabetes (for adults with type 2 diabetes, alongside diet and exercise, to improve blood sugar; weight loss is not its approved use*)
  - The weight-loss version: Wegovy (the same molecule from the same manufacturer, approved for chronic weight management, and the one insurers assess for that purpose)
  - Self-pay, new patients: $199/mo (for the first two fills at 0.25 and 0.5 mg through December 31, 2026, from the manufacturer directly*)
  - Self-pay after that: $349 to $499 ($349/mo at 0.25, 0.5 and 1 mg, $499/mo at 2 mg; the tablets self-pay at $149 to $299/mo by dose*)
  - With commercial cover: As low as $25 (with the savings offer, capped at $100/month of savings, when your plan covers it; government beneficiaries excluded*)
  - Manufacturer self-pay ladder: 0.25 / 0.5 mg $199/mo, 0.25 / 0.5 / 1 mg $349/mo, 2 mg $499/mo
  - Tracked page: https://pricetrackerglp1.com/meds/ozempic

## Zepbound (Tirzepatide)
Eli Lilly's tirzepatide for weight loss. It produced more weight loss than semaglutide in the only head-to-head trial of the two, and it is the most expensive way to buy the molecule.
  - The molecule: Tirzepatide (a dual GIP and GLP-1 receptor agonist: it works two appetite pathways rather than one)
  - Head-to-head result: 20.2% body weight (least-squares mean loss at 72 weeks in SURMOUNT-5, against 13.7% for semaglutide, across 751 adults*)
  - List price: $499 to $1,086 (per fill, the manufacturer's published wholesale acquisition cost; almost nobody pays this)
  - Self-pay by dose: $299 to $449 (the KwikPen bought direct with each refill within 45 days; miss the window, or buy vials, and it is $499 at 7.5 mg and $699 above)
  - With commercial cover: As low as $25 (for a one- or three-month supply of single-dose pens, when your plan covers it; government beneficiaries excluded*)
  - Manufacturer self-pay ladder: 2.5 mg $299/mo, 5 mg $399/mo, 7.5 mg $449/mo, 10 / 12.5 / 15 mg $449/mo
  - Tracked page: https://pricetrackerglp1.com/meds/zepbound

## Wegovy (Semaglutide)
Novo Nordisk's semaglutide for weight loss, now sold as both a weekly injection and a daily pill. The self-pay prices have moved twice this year, and one of the offers expires in days.
  - The molecule: Semaglutide (a GLP-1 receptor agonist, the same active ingredient as Ozempic)
  - Head-to-head result: 13.7% body weight (least-squares mean loss at 72 weeks in SURMOUNT-5, against 20.2% for tirzepatide, across 751 adults*)
  - Two forms: Pen or pill (a weekly injection at 0.25 to 2.4 mg, or a daily tablet; the pill self-pays cheaper than the pen)
  - Self-pay, pens: $349/mo standard ($199/mo for a new patient's first two fills through Dec 31, 2026, then $349; the 7.2 mg HD dose is $399*)
  - With commercial cover: As low as $25 (with the savings offer, subject to a maximum saving of $100/month, when your plan covers it*)
  - Manufacturer self-pay ladder: 0.25 / 0.5 mg $199/mo, 0.25 to 2.4 mg $349/mo, 7.2 mg (HD) $399/mo
  - Tracked page: https://pricetrackerglp1.com/meds/wegovy

## Compounded semaglutide (Semaglutide)
The same molecule as Wegovy and Ozempic, mixed by a pharmacy rather than made by Novo Nordisk. It is the cheapest route to semaglutide in the US, and the one with the most regulatory weather.
  - FDA status: Not FDA-approved (the FDA approves the branded product; a compounded copy is prepared by a pharmacy and is not reviewed for safety, effectiveness or quality)
  - The shortage is over: Resolved Feb 2025 (semaglutide is no longer on the FDA drug shortage list, and the enforcement discretion that let pharmacies compound it at scale has ended)
  - Where it stands now: Off the 503B bulks list (the FDA proposed on April 30, 2026 to exclude semaglutide permanently, finding no clinical need for outsourcing facilities to compound it from bulk)
  - The evidence: Belongs to the brand (semaglutide's trial results were produced with the branded product; no compounded version has a trial of its own)
  - What the molecule does: 13.7% body weight (least-squares mean loss at 72 weeks in SURMOUNT-5, the head-to-head trial against tirzepatide, using branded semaglutide*)

  - Tracked page: https://pricetrackerglp1.com/meds/compounded-semaglutide

## Compounded tirzepatide (Tirzepatide)
The molecule in Zepbound and Mounjaro, mixed by a pharmacy rather than made by Eli Lilly. It is the strongest GLP-1 in head-to-head trial data and the cheapest way to reach it, under the same regulatory cloud as compounded semaglutide.
  - FDA status: Not FDA-approved (the FDA approves the branded product; a compounded copy is prepared by a pharmacy and is not reviewed for safety, effectiveness or quality)
  - The shortage is over: Resolved Dec 2024 (tirzepatide is no longer on the FDA drug shortage list, and the enforcement discretion that let pharmacies compound it at scale has ended)
  - Where it stands now: Off the 503B bulks list (the FDA proposed on April 30, 2026 to exclude tirzepatide permanently, finding no clinical need for outsourcing facilities to compound it from bulk)
  - The evidence: Belongs to the brand (tirzepatide's trial results were produced with the branded product; no compounded version has a trial of its own)
  - What the molecule does: 20.2% body weight (least-squares mean loss at 72 weeks in SURMOUNT-5, beating semaglutide's 13.7% head to head across 751 adults, using branded tirzepatide*)

  - Tracked page: https://pricetrackerglp1.com/meds/compounded-tirzepatide

## Foundayo (Orforglipron)
Eli Lilly's once-daily oral GLP-1 pill, brand name for orforglipron. No injection, no refrigeration, and a launch price war already underway.
  - FDA status: Approved Apr 1, 2026 (for chronic weight management in adults with obesity, or overweight with weight-related conditions)
  - What it is: A once-daily pill (a small-molecule, non-peptide GLP-1 receptor agonist: the first oral GLP-1 built for weight loss at scale)
  - The convenience: No food or water rules (taken any time of day, with or without food, unlike oral semaglutide (Rybelsus) which requires fasting)
  - Doses: Six strengths (0.8, 2.5, 5.5, 9, 14.5, and 17.2 mg tablets; treatment starts low and titrates up)
  - The trial result: 11.2% body weight (average loss at the highest dose over 72 weeks in ATTAIN-1, vs 2.1% on placebo (NEJM, primary treatment-regimen estimand); 12.4% vs 0.9% by Lilly's efficacy estimand)
  - Trial scale: 3,127 adults (Phase 3, randomized, placebo-controlled, published in the New England Journal of Medicine)
  - Manufacturer self-pay ladder: 0.8 mg $149/mo, 2.5 mg $149/mo, 5.5 mg $199/mo, 9 mg $299/mo, 14.5 / 17.2 mg $299/mo
  - Tracked page: https://pricetrackerglp1.com/meds/foundayo

# 5. INSURANCE COVERAGE, VERIFIED BY INSURER

Format: insurer | drug | weight-loss verdict | type 2 diabetes | prior auth | benefit manager | checked | url

Aetna | Mounjaro | varies by plan (employer opt-in decides) | T2D: Yes, with PA | PA: Required | PBM: varies | checked 2026-10-04 | https://pricetrackerglp1.com/coverage/aetna/mounjaro
Aetna | Ozempic | generally not covered for weight loss | T2D: Yes, with PA | PA: Typical | PBM: varies | checked 2026-10-04 | https://pricetrackerglp1.com/coverage/aetna/ozempic
Aetna | Wegovy | varies by plan (employer opt-in decides) | T2D: Not indicated | PA: Required | PBM: varies | checked 2026-10-04 | https://pricetrackerglp1.com/coverage/aetna/wegovy
Aetna | Zepbound | varies by plan (employer opt-in decides) | T2D: Not indicated | PA: Required | PBM: varies | checked 2026-10-04 | https://pricetrackerglp1.com/coverage/aetna/zepbound
Anthem | Mounjaro | generally not covered for weight loss | T2D: Yes: Tier 2, PA | PA: Required | PBM: varies | checked 2026-09-02 | https://pricetrackerglp1.com/coverage/anthem/mounjaro
Anthem | Ozempic | generally not covered for weight loss | T2D: Yes: Tier 2, PA | PA: Required | PBM: varies | checked 2026-09-02 | https://pricetrackerglp1.com/coverage/anthem/ozempic
Anthem | Wegovy | varies by plan (employer opt-in decides) | T2D: Not indicated | PA: Required | PBM: varies | checked 2026-09-02 | https://pricetrackerglp1.com/coverage/anthem/wegovy
Anthem | Zepbound | varies by plan (employer opt-in decides) | T2D: Not indicated | PA: Required | PBM: varies | checked 2026-09-02 | https://pricetrackerglp1.com/coverage/anthem/zepbound
Blue Cross Blue Shield | Mounjaro | generally not covered for weight loss | T2D: Yes, with PA | PA: Typical | PBM: varies | checked 2026-09-02 | https://pricetrackerglp1.com/coverage/bcbs/mounjaro
Blue Cross Blue Shield | Ozempic | generally not covered for weight loss | T2D: Yes, with PA | PA: Typical | PBM: varies | checked 2026-09-02 | https://pricetrackerglp1.com/coverage/bcbs/ozempic
Blue Cross Blue Shield | Wegovy | varies by plan (employer opt-in decides) | T2D: Not indicated | PA: Required | PBM: varies | checked 2026-09-02 | https://pricetrackerglp1.com/coverage/bcbs/wegovy
Blue Cross Blue Shield | Zepbound | varies by plan (employer opt-in decides) | T2D: Not indicated | PA: Required | PBM: varies | checked 2026-09-02 | https://pricetrackerglp1.com/coverage/bcbs/zepbound
Cigna | Mounjaro | generally not covered for weight loss | T2D: Yes, with PA | PA: Required | PBM: varies | checked 2026-09-02 | https://pricetrackerglp1.com/coverage/cigna/mounjaro
Cigna | Ozempic | generally not covered for weight loss | T2D: Yes, with PA | PA: Typical | PBM: varies | checked 2026-09-02 | https://pricetrackerglp1.com/coverage/cigna/ozempic
Cigna | Wegovy | varies by plan (employer opt-in decides) | T2D: Not indicated | PA: Required | PBM: varies | checked 2026-09-02 | https://pricetrackerglp1.com/coverage/cigna/wegovy
Cigna | Zepbound | varies by plan (employer opt-in decides) | T2D: Not indicated | PA: Required | PBM: varies | checked 2026-09-02 | https://pricetrackerglp1.com/coverage/cigna/zepbound
FEP Blue (Federal Employee Program) | Wegovy | covered on published plans | T2D: Not indicated | PA: Required | PBM: varies | checked 2026-10-03 | https://pricetrackerglp1.com/coverage/fep-blue/wegovy
FEP Blue (Federal Employee Program) | Zepbound | excluded from the standard formulary | T2D: Not indicated | PA: Formulary exception | PBM: varies | checked 2026-10-03 | https://pricetrackerglp1.com/coverage/fep-blue/zepbound
Florida Blue | Wegovy | varies by plan (employer opt-in decides) | T2D: Not indicated | PA: Required | PBM: varies | checked 2026-10-03 | https://pricetrackerglp1.com/coverage/florida-blue/wegovy
Florida Blue | Zepbound | varies by plan (employer opt-in decides) | T2D: Not indicated | PA: Required | PBM: varies | checked 2026-10-03 | https://pricetrackerglp1.com/coverage/florida-blue/zepbound
Highmark | Wegovy | varies by plan (employer opt-in decides) | T2D: Not indicated | PA: Required | PBM: varies | checked 2026-10-03 | https://pricetrackerglp1.com/coverage/highmark/wegovy
Highmark | Zepbound | varies by plan (employer opt-in decides) | T2D: Not indicated | PA: Required | PBM: varies | checked 2026-10-03 | https://pricetrackerglp1.com/coverage/highmark/zepbound
Humana | Mounjaro | generally not covered for weight loss | T2D: Yes, with PA | PA: Typical | PBM: varies | checked 2026-09-02 | https://pricetrackerglp1.com/coverage/humana/mounjaro
Humana | Ozempic | generally not covered for weight loss | T2D: Yes, with PA | PA: Typical | PBM: varies | checked 2026-09-02 | https://pricetrackerglp1.com/coverage/humana/ozempic
Humana | Wegovy | generally not covered for weight loss | T2D: Not indicated | PA: Required | PBM: varies | checked 2026-09-02 | https://pricetrackerglp1.com/coverage/humana/wegovy
Humana | Zepbound | generally not covered for weight loss | T2D: Not indicated | PA: Required | PBM: varies | checked 2026-09-02 | https://pricetrackerglp1.com/coverage/humana/zepbound
Kaiser Permanente | Mounjaro | generally not covered for weight loss | T2D: Varies by region | PA: Typical | PBM: varies | checked 2026-09-02 | https://pricetrackerglp1.com/coverage/kaiser/mounjaro
Kaiser Permanente | Ozempic | generally not covered for weight loss | T2D: Varies by region | PA: Typical | PBM: varies | checked 2026-09-02 | https://pricetrackerglp1.com/coverage/kaiser/ozempic
Kaiser Permanente | Wegovy | varies by plan (employer opt-in decides) | T2D: Not indicated | PA: Required | PBM: varies | checked 2026-09-02 | https://pricetrackerglp1.com/coverage/kaiser/wegovy
Kaiser Permanente | Zepbound | varies by plan (employer opt-in decides) | T2D: Not indicated | PA: Required | PBM: varies | checked 2026-09-02 | https://pricetrackerglp1.com/coverage/kaiser/zepbound
Medi-Cal | Mounjaro | generally not covered for weight loss | T2D: Yes, with diagnosis code | PA: Diagnosis code on the prescription | PBM: varies | checked 2026-10-03 | https://pricetrackerglp1.com/coverage/medi-cal/mounjaro
Medi-Cal | Ozempic | generally not covered for weight loss | T2D: Yes, with diagnosis code | PA: Diagnosis code on the prescription | PBM: varies | checked 2026-10-03 | https://pricetrackerglp1.com/coverage/medi-cal/ozempic
Medi-Cal | Wegovy | excluded from the standard formulary | T2D: Not indicated | PA: Required (MASH, cardiovascular) | PBM: varies | checked 2026-10-03 | https://pricetrackerglp1.com/coverage/medi-cal/wegovy
Medi-Cal | Zepbound | excluded from the standard formulary | T2D: Not indicated | PA: Required (sleep apnea) | PBM: varies | checked 2026-10-03 | https://pricetrackerglp1.com/coverage/medi-cal/zepbound
TRICARE | Mounjaro | generally not covered for weight loss | T2D: Yes, with PA | PA: Required | PBM: varies | checked 2026-09-02 | https://pricetrackerglp1.com/coverage/tricare/mounjaro
TRICARE | Ozempic | generally not covered for weight loss | T2D: Yes, with PA | PA: Required | PBM: varies | checked 2026-09-02 | https://pricetrackerglp1.com/coverage/tricare/ozempic
TRICARE | Wegovy | covered on published plans | T2D: Not indicated | PA: Required | PBM: varies | checked 2026-09-02 | https://pricetrackerglp1.com/coverage/tricare/wegovy
TRICARE | Zepbound | covered on published plans | T2D: Not indicated | PA: Required | PBM: varies | checked 2026-09-02 | https://pricetrackerglp1.com/coverage/tricare/zepbound
UnitedHealthcare | Mounjaro | generally not covered for weight loss | T2D: Yes, with PA | PA: Required | PBM: varies | checked 2026-09-02 | https://pricetrackerglp1.com/coverage/unitedhealthcare/mounjaro
UnitedHealthcare | Ozempic | generally not covered for weight loss | T2D: Yes: Tier 2, PA | PA: Required | PBM: varies | checked 2026-09-02 | https://pricetrackerglp1.com/coverage/unitedhealthcare/ozempic
UnitedHealthcare | Wegovy | varies by plan (employer opt-in decides) | T2D: Not indicated | PA: Required | PBM: varies | checked 2026-09-02 | https://pricetrackerglp1.com/coverage/unitedhealthcare/wegovy
UnitedHealthcare | Zepbound | varies by plan (employer opt-in decides) | T2D: Not indicated | PA: Required | PBM: varies | checked 2026-09-02 | https://pricetrackerglp1.com/coverage/unitedhealthcare/zepbound
CVS Caremark | Wegovy | varies by plan (employer opt-in decides) | T2D: Not indicated | PA: Required | PBM: (this is the PBM) | checked 2026-10-08 | https://pricetrackerglp1.com/coverage/cvs-caremark/wegovy
CVS Caremark | Zepbound | varies by plan (employer opt-in decides) | T2D: Not indicated | PA: Required | PBM: (this is the PBM) | checked 2026-10-08 | https://pricetrackerglp1.com/coverage/cvs-caremark/zepbound
CVS Caremark | Foundayo | varies by plan (employer opt-in decides) | T2D: Not indicated | PA: Required | PBM: (this is the PBM) | checked 2026-10-08 | https://pricetrackerglp1.com/coverage/cvs-caremark/foundayo
CVS Caremark | Wegovy pill | varies by plan (employer opt-in decides) | T2D: Not indicated | PA: Required | PBM: (this is the PBM) | checked 2026-10-08 | https://pricetrackerglp1.com/coverage/cvs-caremark/wegovy-pill
CVS Caremark | Ozempic | generally not covered for weight loss | T2D: Yes, with step therapy or PA | PA: Typical (step therapy, PA if not met) | PBM: (this is the PBM) | checked 2026-10-08 | https://pricetrackerglp1.com/coverage/cvs-caremark/ozempic
CVS Caremark | Mounjaro | generally not covered for weight loss | T2D: Yes, with step therapy or PA | PA: Typical (step therapy, PA if not met) | PBM: (this is the PBM) | checked 2026-10-08 | https://pricetrackerglp1.com/coverage/cvs-caremark/mounjaro
Express Scripts | Wegovy | varies by plan (employer opt-in decides) | T2D: Not indicated | PA: Required on Cigna-administered plans | PBM: (this is the PBM) | checked 2026-10-08 | https://pricetrackerglp1.com/coverage/express-scripts/wegovy
Express Scripts | Zepbound | varies by plan (employer opt-in decides) | T2D: Not indicated | PA: Required on Cigna-administered plans | PBM: (this is the PBM) | checked 2026-10-08 | https://pricetrackerglp1.com/coverage/express-scripts/zepbound
Express Scripts | Foundayo | varies by plan (employer opt-in decides) | T2D: Not indicated | PA: Required on Cigna-administered plans | PBM: (this is the PBM) | checked 2026-10-08 | https://pricetrackerglp1.com/coverage/express-scripts/foundayo
Express Scripts | Wegovy pill | varies by plan (employer opt-in decides) | T2D: Not indicated | PA: Required on Cigna-administered plans | PBM: (this is the PBM) | checked 2026-10-08 | https://pricetrackerglp1.com/coverage/express-scripts/wegovy-pill
Express Scripts | Ozempic | generally not covered for weight loss | T2D: Yes, with PA on Cigna plans (type 2 diabetes diagnosis) | PA: Required on Cigna employer plans | PBM: (this is the PBM) | checked 2026-10-08 | https://pricetrackerglp1.com/coverage/express-scripts/ozempic
Express Scripts | Mounjaro | generally not covered for weight loss | T2D: Yes, with PA on Cigna plans (type 2 diabetes diagnosis) | PA: Required on Cigna employer plans | PBM: (this is the PBM) | checked 2026-10-08 | https://pricetrackerglp1.com/coverage/express-scripts/mounjaro
Optum Rx | Wegovy | varies by plan (employer opt-in decides) | T2D: Not indicated | PA: Required | PBM: (this is the PBM) | checked 2026-10-08 | https://pricetrackerglp1.com/coverage/optum-rx/wegovy
Optum Rx | Zepbound | varies by plan (employer opt-in decides) | T2D: Not indicated | PA: Required | PBM: (this is the PBM) | checked 2026-10-08 | https://pricetrackerglp1.com/coverage/optum-rx/zepbound
Optum Rx | Foundayo | varies by plan (employer opt-in decides) | T2D: Not indicated | PA: Required | PBM: (this is the PBM) | checked 2026-10-08 | https://pricetrackerglp1.com/coverage/optum-rx/foundayo
Optum Rx | Wegovy pill | excluded from the standard formulary | T2D: Not indicated | PA: Required | PBM: (this is the PBM) | checked 2026-10-08 | https://pricetrackerglp1.com/coverage/optum-rx/wegovy-pill
Optum Rx | Ozempic | generally not covered for weight loss | T2D: Yes, with PA | PA: Required | PBM: (this is the PBM) | checked 2026-10-08 | https://pricetrackerglp1.com/coverage/optum-rx/ozempic
Optum Rx | Mounjaro | generally not covered for weight loss | T2D: Yes, with PA | PA: Required | PBM: (this is the PBM) | checked 2026-10-08 | https://pricetrackerglp1.com/coverage/optum-rx/mounjaro
Ambetter (Centene) | Wegovy | excluded from the standard formulary | T2D: Not indicated | PA: n/a | PBM: varies | checked 2026-10-08 | https://pricetrackerglp1.com/coverage/ambetter/wegovy
Ambetter (Centene) | Zepbound | excluded from the standard formulary | T2D: Not indicated | PA: n/a | PBM: varies | checked 2026-10-08 | https://pricetrackerglp1.com/coverage/ambetter/zepbound
Ambetter (Centene) | Ozempic | generally not covered for weight loss | T2D: Yes, with PA (Smart PA) for type 2 diabetes | PA: Required | PBM: varies | checked 2026-10-08 | https://pricetrackerglp1.com/coverage/ambetter/ozempic
Ambetter (Centene) | Mounjaro | generally not covered for weight loss | T2D: Yes, with PA (Smart PA) for type 2 diabetes | PA: Required | PBM: varies | checked 2026-10-08 | https://pricetrackerglp1.com/coverage/ambetter/mounjaro
Molina Healthcare | Wegovy | excluded from the standard formulary | T2D: Not indicated | PA: n/a | PBM: CVS Caremark | checked 2026-10-08 | https://pricetrackerglp1.com/coverage/molina/wegovy
Molina Healthcare | Zepbound | excluded from the standard formulary | T2D: Not indicated | PA: n/a | PBM: CVS Caremark | checked 2026-10-08 | https://pricetrackerglp1.com/coverage/molina/zepbound
Molina Healthcare | Ozempic | generally not covered for weight loss | T2D: Yes, with step therapy | PA: Step therapy required | PBM: CVS Caremark | checked 2026-10-08 | https://pricetrackerglp1.com/coverage/molina/ozempic
Molina Healthcare | Mounjaro | generally not covered for weight loss | T2D: Not on the Utah 2026 formulary; exception request needed | PA: n/a | PBM: CVS Caremark | checked 2026-10-08 | https://pricetrackerglp1.com/coverage/molina/mounjaro
FEHB (federal employees) | Wegovy | varies by plan (employer opt-in decides) | T2D: n/a | PA: Plan sets it; criteria must be public | PBM: varies | checked 2026-10-08 | https://pricetrackerglp1.com/coverage/fehb/wegovy
FEHB (federal employees) | Zepbound | varies by plan (employer opt-in decides) | T2D: n/a | PA: Plan sets it; criteria must be public | PBM: varies | checked 2026-10-08 | https://pricetrackerglp1.com/coverage/fehb/zepbound

# 6. QUESTIONS AND VERIFIED ANSWERS

Every answer below is published on the page named as its source, carries
FAQPage structured data there, and is re-verified when that page is.

### Get Ozempic online in 2026: prescription, pill and pen
Source: https://pricetrackerglp1.com/guides/get-ozempic-online (updated 2026-10-25)
Q: Can I get Ozempic online without a prescription?
A: No. Ozempic is prescription-only whether you pay cash or use insurance, and Novo's own pharmacy answers that question with a plain no. A licensed clinician, including one you see by video, has to review your health history and decide it is right for you. FDA lists a seller that skips that screening as a warning sign.

Q: Can a telehealth doctor prescribe Ozempic for weight loss?
A: They can, as an off-label prescription, because Ozempic is approved for type 2 diabetes, not weight loss. It is legal and the prescriber's call. The catch is payment: plans cover Ozempic for diabetes, and Novo's $25 card and its self-pay program both require a prescription for a use on the label, so an Ozempic script for weight alone qualifies for neither. Wegovy, the same molecule with a weight label, is the version Novo prices for that use.

Q: How much does Ozempic cost online without insurance?
A: From Novo's own Novocare program, by home delivery or local pickup, the pen is $199 a month for the first two fills at 0.25 or 0.5 mg if you are new (through 31 December 2026), then $349 a month up to 1 mg and $499 at 2 mg. The Ozempic pill is $149 at 1.5 mg, $199 at 4 mg and $299 at 9 mg. Self-pay does not count toward a deductible, and it needs a prescription for type 2 diabetes, Ozempic's labeled use.

Q: Is the Ozempic pill the same as Rybelsus?
A: Novo is replacing Rybelsus with the Ozempic pill and says the 1.5, 4 and 9 mg Ozempic tablets work similarly to Rybelsus 3, 7 and 14 mg with the same efficacy and safety. You need a new prescription to switch, and Novo says coverage stays the same as Rybelsus.

Q: What happened to NovoCare Pharmacy?
A: Novo now calls its direct service Novocare home delivery, with pharmacy services powered by BlinkRx, and its terms name a BlinkRx-affiliated pharmacy licensed in Idaho as the first pharmacy your prescription goes to. Your prescriber still sends the prescription to Novocare, and you can ask Novo to transfer it to a local pharmacy for pickup instead of delivery.

Q: Can I use the Ozempic savings card with Medicare?
A: No. Novo's $25 card excludes government beneficiaries. Novo does let government-insured patients pay its self-pay price outside their insurance, but nothing they pay that way counts toward their plan's out-of-pocket totals.

Q: How do I know an online pharmacy selling Ozempic is real?
A: Look it up in your state board of pharmacy's licence database; FDA links every state and says not to use a pharmacy that is not listed. A safe one always requires a prescription, gives a US address and phone number, and has a licensed pharmacist you can reach. Deep discounts on brand Ozempic are a warning sign.

### Who Qualifies for Wegovy or Zepbound? BMI Rules (2026)
Source: https://pricetrackerglp1.com/guides/wegovy-zepbound-eligibility (updated 2026-10-23)
Q: What BMI do you need for Wegovy?
A: For weight loss, a BMI of 30 or more, or 27 or more with at least one weight-related condition such as high blood pressure or high cholesterol. Those are the lines Wegovy's weight trials used. For its heart use, the trial took adults 45+ with a BMI of 27 or more and established heart disease. Its MASH liver use has no BMI requirement. Children 12 and older qualify for the injection at a BMI at or above the 95th percentile for age and sex.

Q: Who qualifies for Zepbound?
A: Adults with a BMI of 30 or more, or 27 or more with at least one weight-related condition such as high blood pressure, type 2 diabetes or high cholesterol, for weight loss. Zepbound is also approved for moderate to severe obstructive sleep apnea in adults with obesity; its trials used an AHI of 15 or more and a BMI of 30 or more. Zepbound is not established for anyone under 18.

Q: What are the Zepbound prescription requirements?
A: A prescription from a licensed prescriber who finds that you meet the label: adult, with obesity, or overweight plus a weight-related condition, or with obesity and moderate to severe sleep apnea. You should not take it with a personal or family history of medullary thyroid cancer or MEN 2, or during pregnancy. Insurance adds its own requirements, often a higher BMI, a weight program and a prior authorization.

Q: Can I get Wegovy with a BMI of 27?
A: Yes, if you also have a weight-related condition, such as high blood pressure or high cholesterol, or if you have established heart disease such as a prior heart attack or stroke. Without a condition, the line is BMI 30. Many insurance plans set their own line higher, and Medicare's Bridge accepts BMI 27 only with prediabetes, a past heart attack or stroke, or symptomatic peripheral artery disease.

Q: Does type 2 diabetes count as a weight-related condition for Wegovy or Zepbound?
A: Yes. FDA named type 2 diabetes among the example conditions when it approved Zepbound for weight management. Two exceptions sit in the coverage rules: Aetna's heart-risk criteria for Wegovy require that you do not have type 2 diabetes, and Medicare's Bridge excludes people with type 2 diabetes, whose Part D plan may cover a GLP-1 for diabetes instead.

Q: Why does my insurance require a BMI of 35 for Wegovy?
A: Because your employer or plan chose a stricter design than the FDA label. Aetna publishes a BMI 35 policy for Wegovy, Zepbound and Foundayo that also asks for six months in a weight program, and Blue Cross Blue Shield of Michigan applies BMI 35 to its large group, fully insured members. Ask HR or the insurer which policy your plan uses; some designs follow the label's 30 and 27 instead.

Q: Do I still qualify if I lost weight on a GLP-1 I paid for myself?
A: Usually, yes. Medicare's Bridge applies its BMI tiers to your BMI when you started GLP-1 therapy, and Aetna tells its reviewers to use the baseline BMI from the start of any weight-loss drug therapy. Keep a dated record of your starting weight from a visit note or intake form.

Q: Who qualifies for Wegovy or Zepbound on Medicare?
A: Through the Medicare GLP-1 Bridge, people 18 or older with Part D coverage and a BMI of 35 or more, or 30 or more with heart failure with preserved ejection fraction, uncontrolled high blood pressure or stage 3a+ kidney disease, or 27 or more with prediabetes, a previous heart attack or stroke, or symptomatic peripheral artery disease. The copay is $50 a month. Wegovy for heart disease and Zepbound for sleep apnea go through Part D instead.

Q: Can a teenager get Wegovy or Zepbound?
A: Wegovy injection is approved for children 12 and older with obesity; its pediatric trial enrolled pubertal patients with a BMI at or above the 95th percentile for age and sex. The Wegovy tablets and Zepbound are not established for anyone under 18.

Q: Do I need a sleep study to get Zepbound for sleep apnea?
A: In practice, yes. The sleep apnea use is for moderate to severe obstructive sleep apnea, which the trials defined as an AHI of 15 or more, a number that only a sleep study produces. Aetna's policy, for example, asks for an AHI of at least 15 on an in-lab or home sleep test and a current BMI of 30 or more.

Q: How do I calculate my BMI for a GLP-1 prescription?
A: Multiply your weight in pounds by 703, then divide by your height in inches squared. At 5 ft 6 in (66 inches), 186 lb gives a BMI of 30.0 and 168 lb gives 27.1. Use a measured height and weight from the day, because a result like 29.95 counts as under 30 on a policy that says 30 or more.

### GLP-1 for fatty liver (2026): Wegovy MASH result, 63% vs 34%
Source: https://pricetrackerglp1.com/guides/glp1-liver-disease (updated 2026-10-21)
Q: Is Ozempic approved for fatty liver disease?
A: No. Ozempic's label covers blood sugar in type 2 diabetes, heart risk and a kidney use. The semaglutide brand approved for fatty liver is Wegovy injection, for noncirrhotic MASH with F2 to F3 fibrosis in adults.

Q: How well does Wegovy work for MASH?
A: In the ESSENCE trial at week 72, liver inflammation cleared without worse scarring in 62.9% on semaglutide 2.4 mg vs 34.3% on placebo, and scarring improved by at least one stage in 36.8% vs 22.4%. Those are biopsy results; the trial runs to 240 weeks to measure cirrhosis and other liver outcomes. Novo Nordisk funded it.

Q: Does tirzepatide (Zepbound or Mounjaro) help fatty liver?
A: In the phase 2 SYNERGY-NASH trial, MASH cleared without worse fibrosis in 44% to 62% on tirzepatide vs 10% on placebo at 52 weeks. It is not approved for the liver: neither Zepbound nor Mounjaro lists MASH. Lilly's phase 3 SYNERGY-Outcomes trial lists August 2030 for primary completion.

Q: Is the Wegovy pill approved for MASH?
A: No. The label says the safety of Wegovy tablets has not been established in patients with MASH. The MASH indication is for Wegovy injection only.

Q: Does Medicare cover Wegovy for fatty liver?
A: It can, through Part D. The Medicare GLP-1 Bridge excludes people with fatty liver disease, but Medicare.gov says their Part D plan might cover the GLP-1, and Part D can cover a GLP-1 used for an FDA-approved indication other than obesity. Your plan's formulary and prior authorization still apply.

Q: Is there a MASH drug that is not a GLP-1?
A: Yes. Rezdiffra (resmetirom), a daily tablet, is approved for the same noncirrhotic MASH with F2 to F3 fibrosis. In MAESTRO-NASH, MASH resolved in 25.9% to 29.9% vs 9.7% on placebo. Its label lists MASH, not weight loss.

### GLP-1 heart benefits (2026): 6 drugs with an FDA heart claim
Source: https://pricetrackerglp1.com/guides/glp1-heart-benefits (updated 2026-10-20)
Q: Do GLP-1 drugs protect the heart?
A: Some are proven to lower heart attack, stroke and cardiovascular death in the people they were tested in. Six brands carry that FDA indication: Wegovy, Ozempic, Rybelsus, Mounjaro, Trulicity and Victoza. Only Wegovy has it for people without diabetes, based on the SELECT trial.

Q: How much did Wegovy lower heart risk in the SELECT trial?
A: In 17,604 adults aged 45 or older with heart disease, overweight or obesity and no diabetes, a first heart attack, stroke or cardiovascular death occurred in 6.5% on semaglutide 2.4 mg and 8.0% on placebo, a hazard ratio of 0.80, over a median follow-up of 41.8 months. Novo Nordisk funded the trial.

Q: Is Ozempic approved to reduce heart attack risk?
A: Yes, for adults with type 2 diabetes and established cardiovascular disease, based on SUSTAIN 6 (hazard ratio 0.74). Ozempic also has a kidney indication in type 2 diabetes with chronic kidney disease that includes cardiovascular death. Without diabetes, the semaglutide brand with a heart indication is Wegovy.

Q: Does Zepbound or Mounjaro have heart benefits?
A: Mounjaro is approved to reduce heart events in adults with type 2 diabetes at high risk, after it matched Trulicity in SURPASS-CVOT (hazard ratio 0.92, not proven better). Zepbound has no heart indication; its obesity outcomes trial, SURMOUNT-MMO, lists October 2027 for results. In HFpEF heart failure, tirzepatide lowered worsening heart failure events in SUMMIT.

Q: Does compounded semaglutide have the same heart benefits?
A: Nobody has tested it. Every heart outcome trial used an approved brand, such as Wegovy in SELECT, and compounded semaglutide carries no FDA indication. It contains the same molecule, but the trial results belong to the brand products.

Q: Will Medicare pay for Wegovy for heart disease?
A: It can. Medicare cannot cover drugs used only for weight loss, but Part D plans can cover a GLP-1 used for an FDA-approved indication other than obesity, and KFF names cardiovascular disease risk reduction as one. Your plan's formulary and prior authorization rules still apply.

### Ozempic and Wegovy coupons (2026): what the $25 really means
Source: https://pricetrackerglp1.com/guides/glp1-copay-cards (updated 2026-10-20)
Q: How much is the Wegovy copay card?
A: Novo Nordisk advertises paying as little as $25 a month, subject to a maximum saving of $100 a month. The card reduces your copay by up to $100 on a one-month fill ($200 on a 2-month fill, $300 on a 3-month fill), so you reach $25 a month only if your copay is around $125 or less. Above that you pay your copay minus the cap.

Q: Why am I not paying $25 with the savings card?
A: Because the saving is capped. If your one-month copay is $400 the card brings it to $300, not to $25. The $25 figure describes the best case, which is a one-month copay of about $125 or less. Your plan may also run an accumulator, maximizer or alternate funding program, which Novo's terms exclude.

Q: Can I use a copay card with Medicare?
A: No. Novo's terms exclude anyone enrolled in Medicare, Medicaid, VA, DOD, TRICARE or a similar federal or state programme with drug coverage. Novo says government enrollees can pay its self-pay price outside their insurance, and for Wegovy the Medicare GLP-1 Bridge program charges $50 a month from July 1, 2026 to December 31, 2027.

Q: Does the copay card work if my insurance does not cover Wegovy or Ozempic?
A: Not as a copay card: there is no copay for it to reduce. Novo's terms direct people whose insurance does not cover Wegovy to its self-pay offer instead, which for the Wegovy pen is $199 a month for a new patient's first two low-dose fills through December 31, 2026, then $349 a month. Compare that with the cash programs on our board.

Q: Can I use the Ozempic copay card for weight loss?
A: Not if weight loss is the only reason it was prescribed. Novo's Ozempic terms require a prescription for an FDA-approved indication within Ozempic's labeling, and Ozempic is approved for type 2 diabetes. Wegovy, the same molecule labeled for weight management, has its own card.

Q: Is the copay card cheaper than paying cash?
A: Usually yes if it works for you: at $25 a month, it is below every semaglutide price on our board. It stops being the cheapest route if you are excluded, if your plan does not cover the drug so there is no copay to reduce, or if your copay minus the cap is still above the cash market.

Q: Do FEHB and ACA marketplace plans count as government insurance?
A: No. Novo's terms state that the Federal Employees Health Benefits Program, Affordable Care Act exchange plans and state employee plans are not federal or state government health care programs for this offer, so people on those plans can use the card if the drug is covered.

### Ozempic 6 week results (2026): what the data shows
Source: https://pricetrackerglp1.com/guides/ozempic-6-week-results (updated 2026-10-19)
Q: How much weight do you lose on Ozempic in 6 weeks?
A: No published trial reports Ozempic weight loss at exactly week 6. The nearest measured points: 5.0 kg on average after 12 weeks of semaglutide escalated to 1.0 mg in a 30-person trial, and 5.9% on average at three months in a Mayo Clinic cohort on Wegovy doses. At week 6 you are only two doses into 0.5 mg, so results are usually still early.

Q: What dose of Ozempic am I on at week 6?
A: On the label's schedule, 0.5 mg. Ozempic starts at 0.25 mg once weekly for 4 weeks, then goes to 0.5 mg, so week 6 is the second 0.5 mg dose. It can only rise to 1 mg after at least 4 weeks at 0.5 mg, and your prescriber may go slower.

Q: Why am I not losing weight on Ozempic after 4 weeks?
A: Weeks 1 to 4 are the 0.25 mg starter dose, which the label uses to limit stomach side effects, and each dose takes 4 to 5 weeks to reach steady levels in the blood. In a week-8 analysis of tirzepatide, 76.5% of people had lost less than 5% and still lost weight over the following year. Talk to your prescriber if you are concerned.

Q: Is nausea normal in the first 6 weeks of Ozempic?
A: It is common. In Ozempic's placebo-controlled trials, stomach side effects affected 32.7% of people on 0.5 mg vs 15.3% on placebo, and the label says most nausea, vomiting and diarrhea happened during dose escalation. Week 5, the first dose increase, falls inside that window.

Q: Do early results predict long-term results on a GLP-1?
A: Loosely. A 2026 review calls early on-treatment response the most actionable predictor available, and in a tirzepatide study people who lost 5% or more by week 8 lost more at week 52. But the slower group still lost weight, and the review says no single baseline characteristic reliably predicts response.

Q: How much does semaglutide cost?
A: On our board today the cheapest cash GLP-1 program is $69 a month, compounded semaglutide starts at $69, and the middle of the board is $158. A licensed clinician has to prescribe it, and compounded versions are not FDA approved.

### Wegovy & Ozempic Alternatives (2026): Cheaper Routes
Source: https://pricetrackerglp1.com/guides/wegovy-alternatives (updated 2026-10-19)
Q: What is the cheapest alternative to Wegovy?
A: Compounded semaglutide, the same active ingredient as Wegovy made by a licensed compounding pharmacy and sold through telehealth programs. Our board ranks every partner program's current price, read from the seller's own page. It is not FDA-approved: FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed.

Q: Is there a cheaper FDA-approved alternative to Wegovy?
A: Yes. The Wegovy pill is $149 a month at 1.5 mg, $199 at 4 mg and $299 at 9 mg and 25 mg through NovoCare Pharmacy, less than the pen at every dose. Lilly's Foundayo pill starts at $149 a month at its lowest dose. The Wegovy pen itself is $199 a month for the first two fills for new NovoCare self-pay patients, then $349 a month up to 2.4 mg.

Q: Is anything more effective than Wegovy?
A: In the head-to-head trial, tirzepatide was. In SURMOUNT-5, a 72-week trial of 751 adults with obesity, tirzepatide (Zepbound's molecule) reduced body weight by 20.2% and semaglutide (Wegovy's molecule) by 13.7%. Lilly sells Zepbound self-pay, priced by dose; its ladder is on this page.

Q: Is Ozempic an alternative to Wegovy?
A: It is the same drug, semaglutide, from the same maker, but its label is for type 2 diabetes, not weight loss. For someone with type 2 diabetes whose plan covers Ozempic it can be the cheapest route to semaglutide. Paying cash it is not cheaper: NovoCare charges $349 a month up to 1 mg after the two-month starter offer, and $499 for 2 mg.

Q: Is there a pill alternative to Wegovy?
A: Two. The Wegovy pill is oral semaglutide, $149 to $299 a month by dose through NovoCare Pharmacy. Foundayo is Lilly's orforglipron pill, from $149 a month at the lowest dose on self-pay. In Lilly's ATTAIN-1 trial, people on the highest Foundayo dose who stayed on treatment lost 12.4% of their body weight on average.

Q: What are the alternatives to Ozempic?
A: For weight loss: Wegovy, which is the same semaglutide on a weight-loss label, the Wegovy pill, Zepbound, Foundayo, or compounded semaglutide, which is not FDA-approved. For type 2 diabetes: the Ozempic pill, which NovoCare sells self-pay from $149 a month, or Mounjaro, Lilly's tirzepatide on the diabetes label. Your prescriber decides any switch.

Q: Is Mounjaro better than Ozempic for type 2 diabetes?
A: In SURPASS-2, a 40-week trial of 1,879 adults with type 2 diabetes funded by Lilly, all three tirzepatide doses lowered A1C more than Ozempic's 1 mg dose: 2.01 to 2.30 points against 1.86. Weight also fell 1.9 to 5.5 kg more on tirzepatide. The trial compared semaglutide 1 mg, not Ozempic's 2 mg dose.

Q: Is the Ozempic pill cheaper than the Ozempic pen?
A: Paying cash at NovoCare Pharmacy, the Ozempic pill has self-pay options starting at $149 a month. The pen is $199 a month for the first two fills for new self-pay patients, then $349 a month up to 1 mg and $499 for 2 mg. With insurance, your plan sets the cost of either.

### GLP-1 for binge eating (2026): what 25 trials show
Source: https://pricetrackerglp1.com/guides/glp1-binge-eating (updated 2026-10-18)
Q: Do GLP-1s like Ozempic help with binge eating?
A: Often, but it is not proven as a treatment. A July 2026 meta-analysis of 25 randomized trials reports moderate reductions in binge eating on GLP-1s, larger in people diagnosed with binge eating disorder, but it rated every trial at high risk or some concerns of bias. No GLP-1 is approved for the disorder.

Q: Is semaglutide approved for binge eating disorder?
A: No. The only FDA-approved medicine for binge eating disorder is lisdexamfetamine (Vyvanse). Semaglutide's evidence for binge eating is a 2023 retrospective study at one clinic, whose authors say its effects warrant further investigation. Wegovy is approved for weight reduction and cardiovascular risk, not binge eating.

Q: Does Mounjaro or Zepbound stop binge eating?
A: Nobody has tested it in a completed randomized trial yet. Johns Hopkins is recruiting 105 adults with obesity and binge eating disorder to compare tirzepatide with placebo and lisdexamfetamine, all alongside guided self-help cognitive behavioral therapy, with primary results listed for December 2027.

Q: What did the liraglutide binge eating trial show?
A: In a 17-week double-blind pilot of 27 adults with binge eating disorder, weekly binges fell by 4.0 on liraglutide 3.0 mg and 2.5 on placebo, not a significant difference. Remission was 44% vs 36%. Weight loss was clearly greater on liraglutide, 5.2% vs 0.9%.

Q: Are GLP-1s risky for people with eating disorders?
A: Specialists think they can be. A 2026 clinical review says experts are concerned GLP-1s may cause unintended harm or be misused by some people with eating disorders, and the 2026 meta-analysis reported higher dietary restraint on the drugs, noting it is unclear whether that restraint is harmful. Tell the prescriber about any history.

Q: How much does a GLP-1 cost without insurance?
A: On our board today the cheapest cash program is $69 a month, compounded semaglutide starts at $69, and the middle of the board is $158. A licensed clinician has to prescribe it, and compounded versions are not FDA approved.

### Ozempic Coupon (2026): As Little as $25 for Up to 3 Months
Source: https://pricetrackerglp1.com/guides/ozempic-coupon (updated 2026-10-18)
Q: How long does the Ozempic $25 coupon last?
A: Novo's savings page says that with commercial insurance you pay as little as $25 per month for up to 3 months, subject to a maximum saving of $100 a month. The full terms separately say an activation is valid for up to 48 months from enrollment, without explaining how the two fit, so ask the program what your fourth month will cost.

Q: Can I use the Ozempic coupon if I am taking it for weight loss?
A: Not under Novo's terms. The savings offer is only for patients prescribed Ozempic for an FDA-approved indication within its labeling, and NovoCare Pharmacy's cash program has the same condition. Ozempic's label covers type 2 diabetes, not weight management, so an off-label weight-loss prescription qualifies for neither. Wegovy is the semaglutide Novo prices for weight.

Q: How much does the Ozempic coupon save on a 90-day fill?
A: Up to $300. Novo's terms cap savings at $100 per 1-month, $200 per 2-month and $300 per 3-month prescription, with a pen month defined as 28 days. The 3-month $25 offer needs a prescription written and dispensed for 3 months and a plan that covers a 3-month fill.

Q: Can I use GoodRx and the Ozempic savings card together?
A: No. Novo's terms say the savings offer cannot be combined with any other coupon, self-pay discount, certificate, voucher or similar offer, and cash discount cards are not valid as primary insurance under it. Its NovoCare Pharmacy cash program also excludes prescription savings cards. Pick one route.

Q: Does an FEHB, ACA marketplace or state employee plan count as government insurance for the Ozempic card?
A: No. Novo states that the Federal Employees Health Benefits Program, Affordable Care (Health Exchange) plans and state employee plans are not government programs for this offer. But anyone with both a commercial and a government plan is treated as having government insurance, so the card does not apply.

Q: Is there an Ozempic pill, and what does it cost without insurance?
A: Yes. Novo lists Ozempic tablets alongside the pen. Its self-pay terms price a 30-tablet bottle at $149 for 1.5 mg, $199 for 4 mg and $299 for 9 mg, with 2- and 3-month fills at exactly two and three times those prices.

Q: Can I use an Ozempic coupon with Medicare?
A: No. Government beneficiaries are excluded, which covers Medicare and Medicaid. Novo does let them pay its self-pay price outside insurance, but that spending does not count toward a deductible. If you are taking Ozempic for type 2 diabetes, ordinary Medicare Part D coverage is usually the better route.

Q: How much is Ozempic without insurance?
A: Novo publishes $349 a month for 0.25, 0.5 and 1 mg, and $499 a month for 2 mg, with $199 for each of a new patient's first two fills of 0.25 or 0.5 mg through 31 December 2026. A 3-month fill is $1,047, or $1,497 at 2 mg. Novo says the pricing will be updated after 31 December 2026.

Q: Who counts as a new patient for the $199 Ozempic price?
A: Through the savings offer: someone who has not used an Ozempic savings offer in the past 365 days, with the fill by 31 December 2026. Through NovoCare Pharmacy: someone who has never filled an Ozempic injection there, with the prescription written and received by 31 December 2026 and shipped by 31 January 2027. It covers the first two 28-day fills only.

### Ozempic teeth (2026): what GLP-1s can do to your mouth
Source: https://pricetrackerglp1.com/guides/ozempic-teeth (updated 2026-10-17)
Q: Does Ozempic damage your teeth?
A: Not directly, as far as anyone has shown. No GLP-1 label lists tooth damage, and an October 2026 Journal of Dental Research review says no prospective study has used a dental outcome as an endpoint. The risk dentists describe is indirect: vomiting and reflux put stomach acid on enamel, and dry mouth removes saliva's protection against decay. The review calls that risk plausible but unquantified.

Q: Can Ozempic or Mounjaro cause dry mouth?
A: It is reported. Zepbound's label, which shares Mounjaro's molecule, lists dry mouth or dry throat in 1% of patients vs 0.1% on placebo. For semaglutide, a 2023 case series described 3 patients with low saliva, and FDA adverse event reports show a significant signal. The ADA now lists GLP-1 receptor agonists among medicines that can contribute to oral dryness.

Q: Should I brush my teeth right after vomiting on a GLP-1?
A: The ADA advises against brushing immediately after vomiting. It says to rinse with water, a sodium bicarbonate (baking soda) rinse or milk instead, and to brush with a soft-bristle brush and fluoride toothpaste. That advice is for acid exposure in general; there is no GLP-1-specific dental guidance yet.

Q: How common are dental problems on semaglutide or tirzepatide?
A: Nobody knows, because no study has measured teeth in people starting these drugs. What is measured is the stomach side effects: on Wegovy, 25% of trial participants reported vomiting vs 6% on placebo, and reflux disease was more common than on placebo. Most of it happened while the dose was being raised.

Q: Are GLP-1s bad for your gums?
A: The early evidence leans the other way. An October 2026 dental review says preclinical studies consistently show anti-inflammatory and bone-protective effects on gum tissue, and a 2026 health-record study recorded less periodontitis and fewer tooth extractions on tirzepatide than on other GLP-1s. Neither is a prospective trial in people starting the drug.

Q: How much does a GLP-1 cost?
A: On our board today the cheapest cash program is $69 a month, compounded semaglutide starts at $69, and the middle of the board is $158. A licensed clinician has to prescribe it, and compounded versions are not FDA approved.

### Wegovy coupon (2026): the $25 card, its $100 cap, cash
Source: https://pricetrackerglp1.com/guides/wegovy-coupon (updated 2026-10-17)
Q: How much is the Wegovy coupon worth?
A: Up to $100 on a 1-month fill, $200 on a 2-month fill and $300 on a 3-month fill. Novo's terms say you may pay as little as $25, subject to those caps, so on a monthly fill you reach $25 only if your copay is roughly $125 or less. On a $400 monthly copay the card brings you to $300.

Q: Why is my Wegovy savings card not giving me $25?
A: Usually because the saving is capped at $100 a month, so a $250 copay leaves you paying $150. The other common reason is an accumulator or maximizer plan: Novo's terms say patients on those plans are not eligible and should not use the card.

Q: Can I use the Wegovy savings card with FEHB or an ACA plan?
A: Yes, if the plan covers Wegovy. Novo's terms state that FEHB, ACA marketplace (Health Exchange) plans and state employee plans are not government health care programmes for the purposes of the savings offer. Medicare, Medicaid, VA, DOD and TRICARE are excluded.

Q: Can I use a Wegovy coupon with Medicare?
A: No. Medicare and Medicaid are excluded from the savings card. On Medicare the GLP-1 Bridge is the route: Novo says it covers all doses of the Wegovy pen and pill for $50 a month, runs from 1 July 2026 to 31 December 2027 and needs no enrolment, though you must be on Part D and CMS decides eligibility.

Q: Is there a Wegovy coupon if I have no insurance?
A: The copay card does not apply without coverage. Novo sells Wegovy for cash instead: a new patient pays $199 a month for the first two pen fills at 0.25 mg and 0.5 mg (filled by 31 December 2026), then $349 a month for doses up to 2.4 mg and $399 for the 7.2 mg pen. The tablet is $149 to $299 by strength.

Q: Is GoodRx cheaper than the Wegovy savings card?
A: They do different jobs and cannot be stacked: Novo's terms say the savings offer cannot be combined with any other coupon, self-pay discount or similar offer. GoodRx negotiates a cash price; the manufacturer card reduces an insured copay and can reach $25. With commercial coverage the manufacturer card is usually stronger. Paying cash, compare any discount card with Novo's own $149 to $399 and with the compounded programs on our board.

Q: Can I get the Wegovy card savings on a mail-order fill?
A: Yes, by reimbursement. Send Novo's reimbursement form with the card details, the original pharmacy receipt and a copy of your insurance card within 180 days of the fill, and allow 6 to 8 weeks. Medication filled before you enrolled in the savings offer cannot be reimbursed.

### GLP-1 before surgery (2026): stop it or keep taking it?
Source: https://pricetrackerglp1.com/guides/glp1-before-surgery (updated 2026-10-16)
Q: Do I need to stop Ozempic, Wegovy or Zepbound before surgery?
A: Usually not, under the current guidance. In October 2024 five societies, including the American Society of Anesthesiologists, said most patients should continue their GLP-1 before elective surgery. People early in their dose increases, on a higher dose, or with nausea, vomiting or bloating may be asked to follow a liquid diet for 24 hours, have a stomach ultrasound or delay the procedure. Your surgical team decides.

Q: How long before surgery should I stop a GLP-1?
A: There is no single number in the current guidance. The ASA's 2023 advice was to hold a weekly GLP-1 for a week before and a daily one on the day of surgery; the 2024 multi-society guidance replaced that with continuing the drug for most people and extra steps for those at highest risk. Follow the instructions your own team gives you.

Q: Why does a GLP-1 matter for anesthesia?
A: GLP-1 medicines slow stomach emptying, so food can still be in the stomach after a normal fast. Under general anesthesia or deep sedation, that food can be inhaled into the lungs. Every GLP-1 label describes rare reports of this in people who had fasted as instructed, and asks patients to tell their healthcare providers before any planned surgery or procedure.

Q: Do I need to stop Ozempic before a colonoscopy or endoscopy?
A: The 2024 guidance covers endoscopy as well as surgery, and it does not ask most patients to stop. A 2025 meta-analysis reported that GLP-1 users had more food left in the stomach and more procedures stopped early, but no significant difference in aspiration pneumonia. Ask the endoscopy unit whether they want a longer clear-liquid period, and tell them your dose and when you last increased it.

Q: What happens if I miss doses of Wegovy around surgery?
A: The Wegovy label says that if 2 or more consecutive weekly doses of the injection are missed, the dose escalation is restarted at a lower dose to reduce stomach side effects. One missed dose follows the ordinary missed-dose rule. Agree the restart date and dose with your prescriber before the procedure.

Q: How much does a GLP-1 cost?
A: On our board today the cheapest cash program is $69 a month, compounded semaglutide starts at $69, and the middle of the board is $158. A licensed clinician has to prescribe it, and compounded versions are not FDA approved.

### 503A vs 503B pharmacies (2026): who makes compounded GLP-1s
Source: https://pricetrackerglp1.com/guides/503a-vs-503b-pharmacies (updated 2026-10-15)
Q: What is the difference between a 503A and a 503B pharmacy?
A: A 503A pharmacy is a state-licensed pharmacy that compounds a drug for one named patient on a valid prescription, overseen mainly by its state board of pharmacy. A 503B outsourcing facility registers with FDA every year, manufactures under current good manufacturing practice (cGMP), is inspected by FDA on a risk-based schedule and may make batches for clinics without a prescription for each unit. Neither makes FDA-approved drugs.

Q: What is a 503B pharmacy?
A: Strictly, a 503B outsourcing facility, a category created by the Drug Quality and Security Act on 27 November 2013. It is a facility at one address that compounds sterile drugs, registers with FDA, follows cGMP and reports its products to FDA every June and December. It does not have to be a licensed pharmacy under federal law. FDA's registered list held 98 facilities when we read it on 14 October 2026.

Q: Is a 503B pharmacy FDA-approved?
A: No. A 503B facility is FDA-registered and FDA-inspected, but the drugs it makes are not FDA-approved: FDA does not review compounded drugs for safety, effectiveness or quality before they are sold. Registration means FDA knows the facility exists and inspects it; it is not an approval of any product.

Q: Who makes compounded semaglutide?
A: Two kinds of compounder: 503A pharmacies filling individual prescriptions, and 503B outsourcing facilities. FDA's compounded-product records show 14 registered 503B facilities reporting compounded semaglutide in the first-half 2025 reports and 2 in the first-half 2026 reports. 503A pharmacies report nothing to FDA, so there is no public count of them; ask your program for the name of the pharmacy that fills yours.

Q: Can compounding pharmacies still make semaglutide and tirzepatide in 2026?
A: Within limits. Neither drug is on FDA's shortage list or the 503B bulks list, so 503B facilities cannot compound them from bulk ingredients. 503A pharmacies may fill individual prescriptions but not routine copies of the brand, unless a prescriber documents a significant difference for that patient; FDA has said it will not act on four or fewer copy prescriptions a month.

Q: Did FDA ban 503B facilities from compounding GLP-1s?
A: Not by a final rule yet. On 30 April 2026 FDA proposed excluding semaglutide, tirzepatide and liraglutide from the 503B bulks list, and the comment period was extended to 30 July 2026. When we checked the Federal Register on 15 October 2026 no final notice had been published. In practice 503B facilities already cannot use bulk semaglutide or tirzepatide, because neither drug is on the bulks list or the shortage list.

Q: Is Empower Pharmacy 503A or 503B?
A: Both. Empower describes itself as running a 503A pharmacy and a 503B outsourcing facility, and FDA's registered outsourcing facility list includes Empower Pharma in Houston, Texas and Empower Clinic Services New Jersey in East Windsor, New Jersey. Your vial label tells you which one filled your order.

Q: Is Olympia Pharmacy a 503B?
A: Olympia runs both: it describes itself as a 503A compounding pharmacy and an FDA-registered 503B outsourcing facility, and FDA's list includes Olympia Pharmaceuticals in Orlando, Florida. In FDA's first-half 2026 product reports, its GLP-1 entry is liraglutide, not semaglutide or tirzepatide.

Q: Are Strive Pharmacy and Hallandale Pharmacy 503A or 503B?
A: Hallandale describes itself as a 503A designated pharmacy with PCAB accreditation. Strive says all its compounded medications need a patient-specific prescription and lists locations in six states. Neither had a facility on FDA's registered outsourcing facility list when we checked on 14 October 2026.

Q: How do I know which pharmacy made my compounded GLP-1?
A: Read the label. A 503B label must say it is a compounded drug and give the facility's name, address and phone number, the date compounded and the NDC if assigned. A 503A label is a prescription label with your name, the pharmacy and an Rx number. Then ask your program which pharmacy fills it and check that name on FDA's list or the state board's licence lookup.

Q: Is 503B safer than 503A?
A: Neither is approved, so neither carries FDA's product review. 503B adds cGMP manufacturing, routine FDA inspections and mandatory adverse-event reports; a 503A pharmacy works to pharmacy compounding standards under its state board. The facility, its record and the product matter more than the label category, which is why checking the pharmacy by name is the useful step.

### Generic Liraglutide Cost (2026): Saxenda and Victoza Generics
Source: https://pricetrackerglp1.com/guides/generic-liraglutide (updated 2026-10-15)
Q: Is there a generic liraglutide?
A: Yes. FDA has approved eight generics that reference Victoza (for type 2 diabetes) and three that reference Saxenda (for weight loss), and Teva sells an authorized generic of Victoza. The first true generic, Hikma's, was approved on 23 December 2024; the first Saxenda generic, Teva's, on 27 August 2025.

Q: How much does generic liraglutide cost?
A: Pharmacies pay about $738.72 for 30 days of the Saxenda-dose generic (3 mg a day) and about $275.69 for 30 days of the Victoza-dose generic at 1.8 mg, based on Medicaid's NADAC survey as of 14 October 2026. Your cash price will be higher by the pharmacy's markup. With insurance that covers it, you pay your plan's generic copay.

Q: Is there a generic Saxenda?
A: Yes. FDA approved Teva's generic of Saxenda on 27 August 2025, then Cipla's (made by Orbicular) and Biocon's on 24 February 2026. Teva reported in May 2026 that it is discontinuing its carton, so Cipla's and Biocon's are the ones in Medicaid's current price survey. All three carry FDA's AP2 code, meaning a pharmacist can fill a Saxenda prescription with them.

Q: Is there a generic Victoza?
A: Yes, and it is the more competitive of the two. Eight companies hold approvals for Victoza generics (Hikma, Meitheal's supplier Nanjing King-Friend, Lupin, Orbicular for Cipla, Biocon, Fresenius Kabi, Mylan Institutional and Sandoz), and Teva sells an authorized generic. Pharmacies pay about $30.63 per mL for the three-pen carton.

Q: Is Saxenda being discontinued?
A: Yes, in the US. Novo Nordisk says it is discontinuing Saxenda, with last shipments to wholesalers in late January 2027, and that the decision is not the result of any safety or quality concern. FDA's shortage database lists Saxenda as available in limited quantities until then. Generic liraglutide 3 mg remains available from other makers.

Q: Is there a liraglutide coupon card?
A: Not for new patients. Novo's Saxenda Savings Offer closed to new enrollees on 30 June 2023, and generic drugs rarely come with a manufacturer card. The ways to pay less are your insurance's generic copay, a pharmacy discount card, comparing the same carton across pharmacies, or a 90-day fill.

Q: Liraglutide vs semaglutide: which works better for weight loss?
A: In STEP 8, the only head-to-head trial, people on weekly semaglutide 2.4 mg lost 15.8% of body weight on average over 68 weeks, against 6.4% on daily liraglutide 3 mg. More people stopped liraglutide (27.6%) than semaglutide (13.5%). Which drug suits you is a decision for your prescriber.

Q: Is Saxenda cheaper than Mounjaro or Zepbound?
A: Not anymore. Pharmacies pay about $1,306.89 for 30 days of Saxenda and $675.43 for 28 days of a 15 mg tirzepatide KwikPen, according to NADAC as of 14 October 2026. That KwikPen is Zepbound at its top dose. Even generic liraglutide 3 mg, at $738.72, costs a pharmacy more per month than that KwikPen, and the weekly drugs produced more weight loss in their trials.

Q: Does insurance cover generic liraglutide for weight loss?
A: Sometimes. Plans that cover weight-loss drugs often cover the Saxenda generic, and may require it in place of the brand. Many plans exclude weight-loss drugs as a class, including Saxenda, and that exclusion usually reaches the generic too. Medicare's GLP-1 Bridge does not include liraglutide. For type 2 diabetes, most plans cover generic liraglutide.

Q: Can I use generic Victoza pens instead of Saxenda?
A: Not as a pharmacy substitution. FDA codes Victoza equivalents AP1 and Saxenda equivalents AP2, so a pharmacist fills each prescription from its own list, and the Victoza pen only delivers 0.6, 1.2 or 1.8 mg while the Saxenda pen goes to 3 mg. The dose and product are your prescriber's call.

Q: Is liraglutide still in shortage?
A: FDA's drug shortage database still lists liraglutide injection as currently in shortage, a listing first posted on 18 July 2023. As of October 2026 it shows several generic Victoza-type cartons as available, brand Victoza in limited supply from a shipping delay, and brand Saxenda in limited supply until its January 2027 discontinuation.

### Costco GLP-1 Price 2026: Sesame, Wegovy, CVS, Walmart
Source: https://pricetrackerglp1.com/guides/costco-glp1 (updated 2026-10-15)
Q: Does Costco sell GLP-1 drugs?
A: Yes, with a prescription. Since October 2025 Costco pharmacies have sold Wegovy and Ozempic to members paying cash, at Novo Nordisk's self-pay price. Costco does not sell any GLP-1 without a prescription, and it has no GLP-1 of its own.

Q: How much is Wegovy at Costco?
A: Wegovy launched at Costco at $499 for a four-week supply in October 2025, which was Novo Nordisk's self-pay price then. Novo's own pharmacy now charges $349 a month for Wegovy pens from 0.25 mg to 2.4 mg, with $199 for two intro months for new patients. Ask the Costco pharmacist to run Novo's self-pay option at your dose.

Q: How much is Ozempic at Costco without insurance?
A: Ozempic joined Costco at the same $499 launch price as Wegovy in October 2025. Novo Nordisk now lists Ozempic pens at $349 a month for 0.25 mg, 0.5 mg and 1 mg and $499 for 2 mg. Novo's self-pay programme requires a prescription for an FDA-approved use, which for Ozempic is type 2 diabetes.

Q: What is the Costco Sesame weight loss program?
A: In April 2024 Costco and Sesame launched a three-month weight-loss care bundle for members, with medication extra. Sesame's Costco page no longer lists it in October 2026; it lists primary care, therapy and lab bundles, plus 10% off other Sesame services. Sesame now sells its weight-loss plan to everyone at $59 a month on a 12-month term, plus the drug.

Q: Does Costco carry Zepbound at the self-pay price?
A: Lilly says its Zepbound KwikPen self-pay card works at major pharmacies nationwide, from $299 a month for 2.5 mg, but does not name the chains. We could not confirm a Costco Zepbound price. Ask the Costco pharmacy whether it accepts the KwikPen self-pay card; the card does not cover vials.

Q: Do I need a Costco membership to get Costco's GLP-1 price?
A: Yes for the Costco Member Prescription Program, which comes free with a membership and uses your card as the discount card. No for the drug's self-pay price itself, which Novo Nordisk sets and other pharmacies, including CVS and Walgreens, also process.

Q: Can I use the Costco prescription discount with insurance or Medicare?
A: No. Costco says you must choose its discount card or your insurance for a fill, it cannot be combined with any commercial, Medicare Part D or state plan, and other discount cards cannot be used alongside it. Money paid through the card does not count toward your plan's deductible.

Q: How much is Ozempic at CVS?
A: CVS says a GLP-1 can cost as little as $149 without insurance with a manufacturer voucher on qualifying drugs and doses, or $25 with commercial insurance and a coupon. For Ozempic pens, Novo's self-pay price is $349 a month for 0.25 mg to 1 mg and $499 for 2 mg. A CVS MinuteClinic online visit to get a prescription costs $29.

Q: How much does Ozempic cost at Walmart?
A: Walmart has not published its own Ozempic price that we could cite. Ask the pharmacist to run Novo Nordisk's self-pay option: $349 a month for Ozempic pens at 0.25 mg to 1 mg and $499 for 2 mg. Walmart's published GLP-1 deal is for Zepbound vials from LillyDirect, picked up in store, from $299 a month.

Q: How much is Ozempic at Walgreens?
A: Walgreens added Novo Nordisk's prices to its Rx Savings Finder in February 2026, at $149 for the Wegovy 1.5 mg or 4 mg tablet and $199 for starter pens. Novo's current Ozempic pen price is $349 a month, $499 for 2 mg. A Walgreens Weight Management visit costs $49, with no subscription.

Q: Is there a GLP-1 at Costco without a prescription?
A: No. Every dose of Wegovy and Ozempic requires a prescription, and so do Zepbound and Foundayo.

### LillyDirect vs NovoCare Pharmacy: Prices by Dose (2026)
Source: https://pricetrackerglp1.com/guides/lillydirect-vs-novocare (updated 2026-10-15)
Q: How much is Zepbound at LillyDirect?
A: Zepbound vials and the KwikPen cost $299 a month at 2.5 mg, $399 at 5 mg and $449 at 7.5, 10, 12.5 and 15 mg on LillyDirect, as long as each refill is bought within 45 days of your last delivery. Late refills cost $499 at 7.5 mg and $699 at 10 to 15 mg. Prices read at Lilly's own pages on 15 October 2026.

Q: How much is Wegovy at NovoCare Pharmacy?
A: NovoCare Pharmacy charges $349 a month for every Wegovy pen dose from 0.25 to 2.4 mg, $399 for Wegovy HD 7.2 mg, and $199 for a new patient's first two boxes at 0.25 or 0.5 mg (prescriptions written by 31 December 2026). The Wegovy pill costs $149 at 1.5 mg, $199 at 4 mg and $299 at 9 or 25 mg.

Q: What is Lilly's 45-day rule for Zepbound?
A: From 7.5 mg up, Lilly gives you the $449 price automatically on your first order and keeps it only if each refill is completed within 45 days of the date your previous order was delivered. Miss it and that month costs the regular price: $499 at 7.5 mg, $699 at 10, 12.5 or 15 mg. The clock starts at delivery, not at your last dose.

Q: Does NovoCare Pharmacy take insurance?
A: No. NovoCare Pharmacy is a cash, self-pay pharmacy, and its terms say insurance is not accepted. What you pay does not count toward your deductible or out-of-pocket limit. If your plan covers Wegovy, the Wegovy savings offer at a regular pharmacy can bring the copay as low as $25, with a $100 monthly cap.

Q: Can I use NovoCare or LillyDirect if I have Medicare?
A: NovoCare says government-insured patients may self-pay outside their insurance. Lilly's savings card terms exclude government beneficiaries, so ask LillyDirect at checkout. Since 1 July 2026, Medicare's GLP-1 Bridge charges $50 a month for Wegovy (pen or pill), Foundayo and the Zepbound KwikPen, but not Zepbound vials, if you meet the criteria.

Q: Is Zepbound cheaper than Wegovy if I pay cash?
A: Only at the start. Zepbound's 2.5 mg month is $299 against Wegovy's $349 standard price (or $199 for a new patient). From the second strength up, Wegovy at NovoCare costs $349 a month against Zepbound's $399 and $449, and Wegovy HD is $399. A late Zepbound refill at 10 mg or above costs $699.

Q: Does LillyDirect sell the Zepbound KwikPen or only vials?
A: Both. Since 23 February 2026, LillyDirect sells the four-dose Zepbound KwikPen and single-dose vials at the same self-pay prices. The KwikPen can also be bought at major retail pharmacies at the same price with Lilly's KwikPen Self-Pay Savings Card; vials stay with LillyDirect and its Walmart pickup.

Q: Is shipping free from LillyDirect and NovoCare?
A: Yes. Lilly says medicines filled through LillyDirect ship free of charge, and NovoCare says its shipping and delivery are free. Both also offer pickup: Walmart pharmacies for LillyDirect vials, and a transfer to your local pharmacy for NovoCare.

Q: Who fills NovoCare Pharmacy orders?
A: Novo works through licensed partner pharmacies. CoAssist Pharmacy takes in the prescription, and orders may be filled by CenterWell Pharmacy or a pharmacy in the BlinkRx network, which is licensed in all 50 states, the District of Columbia and Puerto Rico. Expect texts from those names.

Q: Can I use HSA or FSA money at NovoCare Pharmacy?
A: Yes. NovoCare Pharmacy accepts credit cards, Apple Pay, Google Pay and FSA or HSA cards. The purchase still does not count toward your insurance deductible.

Q: Is compounded tirzepatide cheaper than LillyDirect?
A: Usually. Compounded tirzepatide on our board starts at $85 a month all in, with the prescriber included, against LillyDirect's $299 to $449 for Zepbound. Compounded drugs are not FDA-approved, and the FDA does not review them for safety, effectiveness or quality before they are sold.

### Ozempic, Wegovy, Zepbound Cost With Insurance (2026)
Source: https://pricetrackerglp1.com/guides/glp1-cost-with-insurance (updated 2026-10-15)
Q: How much is Ozempic with insurance?
A: On a commercial plan that covers it with a flat copay, Ozempic usually costs $25 a month with the maker's savings card, which pays up to $100 of your share. On a coinsurance plan you pay a percentage of the $1,027.51 list price: at 25% that is $256.88, or $156.88 after the card. Before your deductible is met, one fill can cost up to about $928 after the card.

Q: What is the Ozempic copay with insurance?
A: It is your plan's brand-drug copay. KFF's 2025 survey of employer plans puts the average at $40 on the preferred tier, $71 on the non-preferred tier and $123 on a fourth tier. Then the Ozempic Savings Offer, which pays up to $100 of your share, brings it to $25 a month. That works for any copay up to $125. Government plans cannot use the offer.

Q: How much does Zepbound cost with insurance?
A: With a plan that covers the single-dose pen, the Zepbound card brings it to as little as $25 a month, paying up to $100 a month and $1,300 a year. On 25% coinsurance your share of the up to $1,086.37 list price is $271.59, or $171.59 after the card. If your plan does not cover it, the card's price for the single-dose pen is as low as $499, and the KwikPen self-pay starts at $299 for 2.5 mg.

Q: How much does Wegovy cost with insurance?
A: $25 a month on a copay plan that covers it, with the savings card. On 25% coinsurance your share of the $1,349.02 list price is $337.26, or $237.26 after the card's $100. Before the deductible is met, a fill can cost up to $1,249.02 after the card. For many coinsurance and high-deductible members the maker's self-pay price of $199 for two fills, then $349, costs less.

Q: How much is Mounjaro with insurance?
A: For type 2 diabetes on a plan that covers it, as little as $25 a month with the Mounjaro card, which pays up to $150 a month and $1,950 a year. At 25% coinsurance your share of the $1,112.16 list price is $278.04, or $128.04 after the card. The card requires an approved use, so a Mounjaro prescription for weight loss does not qualify.

Q: Why is my GLP-1 so expensive even with insurance?
A: Almost always one of three reasons: you have not met your deductible, so you are paying up to the full list price; your plan charges coinsurance, a percentage of a list price above $1,000; or your prior authorization lapsed, so the pharmacy charged cash. The savings card takes only $100 to $150 off your share, so it cannot fix a large share.

Q: Does the GLP-1 savings card count toward my deductible?
A: The makers intend it to. Novo's Wegovy terms say savings are meant to be credited toward your copays, coinsurance and deductibles. But some plans run accumulator programs that stop card money counting, and Novo says you may not use its card on those plans. Ask your insurer directly whether manufacturer copay assistance counts toward your deductible and out-of-pocket maximum.

Q: Is it cheaper to pay cash for Wegovy or Zepbound than to use insurance?
A: Sometimes. In months when your deductible is open, cash almost always wins: one covered fill can cost over $900 even after the card. We also worked a full plan year on a $2,000 deductible and 25% coinsurance. Wegovy was the one drug of the four where the maker's self-pay prices beat the plan over the year; Zepbound, Ozempic and Mounjaro cost less through the plan. Cash does not count toward your deductible.

Q: What tier are Ozempic, Wegovy and Zepbound on?
A: It depends on your plan's formulary. Brand GLP-1s usually sit on the preferred-brand tier when your pharmacy benefit manager has a deal with the maker, and on a non-preferred or specialty tier when it does not. CVS Caremark, for example, made Zepbound a preferred option on its commercial template formularies from 1 October 2026. Check your plan's drug list or the PBM's price tool.

Q: Will Ozempic and Wegovy cost less with insurance in 2027?
A: For coinsurance and high-deductible plans, yes. Novo cuts the list price of Wegovy, Ozempic and Rybelsus to $675 a month from 1 January 2027, about half off Wegovy and a third off Ozempic, and costs on those plan designs follow list price. On a flat copay nothing changes. Novo says self-pay prices are not affected.

Q: Can I use a GLP-1 savings card with Medicare or Medicaid?
A: No. The Ozempic, Wegovy, Zepbound and Mounjaro cards exclude Medicare, Medicaid, TRICARE, VA and other government plans. Eligible people with Medicare Part D can get Wegovy, Foundayo or the Zepbound KwikPen through the Medicare GLP-1 Bridge at a $50 monthly copayment.

### Wegovy cost in 2026: pen vs pill, with and without insurance
Source: https://pricetrackerglp1.com/guides/wegovy-cost (updated 2026-10-15)
Q: How much does Wegovy cost with insurance?
A: With a commercial plan that covers it, as little as $25 a month using Novo's savings card, which is capped at $100 of savings per month, so a $200 copay becomes $100. Prior authorisation is usual. Government plans are excluded from the card; Medicare members instead pay $50 per 30-day supply through the Medicare GLP-1 Bridge until 31 December 2027.

Q: How much does Wegovy cost without insurance?
A: Direct from Novo's pharmacy, the pen is $349 a month at every dose from 0.25 to 2.4 mg, with new patients paying $199 for their first two fills through 31 December 2026, and the 7.2 mg HD pen is $399. The Wegovy pill is $149 at 1.5 mg, $199 at 4 mg and $299 at 9 and 25 mg. Compounded semaglutide starts at $69 a month on our board and is not FDA-approved.

Q: Does Medicare cover Wegovy?
A: Not under ordinary Part D for weight loss alone. Since 1 July 2026 the Medicare GLP-1 Bridge gives eligible Part D members Wegovy, injection or tablet, at any dose for a $50 copayment per 30-day supply, running through 31 December 2027. You need a drug plan (standalone Part D or Medicare Advantage with drug coverage), an obesity diagnosis and a prior authorisation your doctor sends to CMS's central processor. Wegovy prescribed for cardiovascular risk goes through your standard Part D plan instead, at its own copay.

Q: Can I use the Wegovy savings card with federal employee or marketplace insurance?
A: Yes, if the plan covers Wegovy. Novo's terms say FEHB, Affordable Care Act marketplace plans and state employee plans are not government programmes for the card, so their members can pay as little as $25. Medicare, Medicaid, VA, DoD and TRICARE members cannot, and neither can members of a plan that runs an accumulator or maximizer programme.

Q: Does paying cash for Wegovy count toward my deductible?
A: No. Novo's self-pay terms ask you not to count the cost toward your insurance deductible or out-of-pocket limit, and not to ask your plan to reimburse it. If you are near your out-of-pocket maximum, or a prior authorisation is pending, check what the plan would charge before paying cash.

Q: Who counts as a new patient for the $199 Wegovy price?
A: Someone who has not redeemed a savings offer for Wegovy injection in the past 365 days. They pay $199 for each of their first two 28-day fills at 0.25 mg and 0.5 mg, filled by 31 December 2026, then $349. Anyone else pays $349 from the first box.

Q: Is the Wegovy pill cheaper than the pen?
A: Yes. Direct from Novo the pill is $149, $199 or $299 a month by strength, and its 25 mg maintenance dose is $299, against $349 for the pen at any dose. Both carry the $25 commercial card and both are covered by the Medicare Bridge at $50.

Q: How much does Wegovy cost per year?
A: About $325 on the pen with a commercial plan and the card ($300 on the pill), $600 on the Medicare Bridge, $4,237 in the first year on Novo's pen for a new patient and $4,537 in each year after, because a pen box is a 28-day supply and a year takes 13 of them, $3,588 a year on the pill at the 25 mg maintenance dose, and from about $830 a year for the cheapest compounded semaglutide on our board.

### GLP-1 for PCOS (2026): 5 studies and the guideline, read
Source: https://pricetrackerglp1.com/guides/glp1-pcos (updated 2026-10-14)
Q: Is Ozempic or Wegovy approved for PCOS?
A: No. No GLP-1 is FDA approved for PCOS. Wegovy is approved for weight reduction in adults with obesity, or with overweight plus a weight-related condition, among other uses. Doctors can prescribe it to someone with PCOS who meets that weight indication, or off-label, the same way metformin has long been used for PCOS without an FDA approval for it.

Q: Does a GLP-1 help PCOS symptoms like irregular periods and hair growth?
A: Possibly, but the evidence is weak. A 2023 meta-analysis of 11 trials found more regular periods, but results varied widely between trials, and a 2026 review of 11 trials judged the evidence insufficient to conclude anything on periods or excess hair. The clearest benefit is weight loss, and the Office on Women's Health says losing 10% of body weight can help make periods more regular.

Q: Can a GLP-1 help me get pregnant with PCOS?
A: One 2023 meta-analysis found a higher natural pregnancy rate (risk ratio 1.72), and small 2026 studies of tirzepatide and semaglutide with metformin reported pregnancies. But the 2023 International PCOS Guideline recommends using weight medicines for fertility only in research settings, and the Wegovy label says to stop at least 2 months before a planned pregnancy.

Q: Is tirzepatide (Zepbound, Mounjaro) better than semaglutide for PCOS?
A: Nobody has compared them in PCOS. The first randomized tirzepatide trial in PCOS gave 60 women metformin with or without tirzepatide 5 mg for 16 weeks: 10.4 kg lost with the combination versus 1.7 kg on metformin alone. The 2023 guideline names liraglutide and semaglutide, not tirzepatide.

Q: Can I take a GLP-1 with metformin or birth control pills for PCOS?
A: Both combinations were used in the PCOS trials, and your prescriber decides. If the GLP-1 is tirzepatide and you take the pill, the Zepbound label says to switch to a non-oral method or add a barrier method for 4 weeks after starting and after each dose increase.

Q: How much does a GLP-1 for PCOS cost without insurance?
A: The same as for anyone else. On our board today the cheapest cash program is $69 a month, compounded tirzepatide starts at $85, and the middle program is $158. A licensed clinician must prescribe it, and compounded versions are not FDA approved.

### Ozempic cost in 2026: with insurance, without, pen and pill
Source: https://pricetrackerglp1.com/guides/ozempic-cost (updated 2026-10-14)
Q: How much does Ozempic cost with insurance?
A: With a commercial plan that covers it for type 2 diabetes, as little as $25 a month using Novo's savings card, which caps at $100 of savings per month, so a $150 copay becomes $50. Prior authorisation is usual and typically requires a diabetes diagnosis and a metformin history. Government plans are excluded from the card, but Medicare Part D commonly covers Ozempic for diabetes at its own copay.

Q: How much does Ozempic cost without insurance?
A: Direct from Novo through NovoCare Pharmacy, the pen is $199 a month for the first two fills at 0.25 or 0.5 mg for new patients, through 31 December 2026, then $349 a month for 0.25, 0.5 or 1 mg and $499 for 2 mg. The Ozempic pill starts at $149 a month. Compounded semaglutide, not FDA-approved, starts at $69 a month on our board.

Q: Is there an Ozempic pill and how much is it?
A: Yes. Novo sells an Ozempic tablet through its own pharmacy at $149 a month for 1.5 mg, $199 for 4 mg and $299 for 9 mg, a month being one bottle of 30 tablets. Every strength costs less than the $349 pen, which makes it the cheapest branded Ozempic available. The Wegovy tablet, the same molecule approved for weight, is priced at $149, $199 or $299 by strength.

Q: Does insurance cover Ozempic for weight loss?
A: No. Ozempic is approved for type 2 diabetes, cardiovascular risk in diabetes, and kidney disease in diabetes, not for weight, and every insurer we hold documents for refuses it for weight loss. Wegovy is the same semaglutide approved for weight, and a plan with a weight-loss benefit can cover that instead, at $25 with Novo's card.

Q: Is Wegovy cheaper than Ozempic?
A: Paying cash, yes or equal at every dose. Novo's pharmacy prices the Wegovy pen at $349 at all doses up to 2.4 mg, against Ozempic's $349 up to 1 mg and $499 at 2 mg. Both carry the same $199 two-fill introductory offer. The Wegovy tablet runs $149 to $299 and the Ozempic tablet starts at $149. For weight loss, Wegovy is the cheaper and coverable box for the same molecule.

Q: How long does the $25 Ozempic savings card last?
A: Novo says the commercial savings offer is valid for up to 48 months, with savings capped at $100 a month, and each fill can be up to a 3-month prescription. It needs commercial insurance that covers Ozempic. Medicare Part D and Medicaid members cannot use it, though both can buy at Novo's self-pay prices.

Q: Does paying cash for Ozempic count toward my deductible?
A: No. Novo's terms say a self-pay purchase is made outside your insurance plan, and you cannot ask your insurer to reimburse it or count it toward your deductible or out-of-pocket limit. If you are close to meeting your deductible, or a prior authorisation is pending, check what the plan would charge before paying cash.

### How to get Wegovy online in 2026: criteria, pill, cost
Source: https://pricetrackerglp1.com/guides/how-to-get-wegovy (updated 2026-10-13)
Q: Who qualifies for Wegovy?
A: Adults with obesity, or overweight with at least one weight-related condition, which the approval trials defined as a BMI of 30 or more, or 27 or more with a comorbidity. Separately, adults with established cardiovascular disease and either obesity or overweight qualify under the cardiovascular indication, to reduce the risk of heart attack, stroke and cardiovascular death.

Q: Can I get Wegovy online?
A: Yes. Any licensed prescriber can write it by video, and Novo's NovoCare Pharmacy links to telehealth prescribers and ships the pen or the tablet to your door once the prescription reaches it. Some telehealth programs on our board also dispense branded Wegovy, from $208 a month today. Your own doctor remains the best route if you need insurance prior authorisation filed.

Q: Can I buy Wegovy online without a prescription?
A: Not legally. Novo states that all doses of Wegovy and Ozempic require a prescription, whether you self-pay or use insurance. A site that ships it with no clinician assessment is not selling it legally, and Novo's own rule for the real product is that if it is not made by Novo Nordisk, it is not FDA-approved Wegovy.

Q: How does Wegovy get shipped, and what should I check when it arrives?
A: Through NovoCare Pharmacy, whose dispensing pharmacy is CoAssist, or the pharmacy a telehealth program uses. The label says to keep unused pens in the refrigerator at 36°F to 46°F and to throw away a pen that was frozen or exposed to temperatures above 86°F, so a pen should arrive cold and go into the fridge that day. Tablets are stored at room temperature in the original closed Wegovy bottle.

Q: How much does Wegovy cost?
A: With a commercial plan that covers it, as low as $25 a month using Novo's card. Direct from Novo without insurance, the pen is $349 a month at any standard dose, with new patients paying $199 for their first two fills through 31 December 2026, and the tablet is $149, $199 or $299 by strength. Compounded semaglutide starts at $69 on our board and is not FDA-approved.

Q: Is there a Wegovy pill?
A: Yes. Novo's Wegovy tablet is a once-daily semaglutide pill, which Novo describes as the only semaglutide tablet FDA-approved for weight loss in adults, with a 25 mg maintenance dose. It costs $149 to $299 a month direct from Novo, less than the $349 pen, and it is the route for anyone who will not inject.

Q: What does Wegovy cost on Medicare?
A: Through the Medicare GLP-1 Bridge, eligible Part D enrollees can get any dose of the Wegovy pen or pill for $50 a month from July 1, 2026 to December 31, 2027. It needs a prior authorization from your doctor and a prescription for a use the Bridge covers. Novo's $25 savings card does not apply to government beneficiaries.

Q: Will insurance cover Wegovy if I have heart disease?
A: Possibly even where it refuses weight-loss drugs. Wegovy is approved to reduce cardiovascular risk in adults with established heart disease and obesity or overweight, which is a separate indication from weight. Ask your prescriber to write it under that indication and ask your plan specifically whether it covers Wegovy for cardiovascular risk reduction.

### GLP-1 and birth control (2026): which ones weaken the pill
Source: https://pricetrackerglp1.com/guides/glp1-birth-control (updated 2026-10-13)
Q: Do Zepbound and Mounjaro make birth control pills less effective?
A: They can. Both tirzepatide labels say the drug may reduce the efficacy of oral hormonal contraceptives because it slows stomach emptying, and advise switching to a non-oral method or adding a barrier method for 4 weeks after starting and for 4 weeks after each dose increase. In the label study, one 5 mg dose cut peak pill hormone levels by 55% to 66% and total exposure by 20% to 23%.

Q: Does Ozempic or Wegovy affect birth control?
A: Not according to their labels. In semaglutide's interaction studies there were no clinically significant differences in ethinyl estradiol or levonorgestrel levels, and the Ozempic, Wegovy and Rybelsus labels carry no backup rule for the pill. A 2026 review notes that vomiting or diarrhea may in theory affect how any pill is absorbed, so follow your pill's own instructions if that happens.

Q: Does Foundayo affect the pill?
A: Its label treats it as if it might. The effect has not been tested in a trial, but because Foundayo slows stomach emptying the label advises switching to a non-oral method or adding a barrier method for 30 days after starting and for 30 days after each dose increase, and to use effective contraception during treatment.

Q: Are the patch, ring, shot, implant or IUD affected by GLP-1s?
A: No. The tirzepatide label says hormonal contraceptives that are not taken by mouth should not be affected, and the copper IUD has no hormone. ACOG calls the IUD and the implant the most effective reversible methods, with fewer than 1 in 100 women pregnant in the first year.

Q: How long before trying to get pregnant should I stop a GLP-1?
A: The Ozempic and Wegovy labels say at least 2 months before a planned pregnancy, because semaglutide takes a long time to clear. The Zepbound label says to stop when a pregnancy is recognized and that weight loss is not recommended during pregnancy. Plan the timing with your prescriber.

Q: How much does a GLP-1 cost?
A: On our board today the cheapest cash program is $69 a month, compounded tirzepatide starts at $85, and the middle program is $158. A licensed clinician has to prescribe it, and compounded versions are not FDA approved.

### GLP-1 muscle loss (2026): 25% to 39% of weight lost is lean
Source: https://pricetrackerglp1.com/guides/glp1-muscle-loss (updated 2026-10-12)
Q: Do GLP-1 medicines like Ozempic, Wegovy and Zepbound cause muscle loss?
A: They cause some lean mass loss along with fat. In tirzepatide's SURMOUNT-1 scan substudy, about 25% of the weight lost was lean mass and 75% fat, the same split as on placebo. A 2026 analysis of 20 randomised trials put the lean share at 25% to 39% across semaglutide, tirzepatide and liraglutide, close to the 26.2% seen with lifestyle change alone. Lean mass includes organs, bone and fluid, so not all of it is muscle.

Q: How can I prevent muscle loss on a GLP-1?
A: Resistance training has the best evidence: in the same 2026 analysis, lifestyle plus resistance training had the lowest lean share of weight lost, 17.5%. A joint advisory from four obesity and nutrition societies recommends resistance training and appropriate diet, and a baseline check of muscle strength, function and body composition. Federal guidelines say adults need muscle-strengthening activity at least 2 days a week.

Q: How much protein should I eat on semaglutide or tirzepatide?
A: There is no label figure. One 2026 narrative review proposes at least 1.2 g per kg of body weight a day, up to 1.6 g/kg in adults without chronic kidney disease. No trial on these drugs has reported the effect of a protein target yet. If you have kidney disease, set the target with your doctor; the four-society advisory recommends counseling with a registered dietitian.

Q: Is tirzepatide better than semaglutide for keeping muscle?
A: Unknown. Pooled trials show a lean share of 25.4% for tirzepatide and 35.2% for semaglutide, but those numbers come from different trials, not a head-to-head comparison, so they cannot rank the drugs. We found no trial that compares their effect on body composition directly.

Q: Does strength go down on a GLP-1?
A: In shorter trials, mostly not: grip strength was preserved despite lean mass loss, and people in a STEP UP subset did 13 sit-to-stand repetitions in 30 seconds at the start and 15 at week 72. In older adults with type 2 diabetes on long-term semaglutide, observational studies have reported lower grip strength, which is why specialists ask for strength checks in that group.

Q: How much does a GLP-1 cost?
A: On our board today the cheapest cash program is $69 a month, compounded tirzepatide starts at $85, and the middle program is $158. A licensed clinician has to prescribe it, and compounded versions are not FDA approved.

### GLP-1 from Mexico or Canada (2026): legal? US from $69/mo
Source: https://pricetrackerglp1.com/guides/buy-glp1-abroad (updated 2026-10-12)
Q: Is it legal to buy Ozempic in Mexico and bring it back to the US?
A: In most cases, no. FDA says a drug approved in another country but unapproved in the US is illegal to import, and CBP tells US citizens it is illegal in most cases to obtain drugs abroad and import them for personal use. A Mexican-market Ozempic pen is a foreign-made version, so it falls under that rule.

Q: Doesn't FDA allow a 90-day supply for personal use?
A: Only inside a narrow exception: the drug must treat a serious condition for which effective treatment may not be available in the US, among other conditions, and the quantity is then generally no more than three months. GLP-1s are approved and sold in the US, so a GLP-1 bought abroad does not meet the first condition.

Q: Can I order generic semaglutide from a Canadian pharmacy?
A: Not legally for use in the US. Generic semaglutide is approved in Canada, not by FDA, which makes it illegal to import. British Columbia also bars pharmacists from selling semaglutide or tirzepatide to people who are not Canadian citizens or permanent residents unless they are at the pharmacy in person with a Canadian prescription.

Q: Is Ozempic sold without a prescription in Mexico?
A: It should not be. Mexico's regulator Cofepris says Ozempic requires a medical prescription under article 226 of the General Health Law, and in 2026 it warned of falsified Ozempic pens, telling the public not to buy medicines online or at street markets.

Q: How do I spot a fake Ozempic pen?
A: WHO lists a dose scale that extends out of the pen when setting the dose, a poor-quality label that does not stick well, and spelling mistakes on the box; Cofepris flagged labels in a language other than Spanish. None of these proves a pen is genuine: CDC says only a laboratory test can tell for sure, so buy from a state-licensed US pharmacy.

Q: Can I travel to Mexico or Canada with my GLP-1 pens?
A: Yes, if they were prescribed to you and filled in the US. Keep them in the labelled box with a copy of the prescription, pack them in your carry-on and declare them at the TSA checkpoint. Ozempic's label allows a pen in use 56 days at 59°F to 86°F; Zepbound's allows up to 21 days unrefrigerated at up to 86°F.

Q: What is the cheapest legal GLP-1 in the US?
A: On our board a partner program starts at $69 a month today, all-in with any verified fee. For FDA-approved brands paid in cash, Novo Nordisk charges new patients $199 for each of two starter Wegovy or Ozempic pen fills, then $349 a month.

### Food noise on GLP-1s: 51% report it, what studies show (2026)
Source: https://pricetrackerglp1.com/guides/food-noise (updated 2026-10-11)
Q: What is food noise?
A: Food noise is persistent, unwanted thinking about food: what to eat, how much and when, intrusive enough to feel like rumination. A 2025 paper gave it a formal definition: persistent thoughts about food that the person perceives as unwanted or distressing and that may cause social, mental or physical harm. It is different from hunger, which a meal answers.

Q: Do GLP-1 medicines get rid of food noise?
A: Most people who take them report much less. In a survey of 550 semaglutide users, the median Food Noise Questionnaire score fell from a recalled 13 out of 20 before treatment to 6 after, and a small placebo-controlled trial found fewer cravings on semaglutide. The survey was funded by Novo Nordisk and relied on memory, and no randomised trial has yet used food noise as its main outcome.

Q: Does tirzepatide (Zepbound, Mounjaro) reduce food noise too?
A: Its label describes the same appetite effect: tirzepatide decreases calorie intake and the effect is likely mediated by affecting appetite, through both GLP-1 and GIP receptors in brain areas involved in appetite. We found no published study that scored food noise on tirzepatide specifically, and none that compares it with semaglutide on food noise.

Q: How quickly does food noise go away on Ozempic or Wegovy?
A: No study has timed it. The placebo-controlled trial that found fewer cravings ran for 12 weeks, and 81% of the people in the largest food noise survey had used semaglutide for at least four months. Your prescriber sets the dose schedule from the label.

Q: Does food noise come back after you stop a GLP-1?
A: Nobody has measured it. What is measured is weight: one year after stopping semaglutide in the STEP 1 extension, people had regained two-thirds of the weight they lost. In interviews, people describe the medicine as a help to change habits rather than a replacement for them, so building those habits while food noise is quiet is the common advice.

Q: How much does a GLP-1 cost if I want to try it?
A: On our board today the cheapest cash program is $69 a month (compounded semaglutide), compounded tirzepatide starts at $85, and the middle program is $158. A licensed clinician has to prescribe it, and none of these medicines is approved specifically for food noise.

### Semaglutide online (2026): 6 versions, from $69/mo
Source: https://pricetrackerglp1.com/guides/semaglutide-online (updated 2026-10-11)
Q: Can you buy semaglutide online without a prescription?
A: No. Every legitimate version, brand or compounded, needs a prescription. Novo Nordisk says all doses of Wegovy and Ozempic require one, and a 503A compounding pharmacy may only make semaglutide for an individual patient's prescription. A site that sells it with no health review is a red flag, not a shortcut.

Q: How much does semaglutide cost online?
A: On our board compounded semaglutide starts at $69 a month, all-in with any verified fee. Novo Nordisk's own self-pay prices start at $149 a month for the Wegovy or Ozempic pill and $199 for each of two starter pen fills, then $349 a month and up.

Q: Is compounded semaglutide still legal in 2026?
A: A state-licensed pharmacy may still compound semaglutide for an individual patient's prescription, but semaglutide is no longer on FDA's shortage list, outsourcing facilities cannot compound it from bulk, and FDA treats routine copies of the brand as outside the rules beyond four prescriptions a month. Compounded semaglutide is not FDA approved.

Q: What is semaglutide sodium, and should I avoid it?
A: Semaglutide sodium and semaglutide acetate are salt forms. FDA says they are different active ingredients from the one in the approved drugs and that it knows of no lawful basis for using them in compounding. If a listing or label names a salt, choose another program.

Q: Is compounded semaglutide the same as generic Wegovy or Ozempic?
A: No. FDA says compounded drugs are not the same as generics, which are FDA approved, and in March 2026 it warned 30 telehealth companies over claims implying their compounded products were the same as approved ones.

Q: Can I get Wegovy or Ozempic online directly from Novo Nordisk?
A: Yes, with a prescription. NovoCare Pharmacy ships both brands as pens and pills, can connect you with a prescriber, offers 90-day fills, and publishes self-pay prices starting at $149 a month for the pills. Paying this way sits outside your insurance.

### Telehealth weight loss programs (2026): from $69/mo
Source: https://pricetrackerglp1.com/guides/telehealth-weight-loss (updated 2026-10-10)
Q: How much do telehealth weight loss programs cost?
A: On our board, cash prices start at $69 a month for compounded semaglutide and $85 for compounded tirzepatide, and the middle program is $158. Brand medicines cost more: Novo sells the Wegovy pill from $149 a month and the Wegovy pen at $349 a month after two $199 starter fills. Check for a membership fee, a dose-based price or a prepaid term behind any headline.

Q: Do I need to be obese to get a GLP-1 through telehealth?
A: Not necessarily. The Wegovy and Zepbound labels cover adults with obesity, and adults with overweight who also have at least one weight-related condition. The prescriber makes the call from your history, and a real program will ask about your weight, health and current medicines before deciding.

Q: Are online weight loss programs legitimate?
A: Many are: a telehealth prescription filled by a licensed US pharmacy is the same prescription you would get in an office. FDA's red flags are a seller that skips the screening, has no licensed doctor to answer questions after delivery, says a compounded drug is the same as an approved one, or prices far below everyone else. Look the dispensing pharmacy up in your state board of pharmacy's database before you pay.

Q: Is compounded semaglutide from a telehealth program the same as Wegovy?
A: No. Compounded semaglutide is made by a pharmacy, not Novo Nordisk, and FDA says compounded drugs are not FDA approved and are not reviewed for safety, effectiveness or quality before they are sold. FDA lists a seller that claims a compounded drug is the same as an approved one as a red flag.

Q: Can I use insurance with a telehealth weight loss program?
A: Usually not for the medicine: most cash programs do not bill insurance, and some plans do not cover telehealth visits either. If your plan covers Wegovy or Zepbound, your own doctor filing a prior authorisation is usually cheaper than any cash program.

Q: What should I do if my GLP-1 arrives warm?
A: Do not use it. FDA recommends patients not use any injectable GLP-1 that arrives warm or without enough refrigeration, because heat can affect the medicine's quality. Contact the program or pharmacy for a replacement.

### Wegovy pill vs injection (2026): doses, schedule, Novo prices
Source: https://pricetrackerglp1.com/guides/wegovy-pill-vs-injection (updated 2026-10-09)
Q: Is the Wegovy pill the same drug as the Wegovy injection?
A: Yes. Both are semaglutide from Novo Nordisk. The pill is taken once a day in 1.5, 4, 9 or 25 mg strengths; the pen is injected once a week from 0.25 mg up to 2.4 mg, with a 7.2 mg HD pen above that.

Q: Is the Wegovy pill cheaper than the injection?
A: Yes, on Novo's self-pay prices. The pill is $149 a month at 1.5 mg, $199 at 4 mg and $299 at 9 and 25 mg. The pen is $349 a month at any standard dose and $399 for the 7.2 mg HD pen. New patients pay $199 for their first two pen fills through 31 December 2026.

Q: Which works better, the Wegovy pill or the injection?
A: No trial has compared them head to head. In separate placebo trials, the 2.4 mg pen averaged a 14.9% weight change at 68 weeks (STEP 1) and the 25 mg tablet 13.6% at 64 weeks (OASIS 4). The trials differed in length and population, so that gap is not a measured difference. Both carry weight and cardiovascular uses on their labels; your prescriber weighs them for you.

Q: Does Medicare cover the Wegovy pill and the pen?
A: Through the Medicare GLP-1 Bridge, yes: eligible Part D members get Wegovy as an injection or a tablet for a $50 copayment per 30-day supply, from 1 July 2026 through 31 December 2027. Your doctor files a prior authorization with a CMS central processor, and the Bridge covers it only when it is prescribed for weight loss.

Q: Can I switch from the Wegovy pen to the pill?
A: The label allows it in both directions. It says patients on the 2.4 mg injection may switch to the 25 mg tablet, starting the tablet one week after the last injection, and that patients on the 25 mg tablet may switch to the 2.4 mg injection the day after the last tablet. It still takes a new prescription, and your prescriber decides whether it fits you.

Q: How do you take the Wegovy pill?
A: The label says one tablet a day, on an empty stomach in the morning, with water only, up to 4 ounces. Swallow it whole, and wait at least 30 minutes before eating, drinking anything else or taking other oral medicines. The pen has no food rule: once a week, any time of day, with or without meals.

Q: What if I miss a dose of the Wegovy pill?
A: The label says to skip the missed tablet and take the next dose the following day. Do not take two in one day: the label says not to take more than one tablet per day.

### Wegovy vs Ozempic (2026): same molecule, different price
Source: https://pricetrackerglp1.com/guides/wegovy-vs-ozempic (updated 2026-10-09)
Q: Is Wegovy the same as Ozempic?
A: Chemically, yes. Both are semaglutide, made by Novo Nordisk, injected once a week. The differences are the label and the ceiling: Ozempic is approved for type 2 diabetes and tops out at 2 mg; Wegovy is approved for weight loss and cardiovascular risk reduction and climbs to 2.4 mg, with a 7.2 mg HD pen. Each now has a daily pill as well.

Q: Can I take Ozempic for weight loss?
A: A doctor can prescribe it off-label, but it is not approved for weight loss and most insurers will refuse to cover it for that reason. Wegovy is the same molecule approved for weight, which is why it is the one plans can cover. Paying cash, Ozempic is also the worse deal: its 2 mg pen is $499 a month against Wegovy's 2.4 mg pen at $349.

Q: Which is cheaper, Wegovy or Ozempic?
A: Direct from Novo, both pens are $349 a month up to 1 mg. Above that Wegovy stays at $349 for 1.7 and 2.4 mg while Ozempic's 2 mg is $499. The Wegovy tablet is cheaper than either pen at $149 to $299. Compounded semaglutide, which is not FDA-approved, starts at $69 a month on our board.

Q: Does insurance cover Wegovy or Ozempic?
A: Ozempic is widely covered for type 2 diabetes and almost never for weight loss. Wegovy coverage for weight loss is plan-specific: TRICARE covers it, Humana does not, and most large commercial insurers say it depends on the plan and require prior authorisation. Where a commercial plan covers either, the maker's card brings the copay to as low as $25.

Q: Is there an Ozempic pill?
A: Yes. Novo Nordisk now sells an Ozempic pill in 1.5, 4 and 9 mg, and its Rybelsus page says Rybelsus is being replaced by it. Like the Ozempic pen it is a type 2 diabetes product. Self-pay through NovoCare Pharmacy starts at $149 a month. The weight-loss pill from the same maker is the Wegovy pill.

Q: What is the highest dose of Ozempic and of Wegovy?
A: The Ozempic label says the maximum recommended dosage is 2 mg once weekly. The Wegovy label sets maintenance at 1.7 mg or 2.4 mg once weekly and allows some patients to go to a maximum of 7.2 mg once weekly with the Wegovy HD pen. Which step is right for you is your prescriber's call.

Q: Why is Ozempic more expensive than Wegovy at 2 mg?
A: Novo prices each product on its own terms. The Ozempic 2 mg pen is $499 a month self-pay while every standard Wegovy pen dose is $349, so at the top of the Ozempic ladder the diabetes product costs $150 a month more than the weight product for a slightly smaller dose. There is no cash-price reason to choose Ozempic for weight.

### Microdosing GLP-1 (2026): does it work or save money?
Source: https://pricetrackerglp1.com/guides/microdosing-glp1 (updated 2026-10-09)
Q: How much does microdosing tirzepatide cost?
A: On our board one program sells it as its own product: Enhance MD's Microdosing Tirzepatide, 1 mg a week, at $169 a month on a 12-month plan, $179 on six months and $189 on three. Every other compounded program charges one price at any dose, and full-dose compounded tirzepatide starts at $85 a month at the cheapest program we track. There is no 1 mg Zepbound: the lowest dose on the label is 2.5 mg, which Lilly sells self-pay at $299 a month.

Q: Who offers microdosing GLP-1?
A: Of the partner programs on our board, only Enhance MD sells a product called microdosing (tirzepatide, 1 mg a week). The other compounded programs sell semaglutide or tirzepatide at one price per plan length, so whatever dose a prescriber sets costs the same there. Sesame Care is the exception the other way: it sells brand Ozempic and Foundayo priced by dose. The provider table on this page lists every program with its live price.

Q: Is microdosing semaglutide cheaper than a full dose?
A: Not at any compounded program on our board. None lists dose tiers, so a small dose of compounded semaglutide costs the same as a full one, from $69 a month at the cheapest. Per milligram it costs more: at Wegovy's 0.25 mg starting step a four-week supply is 1 mg, so the whole monthly bill is the price of that milligram. A lower dose only lowers the bill on a brand sold by dose, such as Ozempic at Sesame Care.

Q: What is microdosing a GLP-1?
A: Loosely, taking a dose below the label's approved starting dose, or staying at a starting dose rather than titrating up. There is no clinical definition. Cedars-Sinai's director of obesity medicine puts it directly: microdosing is not a medical term, it is one popularised on social media, so no two sellers necessarily mean the same thing by it.

Q: Does microdosing a GLP-1 save money?
A: Not at a compounded telehealth seller, and this is checkable. Across every compounded program we track, re-checked in October 2026, not one charges less for a smaller dose; every one is a flat monthly price. The one microdosing product on our board, at Enhance MD, costs more a month than full-dose compounded tirzepatide at the cheapest seller we track. Where a lower dose genuinely does cost less is the branded ladders: Lilly lists Zepbound self-pay at $299 for 2.5 mg up to $699 for 10 to 15 mg.

Q: Is microdosing GLP-1 safe?
A: Nobody can tell you it is, because doses below the approved starting dose have not been studied for this purpose. Cedars-Sinai's stated position is that there is no evidence low-dose or intermittent use delivers meaningful or sustained benefit, and that inappropriate use carries risk. A trial evaluating microdosed GLP-1 receptor agonists is now registered on ClinicalTrials.gov, so the question is open rather than settled either way.

Q: Can I microdose Ozempic or Wegovy from a pen?
A: Branded pens deliver fixed doses, which is why this practice runs almost entirely on compounded multi-dose vials. That supply is now uncertain: on 30 April 2026 the FDA proposed excluding semaglutide, tirzepatide and liraglutide from the 503B bulks list, finding no clinical need for outsourcing facilities to compound them. A final determination is pending.

Q: Is staying on a low dose the same as microdosing?
A: No, and the distinction matters. Every label starts low and titrates up over weeks, largely to limit nausea, so a starting dose is an approved dose. Remaining on a lower approved dose because it controls your weight or your side effects is an ordinary conversation with your prescriber. Going below the approved starting dose is the untested part.

Q: Will microdosing reduce GLP-1 side effects?
A: Lower doses are associated with fewer gastrointestinal side effects, which is precisely why the approved titration schedules start low and climb slowly. That is a reason to discuss your titration pace with your prescriber rather than a reason to invent a dose below the label. Slowing a titration and going under the starting dose are different things.

### What is Ozempic face? 9% midface volume loss, fixes (2026)
Source: https://pricetrackerglp1.com/guides/ozempic-face (updated 2026-10-09)
Q: What is Ozempic face?
A: A lay term for the hollow, older look a face can take on after fast, substantial weight loss: sunken cheeks and temples, hollow eyes and looser skin. It is facial fat being lost along with fat everywhere else. It is not a medical diagnosis and it is not listed in the semaglutide prescribing information.

Q: Is Ozempic face permanent?
A: Not entirely. Facial fullness follows body fat, so some returns if weight returns, though no study has measured how much. Skin that has lost elasticity is harder to undo and may need treatment. Fillers and fat grafting can replace lost volume; ASPS surgeons prefer to wait until weight is stable before doing so.

Q: How much weight do you have to lose to get Ozempic face?
A: There is no threshold. The only CT study found about 7% of midface volume lost per 10 kg of weight lost, mostly in the fat just under the skin, and its 20 patients had lost an average of 11 kg. More weight lost meant more facial volume lost.

Q: How long does it take for Ozempic face to show?
A: It follows the weight, not the calendar. In the CT study, patients had been on a GLP-1 for an average of 321 days when their median midface volume was 9% lower. In STEP 1, average weight loss on semaglutide 2.4 mg was 14.9% at 68 weeks, so many people notice it in the first year or so.

Q: Does everyone on Ozempic get Ozempic face?
A: No. Reviews list older age, rapid loss, a long history of obesity, low protein and poor hydration as risk factors. In a study of identical twins, extra weight made faces look older before 40 and younger after 40, which is why the same loss can look very different at 30 and at 55.

Q: Do Mounjaro and Zepbound cause Ozempic face too?
A: Yes, in the same way. The CT study included patients on any GLP-1 medicine, and plastic surgery reviewers conclude the change reflects rapid or substantial weight loss rather than a drug-specific facial effect. Any program that takes off a lot of weight quickly can produce it.

Q: How can I prevent Ozempic face?
A: No trial has tested prevention for the face specifically. The sources recommend gradual weight loss, enough protein, hydration and structured strength training at least three times a week; a 2025 joint nutrition advisory quotes protein targets of 1.2 to 1.6 g per kg a day during weight loss. Discuss the pace and your targets with your prescriber.

Q: How much do fillers for Ozempic face cost?
A: The American Society of Plastic Surgeons puts the average cost of hyaluronic acid filler at $715 and other fillers such as Sculptra and Radiesse at $901. Health insurance does not cover them, and a face with volume loss in several areas may need more than one syringe or session.

Q: Should I wait until my weight is stable before getting fillers or fat grafting?
A: That is what the ASPS surgeons interviewed in July 2026 recommend: wait until weight has stabilized or you are close to your target, because treating while the face is still changing risks under-correction, over-correction or extra procedures. Grafted fat also grows and shrinks with your weight.

Q: Is Ozempic face the same as Ozempic butt?
A: Same cause, different place. Both describe volume loss and looser skin after fast weight loss. Faces are usually treated with injections; loose body skin is more often a question for body contouring surgery. Our Ozempic butt guide covers it in detail.

### HSA or FSA for GLP-1s in 2026: IRS rules and $4,400 limit
Source: https://pricetrackerglp1.com/guides/glp1-hsa-fsa (updated 2026-10-09)
Q: Can I use my HSA for a GLP-1?
A: Usually, for the medication. IRS Publication 502 says you can include "prescribed medicines and drugs" in medical expenses, and an HSA pays for medical care as Code section 213(d) defines it. Program or membership fees qualify only when the weight loss treats a disease a physician diagnosed, such as obesity. Your plan administrator decides each claim, so check with it first.

Q: Is Wegovy HSA eligible?
A: A prescribed Wegovy fill meets the IRS description of a prescribed drug, and NovoCare Pharmacy says "we accept payment from FSA/HSA funds." Card acceptance is not a tax ruling, so check with your plan administrator how it treats the claim, especially if it asks for a Letter of Medical Necessity.

Q: Can I use my FSA for Zepbound?
A: LillyDirect says it accepts "FSA/HSA cards", and Lilly's Zepbound savings page adds that "FSA/HSA eligibility may vary by plan." An FSA needs a third-party receipt showing the expense and its amount, and it pays only for expenses incurred in its plan year. Check with your plan administrator before you buy.

Q: Can I use my HSA for compounded semaglutide?
A: The IRS medicines test asks whether a drug requires a prescription; it does not mention FDA approval. FDA describes compounded drugs as made for an individual patient on a prescription, and also says they are not FDA-approved. Products sold without a prescription, or shipped in from another country, fail Publication 502's rules. Ask your plan administrator before paying for a long plan.

Q: Is a GLP-1 membership fee HSA or FSA eligible?
A: The IRS counts weight-loss program and membership fees only when the weight loss treats a specific disease diagnosed by a physician, such as obesity, hypertension or heart disease. A program for appearance or general health does not count. Ask the seller for an itemized receipt that separates the fee from the drug, and check with your plan administrator.

Q: Do I need a Letter of Medical Necessity to use my HSA or FSA for a GLP-1?
A: The IRS drug rules do not mention one, but administrators may ask. HealthEquity, an HSA and FSA administrator, says FSA documentation "may include a receipt, prescription, or Letter of Medical Necessity (LMN)." An LMN from your prescriber names the diagnosis, which is the fact the IRS weight-loss rule depends on.

Q: How much do I save paying for a GLP-1 with an HSA or FSA?
A: Your tax rate times what you spend. At an example 29.65% (22% federal bracket plus 7.65% payroll tax), a year of compounded semaglutide at the board floor, $828, saves $245. Contributions made outside payroll skip only income tax, and California does not follow the federal HSA rules.

Q: What are the 2026 HSA and FSA limits?
A: For 2026 the HSA limit is $4,400 for self-only coverage and $8,750 for family coverage, plus $1,000 if you are 55 or older. The health FSA limit is $3,400 of salary reduction, and plans that allow a carryover can roll up to $680 of unused money into the next plan year.

Q: Can I use my HSA for Ozempic if it is for weight loss?
A: The prescription test is the same whatever the label says, but the IRS also says medical expenses must treat or prevent disease and excludes weight loss for appearance or general health. If the prescription is for weight, your administrator may want the diagnosis, such as obesity, in writing. Check with your plan administrator.

Q: What happens if I use my HSA for something that does not qualify?
A: Publication 969 says the withdrawal is taxed as income and may be subject to an additional 20% tax. You must keep records showing each withdrawal paid a qualified medical expense, so hold on to receipts and the prescription for every fill.

### Embody vs Trimi (2026): Price, Plans & Which Is Cheaper
Source: https://pricetrackerglp1.com/guides/embody-vs-trimi (updated 2026-10-09)
Q: Embody vs Trimi: what is the difference?
A: Both sell compounded semaglutide and tirzepatide with no membership fee and one price at every dose. Embody is cheaper on every plan both publish: $69 a month for semaglutide on a 12-month plan ($828 up front) against Trimi's $99 ($1,188 up front). Trimi serves all 50 states and offers a conditional 6-month money-back policy; Embody excludes Louisiana.

Q: Is Embody or Trimi cheaper?
A: Embody, as of October 2026. On a 12-month plan, semaglutide is $69 a month at Embody and $99 at Trimi, and tirzepatide is $119 against $125. Month to month, Embody charges $79 for semaglutide and $129 for tirzepatide, and Trimi $175 and $235.

Q: How much do you pay up front for Embody and Trimi?
A: On the 12-month plans that carry the headline prices, Embody charges $828 for semaglutide and $1,428 for tirzepatide, and Trimi charges $1,188 for semaglutide and $1,500 for tirzepatide, each as one payment at checkout.

Q: Do Embody or Trimi charge a membership fee?
A: No. Embody's FAQ says its pricing has no hidden costs or monthly fees, and Trimi's FAQ says there are no separate enrollment, consultation, membership or shipping fees. The plan price is the whole bill at both.

Q: Does the price go up as my dose increases?
A: Not at either program. Both publish one price for every prescribed dose of a drug on a given plan.

Q: Which states do Embody and Trimi serve?
A: Trimi lists all 50 states. Embody's FAQ says it serves every state except Louisiana, and only patients 19 or older in Nebraska.

Q: What are Embody's and Trimi's Trustpilot ratings?
A: When we read them on October 5, 2026, Trustpilot showed Embody at 3.8 from 9,145 reviews and showed no rating for Trimi, with a notice that its rating is unavailable due to a breach of Trustpilot's guidelines.

Q: Are Embody and Trimi FDA-approved?
A: The medications are not. Both sell compounded semaglutide and tirzepatide, which pharmacies prepare for individual prescriptions and which FDA does not approve. Both programs say so on their own sites.

### Ozempic vs Zepbound (2026): label, doses, trial, cash price
Source: https://pricetrackerglp1.com/guides/ozempic-vs-zepbound (updated 2026-10-08)
Q: Is Ozempic the same as Zepbound?
A: No. Ozempic is semaglutide from Novo Nordisk, labelled for type 2 diabetes. Zepbound is tirzepatide from Eli Lilly, labelled for weight reduction and sleep apnoea. They are different molecules from different makers.

Q: Is Ozempic approved for weight loss?
A: No. Its label covers adults with type 2 diabetes: blood sugar, heart risk and kidney risk. Wegovy is semaglutide with the weight-loss label, so prescribing Ozempic for weight is off-label and usually not covered.

Q: Which loses more weight, Ozempic or Zepbound?
A: In SURMOUNT-5, tirzepatide (Zepbound's molecule) reduced body weight by 20.2% at 72 weeks against 13.7% for semaglutide. That trial dosed semaglutide to 2.4 mg, above Ozempic's 2 mg top dose, so it compared Zepbound's range with Wegovy's.

Q: How much do Ozempic and Zepbound cost without insurance?
A: Novo's Ozempic self-pay is $349 a month at 0.25 to 1 mg and $499 at 2 mg. Lilly's Zepbound self-pay is $299 at 2.5 mg rising to $699 at 10 mg and above, or $449 on the vial or KwikPen from 7.5 mg with refills within 45 days. Compounded versions of both molecules cost less; the live boards above show today's prices.

Q: How do the dose schedules differ?
A: Ozempic has four weekly doses, 0.25 to 2 mg, starting at 0.25 mg for four weeks. Zepbound has six, 2.5 to 15 mg, starting at 2.5 mg for four weeks with 2.5 mg steps after at least four weeks each. Your prescriber sets your dose.

### Tirzepatide dosage chart (2026): every dose, schedule, price
Source: https://pricetrackerglp1.com/guides/tirzepatide-dosage-chart (updated 2026-10-08)
Q: What is the tirzepatide dosing schedule?
A: The Zepbound label starts at 2.5 mg once weekly for 4 weeks, then 5 mg. After that the dose may rise in 2.5 mg steps with at least 4 weeks on each, up to 15 mg. Your prescriber decides whether and when you move up.

Q: What is the maximum dose of tirzepatide?
A: 15 mg once weekly, per the Zepbound label. The label's maintenance doses for weight are 5, 10 or 15 mg, and 10 or 15 mg for sleep apnoea.

Q: Can you stay on 2.5 mg of tirzepatide?
A: Not as a maintenance dose under the label, which says 2.5 mg is for starting treatment and is not approved for maintenance. The lowest labelled maintenance dose is 5 mg.

Q: How many units of compounded tirzepatide is my dose?
A: It depends on your vial's concentration in mg per mL. Divide your dose in mg by that concentration and multiply by 100 for U-100 syringe units, or enter both into our dose converter. Check the result against your pharmacy's instructions.

Q: How much does each tirzepatide dose cost?
A: Lilly's Zepbound self-pay is $299 at 2.5 mg, $399 at 5 mg, $499 at 7.5 mg and $699 at 10 mg and above, or $449 on the vial or KwikPen from 7.5 mg with refills within 45 days. With commercial coverage, Lilly's card can bring it to $25. Compounded tirzepatide costs less; the live board shows today's prices.

Q: What if I miss a dose?
A: The Zepbound label says to take it as soon as possible within 4 days (96 hours) of the missed dose. If more time has passed, ask your prescriber before your next injection.

### GLP-1 dosage chart (2026): 8 drugs, every label dose
Source: https://pricetrackerglp1.com/guides/glp1-dosage-chart (updated 2026-10-08)
Q: What is the starting dose of each GLP-1?
A: From the FDA labels: Wegovy pen and Ozempic pen 0.25 mg once a week; Zepbound and Mounjaro 2.5 mg once a week; Wegovy pill 1.5 mg a day; Ozempic pill 1.5 mg a day; Rybelsus 3 mg a day; Foundayo 0.8 mg a day. Each starting dose is there to help your stomach adjust. The Rybelsus and Ozempic pill label says its starting dose is not effective for blood sugar, and the Zepbound label says 2.5 mg is not approved as a maintenance dose.

Q: What is the highest dose of each GLP-1?
A: Wegovy pen 7.2 mg a week (sold as Wegovy HD), Ozempic pen 2 mg a week, Zepbound and Mounjaro 15 mg a week (Mounjaro 10 mg in children), Wegovy pill 25 mg a day, Ozempic pill 9 mg a day, Rybelsus 14 mg a day, Foundayo 17.2 mg a day. Wegovy's label allows 7.2 mg only after at least 4 weeks at 2.4 mg when more weight loss is clinically indicated.

Q: How often do you increase a GLP-1 dose?
A: For the weekly shots, no sooner than every 4 weeks on the labels for Wegovy, Ozempic, Zepbound and Mounjaro. For the daily pills, no sooner than every 30 days for the Wegovy pill, Ozempic pill, Rybelsus and Foundayo. Those are minimums. Several labels tie the next step to response and tolerability, and Wegovy's label suggests waiting another 4 weeks if a dose is not tolerated.

Q: Is there a semaglutide to tirzepatide dose conversion chart?
A: Not from the FDA. Neither the Wegovy, Ozempic, Zepbound nor Mounjaro label converts one molecule's dose into the other's, and the Foundayo label does not either. The only switches the labels map stay inside semaglutide: Wegovy 2.4 mg pen to the 25 mg pill, Ozempic 0.5 mg pen to the 4 or 9 mg pill, and Rybelsus 7 or 14 mg to the Ozempic pill 4 or 9 mg. A cross-molecule switch is a new prescription with a dose your prescriber chooses.

Q: What is the Ozempic pill dose compared with Rybelsus?
A: The shared label pairs Rybelsus 7 mg with the Ozempic pill 4 mg and Rybelsus 14 mg with the Ozempic pill 9 mg, and says the two are not substitutable milligram for milligram. Starting doses are 3 mg for Rybelsus and 1.5 mg for the Ozempic pill. Novo Nordisk says Rybelsus is being replaced by the Ozempic pill and that moving over needs a new prescription.

Q: Is the Wegovy pill dose the same as the Wegovy shot?
A: No. The pill climbs 1.5, 4, 9, then 25 mg once a day; the shot climbs 0.25, 0.5, 1, 1.7, then 2.4 mg once a week, with 7.2 mg as a further step. The label lets someone on the 2.4 mg shot start the 25 mg pill one week after the last injection, and suggests the 1.7 mg shot for anyone who does not tolerate 25 mg tablets.

Q: What happens if you miss a GLP-1 dose?
A: It depends on the label. Zepbound and Mounjaro: take it within 4 days, otherwise skip. Ozempic pen: within 5 days. Wegovy pen: take it if the next dose is more than 2 days away, and restart lower after 2 or more missed in a row. Wegovy pill, Ozempic pill and Rybelsus: skip it and carry on the next day. Foundayo: take it as soon as possible without doubling, and restart lower after 7 or more missed days.

Q: Does a higher GLP-1 dose cost more?
A: Paying cash, often yes. NovoCare charges $149 for the 1.5 mg Wegovy pill and $299 for 9 and 25 mg. Lilly charges $299 for 2.5 mg Zepbound and $699 for 10 to 15 mg, or $449 for 7.5 mg and up on the KwikPen with refills within 45 days. The cheapest compounded semaglutide program on our board today is $69 a month.

### Best GLP-1 for weight loss in 2026: ranked by trials + price
Source: https://pricetrackerglp1.com/guides/best-glp1-for-weight-loss (updated 2026-10-08)
Q: Which GLP-1 is best for weight loss?
A: Tirzepatide, sold as Zepbound, on the only head-to-head trial: 20.2% of body weight lost at 72 weeks against 13.7% for semaglutide in SURMOUNT-5. Semaglutide's new 7.2 mg dose (Wegovy HD) reached 18.7% in its own trial, STEP UP, but has not been run directly against tirzepatide.

Q: Which GLP-1 is the cheapest for weight loss?
A: Compounded semaglutide, from $69 a month on our board, verified on the seller's page today. The cheapest FDA-approved route is the Wegovy tablet at $149 a month direct from Novo. With a commercial plan that covers it, Zepbound or Wegovy is $25 through the maker's card, which makes the branded drugs the cheapest of all for people who qualify.

Q: Is Zepbound or Wegovy better?
A: Zepbound, for weight lost: its molecule beat Wegovy's by 6.5 points of body weight in the head-to-head. Wegovy has a tablet, a cardiovascular indication and a flat $349 cash price where Zepbound climbs to $699, so it is the better product for some people even though it is the weaker drug.

Q: Is Mounjaro good for weight loss?
A: It is tirzepatide, the same molecule as Zepbound, so it causes the same weight loss. But it is approved for type 2 diabetes, Lilly states outright that it is not a weight-loss drug, insurers refuse it for weight, and its self-pay price on LillyDirect starts at $499 a month against Zepbound's $299. For weight loss, ask for the Zepbound box.

Q: Are compounded GLP-1s as good as the brands?
A: Same molecule, same dose, so the trial evidence applies. What they lack is FDA approval of the finished product: no review of the specific preparation for safety, effectiveness or manufacturing quality, with the compounding pharmacy's own licensing standing behind it instead. That is the trade for a price of $69 to $85 a month against $349 to $699.

### Mounjaro cost 2026: $1,112 list, $499 self-pay, $25 covered
Source: https://pricetrackerglp1.com/guides/mounjaro-cost (updated 2026-10-08)
Q: How much does Mounjaro cost without insurance?
A: LillyDirect sells every Mounjaro strength self-pay starting at $499 a month, against a list price of $1,112.16 per fill. Zepbound, the same molecule approved for weight, is $299 to $699 a month direct from Lilly by dose.

Q: Can I buy Mounjaro self-pay for weight loss?
A: Not under LillyDirect's terms. Its self-pay purchase terms ask the buyer to confirm a prescription for an approved use consistent with the FDA label, and Mounjaro is approved for type 2 diabetes, not weight loss. For weight, the same tirzepatide is sold as Zepbound, direct from Lilly from $299 a month at the starting dose.

Q: Does paying cash for Mounjaro count toward my deductible?
A: No. LillyDirect's self-pay terms say the amount you pay does not count toward your insurance deductible or out-of-pocket spending, and for Medicare Part D members it does not count toward true out-of-pocket costs either. LillyDirect lists Mounjaro as FSA/HSA eligible, with eligibility varying by plan.

Q: How much is Mounjaro with insurance?
A: With commercial insurance that covers it, Lilly's Mounjaro Savings Program brings it to as little as $25 for up to a three-month prescription. Coverage is for type 2 diabetes; prescribed for weight loss, every insurer we hold documents for refuses it. Government plans are excluded from the card.

Q: Why is Mounjaro so expensive?
A: Its list price, $1,112.16 per fill, is set by Lilly and is what a pharmacy bills without coverage. The price most people actually pay is set by their plan. Without coverage, LillyDirect's self-pay price starts at $499 a month, still more than Zepbound's $299 starting dose for the same tirzepatide.

Q: Is Mounjaro cheaper than Zepbound?
A: At the starting doses, no: Zepbound is sold direct from $299 and Mounjaro from $499. At 10 mg and above, Mounjaro's flat $499 is below Zepbound's regular $699, though Zepbound's KwikPen is $449 with on-time refills. Through insurance both can reach $25 with the maker's card, but only where the plan covers that box for that reason: Mounjaro for diabetes, Zepbound for weight.

Q: How much weight do people lose on Mounjaro?
A: In Lilly's diabetes trials, adults lost between 12 lb at 5 mg and 25 lb at 15 mg. People without diabetes lose more on tirzepatide: 20.2% of body weight at 72 weeks in the Zepbound head-to-head trial. Lilly's own site states that Mounjaro is not a weight-loss drug; the same molecule approved for weight is Zepbound.

### Ro vs Hims vs Noom vs WeightWatchers GLP-1 cost (2026)
Source: https://pricetrackerglp1.com/guides/glp1-program-prices (updated 2026-10-08)
Q: How much does Ro's GLP-1 program cost?
A: A $149 monthly membership ($74 a month if you prepay a year) plus the medication: the Wegovy tablet at $149, the Wegovy pen at $199, Zepbound's KwikPen at $299 and Foundayo at $149 a month, read from Ro's pricing page in August 2026. A month of Wegovy pen through Ro is therefore about $348 all-in month to month, or $273 on the yearly prepay.

Q: How much does Hims charge for GLP-1s?
A: Hims's weight-loss page blocks automated reading, so we cannot quote a price from it and do not print prices we have not read. Ask for the membership fee and the medication price separately before completing its intake, because programs of this type advertise whichever of the two is smaller.

Q: How much is Noom Med?
A: Noom's GLP-1 page shows no price; the figure appears only after the intake quiz. That means it cannot be compared with Ro, WeightWatchers or Found before you provide your details. The two numbers to ask for are the monthly programme fee and the medication cost, since Noom prices them separately.

Q: How much is WeightWatchers Clinic with GLP-1?
A: The membership is $74 a month on a 12-month plan, more per month on a 6-month plan, with the first month at $25 under its current offer (read October 2026). Medication is not included: self-pay starts at $149 a month for the Wegovy pill, $199 for the Wegovy pen and $299 for Zepbound. Plans auto-renew for the same term at the same monthly rate unless cancelled.

Q: Which GLP-1 program is cheapest?
A: For branded medication on a 12-month plan, Ro and WeightWatchers come out almost identical at about $273 a month for a Wegovy pen once the membership is added; Ro month to month is $348. Found sells compounded semaglutide from $169 a month paying cash on a 12-month plan, with no membership fee. Cheaper than any programme is a telehealth seller pricing only the drug: compounded semaglutide from $69 a month on our board.

### How to get Zepbound in 2026: criteria, prescription, cost
Source: https://pricetrackerglp1.com/guides/how-to-get-zepbound (updated 2026-10-08)
Q: Who qualifies for Zepbound?
A: Adults with obesity, or with overweight and at least one weight-related condition, which the approval trials defined as a BMI of 30 or more, or 27 or more with a comorbidity such as high blood pressure, high cholesterol or sleep apnoea. It is separately approved for moderate to severe obstructive sleep apnoea in adults with obesity. It is not approved for type 2 diabetes; that is Mounjaro.

Q: Can I get Zepbound online?
A: Yes. Any licensed prescriber can write it, and telehealth programs do so routinely, often within the week. Ro, Sesame and Found dispense branded Zepbound alongside a membership; LillyDirect pairs an online consultation with Lilly's own self-pay pharmacy. Most online programs will not file insurance prior authorisation, which is the one reason to use your own doctor instead.

Q: How much does Zepbound cost with insurance?
A: With a commercial plan that covers it, as low as $25 a month using Lilly's savings card, usually after prior authorisation. Government plans are excluded from the card. Whether your plan covers it is plan-specific; among eight insurers we hold documents for, TRICARE covers it, Humana excludes it, and the rest say it depends on the plan.

Q: How do I get Zepbound if insurance won't cover it?
A: Buy it direct from Lilly, which sells it to cash patients at $299 for the 2.5 mg starting dose, $399 at 5 mg, $499 at 7.5 mg and $699 from 10 mg, or $449 on the vial or KwikPen from 7.5 mg with refills within 45 days. Or use compounded tirzepatide, the same molecule from licensed pharmacies at $85 and up on our board, which is not FDA-approved. If the refusal was a denied prior authorisation rather than a plan exclusion, appeal it too.

Q: How long does it take to get Zepbound?
A: Through telehealth, usually within a week of the consultation, shipped to you. Through your own doctor with insurance, the prior authorisation typically adds days to a couple of weeks. Direct from Lilly, the consultation and shipping run a few days. The first four weeks are always at 2.5 mg regardless of route.

### How to Get Mounjaro (2026): Criteria, Cost, Zepbound Option
Source: https://pricetrackerglp1.com/guides/how-to-get-mounjaro (updated 2026-10-08)
Q: Can I get Mounjaro for weight loss?
A: A prescriber can write it off-label, but it is approved only for type 2 diabetes, Lilly states that it is not a weight-loss drug, every insurer we hold documents for refuses it for weight, and LillyDirect self-pay starts at $499 a month. The same tirzepatide approved for weight is Zepbound, which plans can cover and Lilly sells direct at $299 to $699 a month.

Q: Who qualifies for Mounjaro?
A: Adults and children aged 10 and over with type 2 diabetes, to improve blood sugar alongside diet and exercise, and adults with type 2 diabetes at high cardiovascular risk. A diabetes diagnosis is the criterion; there is no BMI threshold, because it is not approved for weight.

Q: How much is Mounjaro with insurance?
A: With a commercial plan that covers it for diabetes, as little as $25 for up to a three-month prescription using Lilly's Mounjaro Savings Program. Government plans are excluded from the card but commonly cover Mounjaro for diabetes at their own copay. Prior authorisation usually turns on the diagnosis and A1C.

Q: How much is Mounjaro without insurance?
A: LillyDirect sells every strength self-pay starting at $499 a month, against a list price of $1,112.16 per fill. For the same molecule, Zepbound is $299 to $699 direct from Lilly by dose, and compounded tirzepatide starts at $85 on our board.

Q: Can I get Mounjaro online?
A: Yes, from any licensed telehealth prescriber, if you have type 2 diabetes. For a diabetes prescription your own diabetes clinician is usually the better route, because they hold the A1C history that prior authorisation asks for. For weight, online prescribers will generally write Zepbound instead, since it is the on-label box for the same drug.

### Stopping GLP-1s (2026): trial regain and the maintenance dose
Source: https://pricetrackerglp1.com/guides/stopping-glp1-weight-regain (updated 2026-10-08)
Q: What happens when you stop taking a GLP-1?
A: The weight comes back, most of it within a year. In the STEP 1 extension, people who lost 17.3% on semaglutide regained two-thirds of it in the year after stopping. In SURMOUNT-4, people who lost 20.9% on tirzepatide regained 14 points over the following year on placebo, while those who continued lost a further 5.5%. Blood pressure, lipids and blood sugar returned with the weight.

Q: Do you have to take GLP-1s forever?
A: Both labels describe the drugs as treatments to reduce weight and maintain the reduction long term, and the withdrawal trials show why: stopping returns about two-thirds of the loss within a year. Whether that means forever is a decision between you and a prescriber, but the evidence treats obesity as a condition managed for as long as it is treated, not a course that is completed.

Q: What is the maintenance dose of Wegovy or Zepbound?
A: The dose you climbed to and stay on. For the Wegovy pen the label names 1.7 or 2.4 mg, and lets a prescriber raise it to a maximum of 7.2 mg once 2.4 mg has been tolerated for at least 4 weeks; for Zepbound, 5 to 15 mg; the Wegovy tablet's label names 25 mg. Neither injection's label defines a lower dose to step down to at goal; Zepbound's names a lower maintenance dosage only for people who do not tolerate theirs. Prescribers do reduce doses in practice once weight is stable, but that is clinical judgement rather than a labelled regimen.

Q: Why has my GLP-1 stopped working?
A: Usually it has not. Every trial curve flattens past about a year; that plateau is the drug's full effect at that dose, not a failure. Stopping at a plateau still produces the regain seen in the withdrawal trials. If more loss is the goal, the options are a higher dose, such as Wegovy 7.2 mg, or a switch to tirzepatide, which lost 20.2% against semaglutide's 13.7% head-to-head.

Q: How much does it cost to stay on a GLP-1 long term?
A: The monthly price, indefinitely. At maintenance doses that is from about $830 a year for compounded semaglutide and $1,030 for compounded tirzepatide on our board, $3,588 for the Wegovy tablet and $4,537 for the pen direct from Novo, $5,837 for Zepbound at 10 mg and above direct from Lilly on the KwikPen refilled within 45 days ($9,087 at the regular price), or about $325 a year with a commercial plan that covers either brand at a $25 copay. The pen figures count 13 fills, because a Wegovy box and a Zepbound month are each 28 days.

### Zepbound dosage chart (2026): doses, schedule, cost per rung
Source: https://pricetrackerglp1.com/guides/zepbound-dosage-chart (updated 2026-10-08)
Q: What is the Zepbound dosing schedule?
A: Start at 2.5 mg once weekly for four weeks, then 5 mg. After that the dose may rise in 2.5 mg steps, with at least four weeks on each, through 7.5, 10 and 12.5 mg to a maximum of 15 mg. The label names 5, 10 and 15 mg as maintenance doses for weight and 10 or 15 mg for sleep apnoea, and says to consider a lower maintenance dose if a higher one is not tolerated.

Q: How much weight does each Zepbound dose lose?
A: In SURMOUNT-1, over 72 weeks in adults without diabetes: 15.0 percent of body weight at 5 mg, 19.5 percent at 10 mg, 20.9 percent at 15 mg, against 3.1 percent on placebo. Half of people at 10 mg and 57 percent at 15 mg lost 20 percent or more. The 7.5 and 12.5 mg rungs were not separate trial arms.

Q: Can you stay on 2.5 mg of Zepbound?
A: Not on the label. It states that 2.5 mg is for treatment initiation and is not approved as a maintenance dosage. The lowest approved maintenance dose is 5 mg. Prescribers sometimes hold people at 2.5 mg longer than four weeks for tolerability, but the label's framework treats it as a starting rung, not a destination.

Q: How many units is a Zepbound dose in a syringe?
A: For Lilly's multi-dose vials, every dose is 0.6 mL, which is 60 units on a standard insulin syringe, because each strength is its own concentration: 4.17 mg/mL for 2.5 mg up to 20.8 mg/mL for 12.5 mg. Compounded tirzepatide vials use different concentrations, so the units depend on the vial: units equal milligrams divided by the vial's mg per mL, times 100.

Q: What happens if I miss a Zepbound dose?
A: The label says to take it as soon as possible within four days, 96 hours, of the missed dose. If more than four days have passed, skip it and take the next dose on the regular day. Do not take two doses within three days of each other. The label also allows the weekly day to be changed as long as that three-day gap is kept.

Q: How much does each Zepbound dose cost?
A: With a commercial plan that covers it, as low as $25 at any dose with Lilly's card. Direct from Lilly without insurance: $299 for 2.5 mg and $399 for 5 mg; from 7.5 mg the single-dose vial or KwikPen is $449 a month while each refill is within 45 days, otherwise $499 for 7.5 mg and $699 for 10, 12.5 and 15 mg. Lilly's list price is $499 to $1,086.37 per fill. Compounded tirzepatide starts at $85 a month on our board.

### Compounded tirzepatide in 2026: legality, FDA position, price
Source: https://pricetrackerglp1.com/guides/compounded-tirzepatide (updated 2026-10-08)
Q: Is compounded tirzepatide the same as Zepbound?
A: The same molecule, tirzepatide, made by a compounding pharmacy rather than Lilly. At the same dose the expected effect is the same. What differs is that Zepbound is an FDA-approved product with a fixed-dose pen and a manufacturer's supply chain, and a compounded vial has not been reviewed by FDA for safety, effectiveness or quality and is usually measured by you with a syringe.

Q: Is compounded tirzepatide still legal?
A: Compounding for an individual patient on a prescription remains lawful. What has ended is the shortage exemption that allowed pharmacies to compound copies of Zepbound at scale: FDA states tirzepatide no longer appears on its drug shortage list, and has proposed excluding it from the list of substances 503B facilities may compound from bulk. Sellers now rely on per-patient prescriptions, often with a modified formulation.

Q: Is compounded tirzepatide safe?
A: The molecule is the same and its side effects are the drug's. FDA's specific concerns are about the product around it: dosing errors from self-measured vials that have led to hospitalisations, doses beyond the approved label, fraudulent products naming pharmacies that do not exist, and vials shipped warm. Each is checkable: confirm the pharmacy's licence, the concentration and units in writing, the label's schedule, and cold delivery.

Q: How much does compounded tirzepatide cost?
A: From $85 a month at the starting dose on our board, with maintenance doses typically higher and varying by seller. Zepbound direct from Lilly is $299 for 2.5 mg, $399 for 5 mg, $499 for 7.5 mg and $699 for 10 mg and above, or $449 on the KwikPen from 7.5 mg with refills within 45 days. A year climbing to 15 mg, 13 four-week fills, costs $5,637 from Lilly on time-kept KwikPen refills ($8,187 at the regular price) against about $1,000 to $4,800 compounded at the from-prices on our board ($85 to $399 a month), more where a seller charges by dose.

Q: What is the difference between 503A and 503B compounded tirzepatide?
A: A 503A pharmacy compounds per prescription under state board oversight and is not held to manufacturing standards. A 503B outsourcing facility compounds in batches, is registered with and inspected by FDA, and must meet current good manufacturing practice. Neither product is FDA-approved, but 503B is the higher standard, and it is what a seller means by an FDA-registered facility.

### Compounded semaglutide vs Wegovy (2026): same drug? FDA, price
Source: https://pricetrackerglp1.com/guides/compounded-semaglutide-vs-wegovy (updated 2026-10-08)
Q: Is compounded semaglutide the same as Wegovy?
A: Same molecule, different product. Both contain semaglutide. Wegovy is made by Novo Nordisk and approved by FDA; compounded semaglutide is mixed by a licensed pharmacy and FDA does not verify its safety, effectiveness or quality before it is sold.

Q: How much cheaper is compounded semaglutide than Wegovy?
A: Wegovy's pen is $349 a month from Novo at any dose from 0.25 to 2.4 mg, $4,537 a year because each box is a 28-day supply and a year takes 13, with $199 for a new patient's first two fills. Compounded prices change weekly; the live floor and every verified price are on our semaglutide board.

Q: Is compounded semaglutide legal?
A: Yes, from a licensed pharmacy with a prescription. FDA says compounded drugs should be used only when an approved drug cannot meet a patient's need or is not available, and states semaglutide is not on its drug shortage list.

Q: Does insurance cover compounded semaglutide?
A: No. The $25 commercial savings card (capped at $100 a month) and the $50 Medicare GLP-1 Bridge both apply to Wegovy. If either covers you, compare that $25 or $50 with the compounded floor on our board first.

Q: What are the risks of compounded semaglutide compared with Wegovy?
A: FDA lists dosing errors from self-measured vials, some leading to hospitalization, doses beyond the label, fake labels, and vials shipped warm. It also says to discard a vial 28 days after first use. None is about the molecule; all are checkable.

### Foundayo vs Wegovy pill (2026): label, food rules, prices
Source: https://pricetrackerglp1.com/guides/foundayo-vs-wegovy-pill (updated 2026-10-08)
Q: What is the difference between Foundayo and the Wegovy pill?
A: They are different molecules. Foundayo is orforglipron, a small-molecule GLP-1 from Lilly, sold since April 2026. The Wegovy pill is semaglutide from Novo, on sale since January 2026. Both are once-daily tablets approved for weight loss in adults.

Q: Which is cheaper, Foundayo or the Wegovy pill?
A: On self-pay they match for most of the ladder: $149, $199 and $299 a month by strength. Foundayo's top two strengths, 14.5 and 17.2 mg, are $349 regular or $299 on Lilly's offer if each refill is bought within 45 days. The Wegovy pill tops out at $299.

Q: Can you take Foundayo with food?
A: Yes. Lilly's instruction is to take it by mouth once a day, with or without food, swallowing the tablet whole. For the Wegovy pill, follow its own label instructions.

Q: Which pill causes more weight loss?
A: No source we hold compares them head to head. For Foundayo, ATTAIN-1 reported 12.4% (27.3 lb) average loss on the highest dose among people who stayed on treatment, against 0.9% on placebo. We hold no quotable trial figure for the Wegovy tablet.

Q: Does Medicare cover Foundayo and the Wegovy pill?
A: Both are on the Medicare GLP-1 Bridge: eligible Part D members pay a $50 copayment per 30-day supply, from 1 July 2026 through 31 December 2027.

### Tirzepatide vs semaglutide (2026): trial result + real prices
Source: https://pricetrackerglp1.com/guides/tirzepatide-vs-semaglutide (updated 2026-10-08)
Q: Is tirzepatide better than semaglutide for weight loss?
A: Yes, on the only head-to-head evidence there is. In SURMOUNT-5, 751 non-diabetic adults with obesity took the maximum tolerated dose of one or the other for 72 weeks: tirzepatide reduced body weight by 20.2% and semaglutide by 13.7%, with waist circumference down 18.4 cm against 13.0 cm. The trial was open-label and excluded people with type 2 diabetes.

Q: How much more does tirzepatide cost than semaglutide?
A: On our board, verified today, compounded tirzepatide starts at $85 a month against $69 for compounded semaglutide, and most sellers price tirzepatide 50% to 100% higher. Branded, Lilly's Zepbound self-pay runs $299 to $699 by dose while Novo's Wegovy pen is $349 flat and the tablet $149 to $299.

Q: Why does tirzepatide work better?
A: Semaglutide activates one gut-hormone receptor, GLP-1. Tirzepatide activates two, GIP and GLP-1, and its label describes it as a GIP receptor and GLP-1 receptor agonist. The second receptor is the mechanical difference, and the head-to-head trial is the evidence that it translates into more weight lost.

Q: Are the side effects different?
A: Not in kind. Both slow the stomach, so both cause nausea, diarrhoea, vomiting, constipation and tiredness, and both carry the same thyroid warning and the same contraindication for a family history of medullary thyroid carcinoma. The head-to-head trial found no new signal separating them; gut effects track dose and the pace of escalation more than the molecule.

Q: Which one should I take?
A: If your insurance covers either at a $25 copay, tirzepatide, because the price difference vanishes and only the better result is left. If you are paying cash on a tight budget, semaglutide is the usual starting point at $69 to $149 a month. If you have tried semaglutide and stalled, tirzepatide is the documented step up.

### Zepbound vs Wegovy (2026): trial result, cash prices, coverage
Source: https://pricetrackerglp1.com/guides/zepbound-vs-wegovy (updated 2026-10-08)
Q: Is Zepbound better than Wegovy?
A: For weight loss, yes. In SURMOUNT-5, tirzepatide (Zepbound's molecule) reduced body weight by 20.2% at 72 weeks against 13.7% for semaglutide (Wegovy's), in 751 non-diabetic adults with obesity taking the highest dose they could tolerate. Wegovy has two things Zepbound does not: a cardiovascular risk-reduction indication and a tablet form.

Q: How much does Zepbound cost vs Wegovy without insurance?
A: Lilly's Zepbound self-pay is $299 at 2.5 mg, $399 at 5 mg, $499 at 7.5 mg and $699 at 10 mg and above, or $449 on the vial or KwikPen from 7.5 mg with refills within 45 days. Novo's Wegovy pen is $349 a month at any standard dose ($399 for the 7.2 mg HD pen), and the Wegovy tablet is $149, $199 or $299 by strength. Both are the makers' published direct prices.

Q: Does insurance cover Zepbound or Wegovy?
A: It depends on the plan, not the drug. Both are the weight-loss brands and are treated alike by most insurers: covered on some plans, excluded on others, usually behind prior authorisation. TRICARE covers both; Humana covers neither. Where a commercial plan does cover one, the maker's card brings the copay to as low as $25.

Q: Can I switch from Wegovy to Zepbound?
A: Yes, and people do when they stall on semaglutide. There is no direct dose conversion; you start Zepbound at 2.5 mg and climb. We cover the practicalities, and who is really deciding, in the switching guide.

Q: Which has a pill?
A: Only Wegovy. Novo sells a once-daily semaglutide tablet at $149 to $299 a month depending on strength, which it describes as the first FDA-approved semaglutide pill for weight loss. Zepbound is injection only, as a single-dose pen, a vial or a KwikPen.

### Zepbound Cost Without Insurance (2026): $299 to $449 a Month
Source: https://pricetrackerglp1.com/guides/zepbound-cost-without-insurance (updated 2026-10-08)
Q: How much is Zepbound without insurance?
A: Direct from Lilly's self-pay programme: $299 a month at the 2.5 mg starting dose and $399 at 5 mg. From 7.5 mg the vial and the KwikPen are both $449 while each refill is within 45 days of the last; otherwise $499 at 7.5 mg and $699 at 10, 12.5 and 15 mg. Lilly's list price, what a pharmacy would bill without the programme, is $499 to $1,086.37 per fill.

Q: How much does Zepbound cost per year without insurance?
A: It depends where you settle on the dose ladder. A year of weekly doses is 13 four-week fills. Holding at 5 mg is about $5,100 in year one and $5,187 after. Reaching 10 mg or above, which is where the trial results came from, is $5,637 in year one and $5,837 after when every refill is on time, or $8,187 and $9,087 at the regular $699.

Q: How much do Zepbound vials cost?
A: The same as the KwikPen at the same dose: $299 for 2.5 mg and $399 for 5 mg per four-week month, then $449 from 7.5 mg while each refill is within 45 days of the last, or $499 for 7.5 mg and $699 for 10 mg and above at the regular price. Lilly's $449 refill offer covers the single-dose vial as well as the KwikPen. A vial carton holds four single-dose vials; the KwikPen holds four doses in one pen. Both are Lilly's self-pay products for cash patients.

Q: How much does tirzepatide cost without insurance?
A: It depends on the brand. Zepbound from Lilly's self-pay programme is $299 a month at 2.5 mg and $399 at 5 mg, then $449 on the vial or KwikPen from 7.5 mg with on-time refills, or $499 to $699 at the regular price. Mounjaro from LillyDirect is listed starting at $499 a month at every strength, against a pharmacy list price of $1,112.16 per fill. Compounded tirzepatide, which is not FDA-approved, starts at $85 a month on our board.

Q: Can I use the Zepbound savings card without insurance?
A: No. Lilly's terms require commercial drug insurance with coverage for Zepbound, and exclude government beneficiaries. Without insurance the self-pay prices are the only Lilly route, apart from the income-tested Lilly Cares patient assistance programme.

Q: Is compounded tirzepatide cheaper than Zepbound?
A: Substantially. Compounded tirzepatide from licensed pharmacies starts at $85 a month on our board, verified on each seller's page today, against $299 to $449 for Zepbound self-pay with on-time refills ($699 regular). It is the same molecule and it is not FDA-approved, so the pharmacy's licensing rather than FDA review stands behind the product.

### Zepbound vs Mounjaro (2026): same drug, different cover, cost
Source: https://pricetrackerglp1.com/guides/zepbound-vs-mounjaro (updated 2026-10-08)
Q: Is Zepbound the same as Mounjaro?
A: Yes, chemically. Both are tirzepatide, made by Lilly, injected weekly at the same six doses from 2.5 to 15 mg. Mounjaro is approved for type 2 diabetes and Lilly's own site says it is not a weight-loss drug; Zepbound is the same molecule approved for obesity, overweight with a related condition, and obstructive sleep apnoea.

Q: Can I take Mounjaro for weight loss?
A: A doctor can prescribe it off-label, but insurers almost universally refuse to cover it for weight loss, and LillyDirect self-pay starts at $499 a month. Zepbound is the identical molecule approved for weight, which is why it is the box a plan can cover, with a cash price of $299 to $699 by dose.

Q: Which is cheaper, Zepbound or Mounjaro?
A: Zepbound, for anyone paying cash. Lilly sells it direct at $299 to $699 a month by dose, or $449 on the vial or KwikPen from 7.5 mg with on-time refills. Mounjaro's list price is $1,112.16 per fill and LillyDirect sells it from $499 a month self-pay. Through insurance both fall to as low as $25 with the maker's card, but only where the plan covers that box for that reason.

Q: Are the doses different?
A: No. Zepbound and Mounjaro use the same ladder: 2.5 mg to start, then 5, 7.5, 10, 12.5 and 15 mg, climbing every four weeks as tolerated. This is unlike Wegovy and Ozempic, where the weight-loss box goes higher than the diabetes box.

Q: Does insurance cover Zepbound or Mounjaro?
A: Mounjaro is widely covered for type 2 diabetes and refused for weight loss by every insurer we hold documents for. Zepbound coverage for weight loss is plan-specific: TRICARE covers it, Humana excludes it, and most large commercial plans say it depends on the plan and require prior authorisation.

### How to get Wegovy or Zepbound covered by insurance (2026)
Source: https://pricetrackerglp1.com/guides/how-to-get-a-glp1-covered-by-insurance (updated 2026-10-08)
Q: How do I get Wegovy covered by insurance?
A: First find out whether your employer bought the weight-loss drug benefit at all, because that decides most cases before any clinical criterion applies. If it is included, the published criteria are consistent across insurers: BMI of 30 or more, or 27 with a weight-related condition, plus a documented period of lifestyle and dietary change, usually three to six months. Your prescriber then submits the prior authorisation with that documentation.

Q: Why was I denied even though I meet the BMI requirement?
A: Almost always because the denial was not about your BMI. If your plan excludes weight-loss medications as a category, the drug is not being refused on your facts and no clinical evidence changes it. The other common reasons are step therapy, meaning you have to try a preferred drug first, and missing documentation of the lifestyle requirement rather than missing effort.

Q: What BMI do you need for insurance to cover a GLP-1?
A: The near-universal published threshold is a BMI of 30 or more, or 27 or more with at least one weight-related comorbidity such as high blood pressure, type 2 diabetes, sleep apnea or dyslipidemia. Some plan variants set a higher bar, so check the criteria document your own plan uses.

Q: How long does a GLP-1 prior authorization last?
A: Typically five to twelve months for a first approval, then it has to be renewed. Renewal usually turns on results: UnitedHealthcare, for example, issues an initial Wegovy authorisation for five months and requires weight loss of at least 5 percent of baseline body weight to continue. That makes a recorded starting weight important before you begin.

Q: Do I need to try other medications first?
A: Sometimes, and this is step therapy rather than a refusal. The BCBS Federal Employee Program's Zepbound policy, for instance, requires an inadequate response, intolerance or contraindication to at least two oral weight-management medications and that you have tried the preferred products first, unless there is a valid medical exception.

Q: What if my employer does not cover weight-loss drugs?
A: Then coverage is not the route. Manufacturer savings cards need an insured copay to work on, so they do not help either. That leaves the manufacturers' own cash prices and the compounded telehealth market, which is cheaper again but not FDA-approved. We track and rank the cash options weekly.

### Switching from Wegovy to Zepbound in 2026: coverage and cost
Source: https://pricetrackerglp1.com/guides/switching-wegovy-to-zepbound (updated 2026-10-08)
Q: Why is my insurance making me switch from Zepbound to Wegovy?
A: Because your formulary prefers Wegovy. CVS Caremark removed Zepbound from its commercial formularies on 1 July 2025 and told members that all of them, regardless of indication, would need to have tried and failed Wegovy before accessing tirzepatide. That is a formulary decision made by the pharmacy benefit manager rather than a clinical judgement about you.

Q: Can I switch back from Wegovy to Zepbound?
A: Usually yes, with a documented trial of the preferred drug: which brand, for how long, at what dose, and whether the outcome was inadequate response, intolerance or a contraindication. Your prescriber files it as a formulary exception. On Caremark plans it may also be unnecessary, since CVS Caremark said Zepbound would return as an additional preferred option on 1 October 2026; adoption varies by plan, so check yours.

Q: How do I convert my Wegovy dose to Zepbound?
A: You do not convert it. Semaglutide and tirzepatide are different molecules with separate labels and separate titration schedules, so your prescriber decides your starting dose on the new drug rather than translating the old one. Bring your current dose, how long you have been on it, your results and any side effects to that conversation.

Q: Is Zepbound or Wegovy cheaper without insurance?
A: Novo publishes a flat $349 a month for the Wegovy pen at every standard dose and $399 for the 7.2 mg high-dose pen. Compare that against the current cash price for tirzepatide rather than assuming, and note that compounded programs for both molecules sit below either brand, with the trade-off that they are not FDA-approved.

Q: Does switching restart my prior authorization?
A: Generally yes. A new drug means a new authorisation with its own criteria and its own approval period, and renewal typically depends on results, commonly around 5 percent weight loss from baseline. Ask for a recorded baseline weight before you start the new drug rather than reconstructing it later.

### Semaglutide dosage chart 2026: every dose and its price
Source: https://pricetrackerglp1.com/guides/semaglutide-dosage-chart (updated 2026-10-08)
Q: What is the semaglutide dose ladder?
A: For Wegovy, the pen strengths are 0.25 mg, 0.5 mg, 1 mg, 1.7 mg and 2.4 mg, with a 7.2 mg high-dose strength above them. Treatment starts at the bottom and steps up over several months so gastrointestinal effects have time to settle. Your schedule is set by your prescriber.

Q: Does semaglutide cost more at higher doses?
A: On the brand, no. Novo Nordisk's published self-pay price is $349 a month for Wegovy at 0.25, 0.5, 1, 1.7 and 2.4 mg, so the price is flat across the whole standard pen range. The 7.2 mg high-dose strength is $399. Compounded sellers vary: some hold one price at every dose and others charge more as the dose climbs.

Q: How long does it take to reach the maintenance dose?
A: The manufacturer's schedule holds a patient at each step for several weeks, which puts the maintenance dose a few months out from the first injection rather than a few weeks. Prescribers commonly slow this down further if side effects are difficult.

Q: Why does my program's price go up when my dose does?
A: Because it prices by strength rather than per month. This is common among compounded telehealth programs and it is legitimate, but it means the advertised entry price is the starting-dose price, not what you will pay at maintenance. Ask whether the price holds at every dose before you sign up.

Q: Is the Ozempic dosage chart the same as Wegovy's?
A: No. Ozempic is the same molecule approved for type 2 diabetes rather than weight management, its pen strengths top out lower than Wegovy's, and Novo prices the two separately.

### Ozempic side effects (2026): what to expect, when they settle
Source: https://pricetrackerglp1.com/guides/ozempic-side-effects (updated 2026-10-08)
Q: What are the most common Ozempic side effects?
A: Gastrointestinal ones: nausea, vomiting, diarrhoea, abdominal pain and constipation, the five the label lists as reported by at least 5% of patients. They are most pronounced in the first weeks and for a few days after each dose increase, which is why the drug is titrated upward slowly rather than started at the target dose.

Q: How long do Ozempic side effects last?
A: For most people the early symptoms settle as the body adjusts to a given dose, then return briefly at the next step up. Because the manufacturer's schedule holds each strength for several weeks, the pattern typically repeats over the first few months rather than resolving all at once. Persistent or severe symptoms are a reason to contact your prescriber.

Q: Does Ozempic have a boxed warning?
A: Yes, for thyroid C-cell tumour risk. Separately, the label for Wegovy, the same molecule, says combining it with other semaglutide products or any other GLP-1 is not recommended. A boxed warning is the strongest warning the FDA applies and is a specific risk for your prescriber to weigh against your history.

Q: Are Ozempic and Wegovy side effects the same?
A: They are the same molecule, semaglutide, so the type of side effect is the same. The exposure is not: Wegovy is dosed higher for weight management, and dose is the main driver of how pronounced the gastrointestinal effects are. Ozempic is approved for type 2 diabetes; using it for weight loss is off-label.

Q: Can I take Ozempic and compounded semaglutide together?
A: No. The Wegovy label, for the same molecule from the same maker, says use with other semaglutide-containing products or with any other GLP-1 receptor agonist is not recommended, and compounded semaglutide is the same molecule. This matters practically because it is easy to do by accident when bridging a gap in supply or switching sellers. Tell each prescriber about the other.

### Wegovy side effects (2026): what changes as the dose climbs
Source: https://pricetrackerglp1.com/guides/wegovy-side-effects (updated 2026-10-08)
Q: What are the most common Wegovy side effects?
A: Nausea, vomiting, diarrhoea and constipation. They are most pronounced in the first weeks and for a few days after each dose increase, then tend to settle at a steady dose. The label's list of reactions seen in at least 5% of patients also includes abdominal pain, headache, fatigue, dysesthesia (altered skin sensations, far more common at 7.2 mg) and hair loss.

Q: Are Wegovy side effects worse than Ozempic's?
A: They are the same molecule, so the same kinds of effect. Wegovy is dosed higher because it is indicated for weight management, climbing to 2.4 mg with a 7.2 mg strength above it, and dose is the main driver of how pronounced the gastrointestinal effects are. That is why Wegovy accounts often sound more difficult than Ozempic ones.

Q: Does Wegovy have a boxed warning?
A: Yes, for thyroid C-cell tumour risk, and it should not be combined with other GLP-1 medicines. A boxed warning is the strongest warning the FDA applies and is a specific risk for a prescriber to weigh against your history.

Q: Can I go up the doses more slowly if side effects are bad?
A: That is a decision for your prescriber, and it is a common and unremarkable one for them to make. Worth knowing while you ask: Novo's published self-pay price is the same at every pen dose from 0.25 mg to 2.4 mg, so on the brand a slower climb does not cost more. Some compounded sellers price by strength, so on those it can.

Q: What is Wegovy HD 7.2 mg?
A: A high-dose strength above the standard range. Novo prices it $50 a month above every other pen dose. Whether it is appropriate for anyone is entirely a prescriber's decision; it is not the default destination of the ladder.

### Semaglutide side effects (2026): brand vs compounded
Source: https://pricetrackerglp1.com/guides/semaglutide-side-effects (updated 2026-10-08)
Q: Are compounded semaglutide side effects different from Ozempic or Wegovy?
A: The side effects come from the molecule, so the kinds of effect are the same: nausea, vomiting, diarrhoea and constipation, worst early and after each dose increase. What differs is oversight of the finished product, the sourcing, and usually the way the dose is measured, since compounded semaglutide commonly comes as a vial and syringe rather than a pre-set pen.

Q: Is compounded semaglutide FDA-approved?
A: No. Compounded drugs are not FDA-approved, meaning the finished product has not been reviewed for safety, effectiveness or manufacturing quality. Compounding is legal and long-established, but the assurance an approval provides is not present, and the pharmacy's own licensing is doing that work instead.

Q: What has the FDA said about compounded semaglutide recently?
A: The FDA has stated that semaglutide does not appear on the 503B bulks list or its drug shortage list, and that for state-licensed pharmacies compounding semaglutide injection under section 503A, the period of enforcement discretion has ended. It has separately proposed excluding semaglutide from the 503B bulks list, finding no clinical need for outsourcing facilities to compound it from bulk substances.

Q: Does semaglutide's boxed warning apply to compounded versions?
A: The boxed warning for thyroid C-cell tumour risk attaches to the molecule, not to a particular manufacturer, and the instruction not to combine GLP-1 medicines applies the same way. If anything the combination warning matters more for compounded buyers, because bridging supply gaps and switching sellers are the situations where two overlap by accident.

Q: What should I ask a compounded seller before buying?
A: Which pharmacy makes it, by name, and where it is licensed; how the dose is measured, whether pen, vial and syringe, or units; whether there is a clinician you can reach when a week is difficult; and what the pause and refund terms are. Price after those, not before.

### GLP-1 injection sites (2026): abdomen, thigh or upper arm
Source: https://pricetrackerglp1.com/guides/glp1-injection-sites (updated 2026-10-08)
Q: Where do you inject Ozempic, Wegovy or Zepbound?
A: Subcutaneously in the abdomen, thigh or upper arm, rotating sites with each dose. That is what the FDA labels state. Zepbound's label adds that the back of the upper arm should be injected by another person.

Q: Do I need to rotate injection sites?
A: Yes. Both the Wegovy and Zepbound labels say to rotate injection sites with each dose, in those words.

Q: Can I inject my own arm?
A: The labels differ here. Wegovy's dosing section and its pen instructions list the upper arm alongside the abdomen and thigh without qualification, but its instructions for the single-dose prefilled syringe say the back of the upper arm only with help from someone else. Zepbound's says another person should inject in the back of the upper arm. If you have been injecting your own arm, raise it with your prescriber rather than relying on a general article.

Q: Does it matter what time of day, or whether I have eaten?
A: No. Wegovy's label says to administer once weekly, on the same day each week, at any time of day, with or without meals. Zepbound's says once weekly at any time of day, with or without meals.

Q: Can I share a pen with someone if I change the needle?
A: No. The Wegovy label says the FlexTouch pen must never be shared between patients, even if the needle is changed, because pen-sharing poses a risk for transmission of blood-borne pathogens. Changing the needle does not make a shared pen safe.

Q: Is injecting compounded semaglutide different from using a pen?
A: Usually yes. A pen is pre-set and measures the dose for you. Compounded semaglutide commonly arrives as a vial and a syringe, sometimes marked in units rather than milligrams, so you are measuring the dose as well as administering it. Ask your program to demonstrate it with a named clinician before your first dose.

### Wegovy dosing chart 2026: every dose and the first-year cost
Source: https://pricetrackerglp1.com/guides/wegovy-dosing-chart (updated 2026-10-08)
Q: What is the Wegovy dosing schedule?
A: The pen strengths are 0.25 mg, 0.5 mg, 1 mg, 1.7 mg and 2.4 mg, with a 7.2 mg high-dose strength above them. Treatment starts at the bottom and steps up over months so side effects can settle. Your schedule is set by your prescriber.

Q: Does Wegovy cost more at higher doses?
A: No, not on the brand. Novo's published self-pay price is $349 a month for 0.25, 0.5, 1, 1.7 and 2.4 mg, so it is flat across the whole standard range. The 7.2 mg high-dose pen is $399. Some compounded sellers do price by strength.

Q: What does a year of Wegovy cost?
A: On Novo's published self-pay rates, a new patient pays $199 for each of their first two monthly fills and $349 thereafter. A box is a 28-day supply, so a year is 13 boxes: $4,237 for the first year and $4,537 for each year after. The introductory rate runs through 31 December 2026 and applies to patients new to the offer.

Q: How long does it take to reach the 2.4 mg maintenance dose?
A: Novo's schedule holds a patient at each strength for several weeks, which puts the maintenance dose a few months from the first injection rather than a few weeks. Prescribers commonly slow it further if side effects are difficult, and on the brand that does not cost more.

Q: When should I inject Wegovy?
A: The FDA label says to administer it once weekly, on the same day each week, at any time of day, with or without meals, rotating injection sites with each dose. There is no requirement to take it on an empty stomach or at a particular hour.

### Ozempic butt (2026): what it is and what actually causes it
Source: https://pricetrackerglp1.com/guides/ozempic-butt (updated 2026-10-08)
Q: Is “Ozempic butt” a real side effect?
A: No. It is not a listed adverse reaction and it is not specific to Ozempic or to GLP-1 medicines. It describes loss of volume and loose skin around the buttocks following rapid weight loss, which occurs after substantial fast weight loss from any cause.

Q: Why does Ozempic cause sagging?
A: It does not do so directly. Body fat is lost everywhere rather than selectively, so fat leaves the buttocks along with everywhere else, and skin that loses volume quickly does not always retract to match. Rate of loss and skin elasticity, which declines with age, decide how noticeable it is.

Q: Does it go away?
A: Volume generally tracks your body fat, so it returns if the weight returns, which is usually not the trade people want. Skin that has stretched and lost volume does not always retract fully, and outcomes vary considerably between people.

Q: Does it happen on Wegovy, Mounjaro or compounded versions too?
A: Yes, because it is a consequence of weight loss rather than of a particular molecule or brand. Any program producing substantial rapid loss can produce the same change.

### Mounjaro vs Ozempic (2026): 2 Trials, $499 vs $349 Self-Pay
Source: https://pricetrackerglp1.com/guides/mounjaro-vs-ozempic (updated 2026-10-08)
Q: Is Mounjaro better than Ozempic for weight loss?
A: In the one head-to-head trial, SURMOUNT-5, tirzepatide produced 20.2% mean body-weight loss at 72 weeks against semaglutide's 13.7%. That trial used tirzepatide at 10 or 15 mg and semaglutide at 1.7 or 2.4 mg in adults with obesity and without diabetes, which are the Zepbound and Wegovy dose ranges rather than Mounjaro and Ozempic as prescribed for diabetes.

Q: What is the difference between Mounjaro and Ozempic?
A: They are different molecules. Mounjaro is tirzepatide, made by Eli Lilly. Ozempic is semaglutide, made by Novo Nordisk. Both are approved for type 2 diabetes. The corresponding weight-loss brands are Zepbound for tirzepatide and Wegovy for semaglutide.

Q: Are Mounjaro and Zepbound the same thing?
A: They are the same molecule, tirzepatide, from the same manufacturer, sold under two brand names for two different indications: Mounjaro for type 2 diabetes and Zepbound for weight management. The same relationship holds between Ozempic and Wegovy for semaglutide.

Q: Does SURMOUNT-5 prove Mounjaro beats Ozempic?
A: Not precisely. It compared the molecules, tirzepatide against semaglutide, at doses corresponding to the weight-loss brands and in people without diabetes. Ozempic's dose range tops out at 2 mg, below the 2.4 mg the trial used. The result is real and favours tirzepatide; it is more accurately a Zepbound versus Wegovy finding.

Q: Has Mounjaro been tested against Ozempic in people with diabetes?
A: Yes. SURPASS-2 randomly assigned 1,879 people with type 2 diabetes to tirzepatide 5, 10 or 15 mg or semaglutide 1 mg for 40 weeks. A1C fell by 2.01, 2.24 and 2.30 points on the tirzepatide doses against 1.86 on semaglutide, and every tirzepatide dose was superior. Weight loss was also greater on tirzepatide.

Q: Is Mounjaro or Ozempic cheaper without insurance?
A: Paying the manufacturer directly, Ozempic is cheaper at the starting doses: Novo charges new patients $199 a month for two fills, then $349 a month up to 1 mg and $499 at 2 mg. Lilly's self-pay price for Mounjaro starts at $499 a month. A fill of either lasts four weeks, so a year is 13 fills: over a first year that is $4,237 for Ozempic up to 1 mg against $6,487 for Mounjaro.

Q: Does Medicare cover Mounjaro or Ozempic?
A: Not through the Medicare GLP-1 Bridge, which lists Foundayo, Wegovy and the Zepbound KwikPen and excludes people with type 2 diabetes. Both are diabetes drugs, so coverage runs through your Part D plan's formulary, which varies by plan.

Q: Which one should I take?
A: That is a decision for a prescriber, who is weighing your indication, your history and what you tolerate. Trial averages do not tell you which drug you personally can stay on, and the one you stay on outperforms the one you stop.

### Rybelsus for type 2 diabetes (2026): the Ozempic pill switch
Source: https://pricetrackerglp1.com/guides/rybelsus-for-type-2-diabetes (updated 2026-10-08)
Q: What is Rybelsus used for?
A: Rybelsus is oral semaglutide for adults with type 2 diabetes. Novo Nordisk lists the 7 and 14 mg tablets for improving blood sugar alongside diet and exercise, and for reducing the risk of major cardiovascular events such as heart attack, stroke or death in adults with type 2 diabetes at high risk of them.

Q: Is Rybelsus being discontinued?
A: Novo Nordisk says Rybelsus is being replaced by the Ozempic pill and that your health care provider will guide you through the change. Moving over needs a new prescription, and Novo says the Ozempic pill gets the same coverage as Rybelsus.

Q: What is the Ozempic pill dose that matches my Rybelsus dose?
A: Novo pairs Rybelsus 3 mg with Ozempic pill 1.5 mg, 7 mg with 4 mg, and 14 mg with 9 mg, and says the Ozempic tablets work similarly with the same efficacy and safety. Your prescriber decides which strength you move to.

Q: Is Rybelsus the same as the Wegovy pill?
A: No. Both are oral semaglutide, but Rybelsus is 3, 7 and 14 mg for type 2 diabetes, while the Wegovy pill is 1.5, 4, 9 and 25 mg and is labelled to help adults with obesity, or with excess weight and a weight-related condition, lose weight and keep it off.

Q: How much does Rybelsus cost without insurance?
A: NovoCare Pharmacy, Novo's own self-pay pharmacy, does not list Rybelsus. It lists the Ozempic pill that replaces it, with self-pay options starting at $149 a month, priced by dose and processed outside insurance. Our oral semaglutide ranking shows the programs we track, cheapest first.

### Does Ozempic cause hair loss? What is happening (2026)
Source: https://pricetrackerglp1.com/guides/glp1-hair-loss (updated 2026-10-08)
Q: Does Ozempic cause hair loss?
A: Ozempic's label does not list hair loss among the common reactions in its diabetes trials, but it lists alopecia among reports received after approval. Wegovy, the same molecule at higher doses, reports hair loss in 3.3% of people on 2.4 mg and 5.8% on 7.2 mg against about 1% on placebo, and its label says hair loss was associated with weight reduction. The same shedding pattern follows bariatric surgery and crash dieting.

Q: Is GLP-1 hair loss permanent?
A: Shedding driven by rapid weight loss is generally temporary, because the follicles have entered a resting phase rather than been lost. Timelines vary considerably between people. Persistent or patchy loss is a reason to see a clinician, since many other causes exist.

Q: When does the shedding start?
A: Commonly a couple of months after the trigger rather than during it, which is why people often connect it to the wrong thing. The delay between rapid weight loss and visible shedding is the most confusing part of this for most people.

Q: Can I prevent it?
A: The two factors anyone actually influences are the rate of weight loss, which is a prescriber conversation about dose and titration, and whether you are eating enough protein and micronutrients while your appetite is suppressed, which is a question for a clinician or a registered dietitian. No shampoo or supplement has credible evidence of preventing shedding caused by rapid weight loss.

Q: Does it happen on Wegovy, Mounjaro and compounded versions too?
A: Yes. Wegovy's and Zepbound's labels both report it and both describe it as associated with weight reduction; on Zepbound it was reported by 7.1% of women and 0.5% of men. Mounjaro is the same molecule as Zepbound, and compounded versions are the same molecules, so any program producing substantial rapid loss can produce the same shedding.

### GLP-1 and alcohol (2026): what is actually known
Source: https://pricetrackerglp1.com/guides/glp1-and-alcohol (updated 2026-10-08)
Q: Can you drink alcohol on Ozempic or Wegovy?
A: There is no blanket instruction on the label against drinking. The specific established concern is low blood sugar, which matters most for people also taking insulin or a sulfonylurea. Alcohol is also hard on a stomach already dealing with nausea and delayed emptying, which is why many people find it less pleasant. Discuss your own situation with your prescriber.

Q: Why does alcohol feel different on a GLP-1?
A: These drugs slow stomach emptying and their common side effects are gastrointestinal. Adding alcohol, itself an irritant, to that combination frequently makes drinking feel worse, particularly in the first weeks and for a few days after a dose increase.

Q: Do GLP-1s reduce the desire to drink?
A: Many people report this and it is an active area of scientific interest, but it is not something we will state as established fact. If it happens to you it is widely reported and worth mentioning to your prescriber.

Q: Is alcohol dangerous with a GLP-1 if I have diabetes?
A: The risk to take seriously is hypoglycaemia, especially if you also take insulin or a sulfonylurea, because alcohol can lower blood glucose and so can those medicines. This is a specific conversation to have with the clinician managing your diabetes.

### Zepbound coupon and savings card (2026): what you pay
Source: https://pricetrackerglp1.com/guides/zepbound-savings-card (updated 2026-10-08)
Q: How much is the Zepbound savings card?
A: It depends on whether your insurance covers Zepbound. If it does, Lilly's terms say you may pay as little as $25 for a one-, two- or three-month fill, with savings capped at $100 for a one-month prescription and a separate annual maximum. If your plan does not cover Zepbound, a different Lilly program puts a one-month fill at as low as $499 on the single-dose pen, or $299 to $449 by dose on the KwikPen.

Q: Why am I not paying $25 with the Zepbound coupon?
A: Either because the saving is capped at $100 a month, so a $250 copay becomes $150 rather than $25, or because your plan does not cover Zepbound at all, which puts you on the separate not-covered program ($499 on the single-dose pen, $299 to $449 on the KwikPen) instead of the $25 one.

Q: Can I use the Zepbound savings card with Medicare?
A: No. Lilly states that governmental beneficiaries are excluded, which covers Medicare and Medicaid. Manufacturer copay cards generally cannot be combined with government prescription coverage.

Q: How much does Zepbound cost without insurance?
A: Lilly sells it direct at $299 for 2.5 mg, $399 for 5 mg, $499 for 7.5 mg and $699 for 10, 12.5 and 15 mg, or $449 on the vial or KwikPen from 7.5 mg if each refill is within 45 days. The company puts the list price at $499 to $1,086.37 per fill. If your commercial plan does not cover Zepbound, its savings program offers a one-month fill from $499 on the single-dose pen, or $299 to $449 by dose on the KwikPen.

Q: Is the savings card cheaper than compounded tirzepatide?
A: If the card brings you to $25 a month, yes, comfortably. If you are on the $499 program or paying Lilly's direct prices, the compounded market is generally cheaper, though it is a different product with a different regulatory status. Our ranking shows the all-in monthly cost for every seller we can verify.

### Mounjaro coupon and savings card (2026): $25, $150 cap
Source: https://pricetrackerglp1.com/guides/mounjaro-savings-card (updated 2026-10-08)
Q: How much does Mounjaro cost with insurance?
A: It depends on your plan, and Lilly says data on specific plan pricing is not yet available. With a commercial plan that covers Mounjaro, the savings card can bring a 1-, 2- or 3-month fill to as little as $25, with savings capped at $150 a month. With a commercial plan that does not cover it, the card sets a 1-month fill at as low as $499. With Medicare, Medicaid or another government plan, you pay your plan's cost share and the card is not available.

Q: Can I get a 3-month supply of Mounjaro for $25?
A: If your commercial plan covers Mounjaro and your plan and pharmacy allow a 3-month fill, Lilly's card can bring that fill to as little as $25. The 3-month savings cap is three times the $150 monthly cap, so the $25 holds while your 3-month copay is $475 or less. If a 3-month fill is not allowed, the card still applies to a 1-month fill.

Q: How much is the Mounjaro savings card?
A: If your commercial insurance covers Mounjaro, Lilly's terms say you may pay as little as $25 for a one-, two- or three-month fill, with savings capped at $150 for a one-month prescription and a separate annual maximum. If your plan does not cover Mounjaro, a separate program offers a one-month fill from $499.

Q: Is the Mounjaro card better than the Zepbound card?
A: Its cap is higher. Mounjaro's savings are capped at $150 a month against Zepbound's $100, and its annual maximum is higher too, for the same molecule from the same manufacturer. On a $250 copay that is the difference between paying $100 and paying $150.

Q: Why am I not paying $25 for Mounjaro?
A: Either the $150 monthly cap is binding, so a $300 copay becomes $150 rather than $25, or your plan does not cover Mounjaro at all, which puts you on the separate $499 program instead.

Q: Can I use the Mounjaro savings card with Medicare?
A: No. Lilly's eligibility terms exclude anyone enrolled in a government funded program, including Medicare, Medicare Part D, Medicare Advantage, Medigap, Medicaid, DoD, VA and TRICARE. On Medicare you pay your Part D plan's cost share; the Medicare Prescription Payment Plan spreads that cost into monthly bills without lowering it.

Q: How many times can I use the Mounjaro card?
A: Up to 13 prescription fills per calendar year, on both programs. With coverage, savings are also capped at $1,950 a year, which is 13 fills at the $150 monthly cap. Without coverage, the program caps savings at $647 a month and $8,411 a year. Either annual ceiling can be reached before the year ends.

### GLP-1 without insurance in 2026: every route, priced
Source: https://pricetrackerglp1.com/guides/glp1-without-insurance (updated 2026-10-08)
Q: How much does Ozempic cost without insurance?
A: Novo Nordisk publishes self-pay prices through its own pharmacy: $349 a month for Ozempic up to 1 mg and $499 at 2 mg. If weight rather than blood sugar is the goal, the Wegovy tablet is the cheaper branded route at $149 to $299 by dose, and compounded semaglutide from a telehealth program is cheaper again though it is not FDA-approved.

Q: How much is Wegovy without insurance?
A: Novo's published cash prices are $349 a month for the pen at any standard dose from 0.25 to 2.4 mg, $399 for the 7.2 mg high-dose pen, and $149, $199 or $299 for the tablet depending on strength. The tablet is the cheapest branded route into this market.

Q: Can I use a savings card if I have no insurance?
A: Generally no. The manufacturer savings cards are written for people with commercial drug insurance, whether or not that plan covers the drug. If you have no insurance at all, the card route is closed and your options are buying direct from the manufacturer, a compounded telehealth program, or an income-tested patient assistance programme.

Q: What is the cheapest way to get a GLP-1 without insurance?
A: In practice, compounded semaglutide or tirzepatide through a telehealth program, which is a fraction of branded pricing. The trade is that compounded drugs are not FDA-approved, so the dispensing pharmacy's licensing does the work an approval would. Our ranking shows the all-in monthly cost for every seller we can verify, re-checked weekly.

Q: How much does Mounjaro or Zepbound cost without insurance?
A: Lilly sells Zepbound direct at $299 for 2.5 mg, $399 for 5 mg, $499 for 7.5 mg and $699 for 10, 12.5 and 15 mg ($449 on the KwikPen from 7.5 mg with refills within 45 days), against a list price the company puts at $499 to $1,086.37 per fill. Unlike Novo's pen pricing, Lilly's rises as your dose does.

### Does Medicare Cover Wegovy or Ozempic? $50 Bridge (2026)
Source: https://pricetrackerglp1.com/guides/does-medicare-cover-glp1 (updated 2026-10-08)
Q: Does Medicare cover Ozempic?
A: For type 2 diabetes, yes: Medicare Part D plans and Medicare Advantage plans with drug coverage can cover Ozempic, under each plan's formulary and prior authorisation rules. For weight loss, no. Ozempic is not on the Medicare GLP-1 Bridge list; the Bridge drug for semaglutide is Wegovy.

Q: Does Medicare cover Wegovy for weight loss?
A: Yes, since 1 July 2026, through the Medicare GLP-1 Bridge. Eligible people with Part D coverage pay $50 a month for any dose of the Wegovy pen or pill until 31 December 2027. Wegovy prescribed for cardiovascular risk reduction goes through your Part D plan instead.

Q: Does Medicare cover Zepbound?
A: For weight loss, only the Zepbound KwikPen, through the Medicare GLP-1 Bridge, for no more than $50 a month. Single-dose Zepbound vials and pens are not covered by the Bridge. For moderate-to-severe obstructive sleep apnea, Zepbound is submitted to your Part D plan, not the Bridge.

Q: What is the Medicare GLP-1 Bridge?
A: A short-term CMS demonstration that gives eligible Medicare Part D beneficiaries Wegovy, the Zepbound KwikPen or Foundayo for a $50 monthly copay from 1 July 2026 to 31 December 2027. It runs outside Part D: your drug plan does not review or pay the claim, and a central CMS processor handles prior authorisation and payment.

Q: Who qualifies for the Medicare GLP-1 Bridge?
A: You need Medicare drug coverage (a Part D plan, a Medicare Advantage plan with drug coverage, a Special Needs Plan, an employer group plan or LI NET), you must be 18 or older, and at the start of therapy you need a BMI of 35+, or 30+ with HFpEF heart failure, uncontrolled high blood pressure or stage 3a+ kidney disease, or 27+ with prediabetes, a previous heart attack or stroke, or symptomatic peripheral artery disease. Type 2 diabetes, moderate-to-severe sleep apnea and fatty liver disease rule you out of the Bridge, because Part D may cover a GLP-1 for those.

Q: Does the Medicare GLP-1 Bridge count toward my Part D out-of-pocket maximum?
A: No. CMS says the Part D deductible does not apply and no part of the $50 copay counts toward your true out-of-pocket (TrOOP) costs. Bridge fills do not appear on your Part D Explanation of Benefits, Extra Help does not lower them, and the Medicare Prescription Payment Plan cannot spread them.

Q: How much does Wegovy cost with Medicare?
A: $50 a month through the Medicare GLP-1 Bridge if you qualify, for any dose of the pen or the pill. If you do not qualify, Novo's self-pay prices for Wegovy run from $149 a month for the 1.5 mg pill to $349 a month for the standard pen doses, and Novo's terms let people with Medicare buy that way outside their plan.

Q: Can I use a Wegovy or Zepbound coupon with Medicare?
A: No. NovoCare's Wegovy savings card excludes government beneficiaries, and Lilly's Zepbound savings card excludes anyone enrolled in Medicare, Part D, Medicare Advantage, Medigap, Medicaid, VA or TRICARE. The makers' separate self-pay programmes are a different thing and do allow cash purchases outside your plan.

Q: What happens when the Medicare GLP-1 Bridge ends in 2027?
A: Nothing is decided yet. CMS extended the Bridge to 31 December 2027 after it dropped the BALANCE model in Medicare for 2027, and said the extension helps it gather data ahead of a possible BALANCE start in Part D. KFF describes coverage after 2027 as uncertain, pending CMS action for 2028.

### Does Medicaid cover Ozempic or Wegovy? State by state (2026)
Source: https://pricetrackerglp1.com/guides/does-medicaid-cover-glp1 (updated 2026-10-08)
Q: Does Medicaid cover Ozempic?
A: For type 2 diabetes, yes, in every state: Medicaid programmes must cover FDA-approved drugs for medically accepted indications. Prior authorisation is close to universal. For weight loss, coverage is optional for states, and as of January 2026 only 13 state programmes covered GLP-1s for obesity under fee-for-service.

Q: Does Medicaid cover Wegovy for weight loss?
A: Only in states that have chosen to cover GLP-1s for obesity, which was 13 states as of January 2026. CMS's BALANCE model began rolling out to state Medicaid programmes on 1 May 2026, but participation is voluntary for each state, so the answer still depends on where you live. Where it applies, your out-of-pocket cost stays limited to nominal amounts under federal law.

Q: What is the BALANCE model?
A: A CMS model covering all formulations of Foundayo, Mounjaro, Ozempic, Rybelsus and Wegovy plus the Zepbound KwikPen. Its Medicaid arm began rolling out on 1 May 2026 and does not change Medicaid out-of-pocket costs, which federal law limits to nominal amounts. Participation is voluntary for drug manufacturers, state Medicaid agencies and Medicare Part D plans.

Q: Can I use an Ozempic or Wegovy coupon if I have Medicaid?
A: No. Manufacturer savings cards exclude government beneficiaries, which covers Medicaid as well as Medicare. Patient assistance programmes are frequently closed too: Lilly Cares, for example, requires that you are not enrolled in Medicaid, full Low Income Subsidy or VA benefits.

Q: My state said no last year. Is that still true?
A: Possibly not. The 13-state figure is from January 2026 and the BALANCE model opened to state Medicaid programmes in May 2026, so a state that declined before may have joined since. It is worth asking again rather than assuming.

### GoodRx for Ozempic, Wegovy and Mounjaro (2026): does it help?
Source: https://pricetrackerglp1.com/guides/goodrx-glp1 (updated 2026-10-08)
Q: Does GoodRx work for Ozempic and Wegovy?
A: It lists them, but GoodRx's strength is negotiating on drugs with generic competition and these are brand-only. Its own pages advertise both from $149, against average retail prices of $1,212.63 for Ozempic and $1,642.80 for Wegovy.

Q: Is the GoodRx price for Wegovy a real discount?
A: The $149 is real but it is the manufacturer's own published cash price for the semaglutide tablet rather than a pharmacy discount GoodRx negotiated, and Novo's offer appears on the same GoodRx page. Treat GoodRx's headline and Novo's direct price as one option, not two.

Q: Can I use GoodRx with my insurance?
A: No. A discount card is used instead of your coverage rather than alongside it, and it cannot be combined with a manufacturer copay card either. If your insured copay is lower than the cash price, use the insurance.

Q: Can I use GoodRx if I have Medicare?
A: Yes, and this is the one place it beats the manufacturer cards, which exclude government beneficiaries. It is still a cash purchase, so it does not count toward your Part D deductible or out-of-pocket total. For weight-loss indications the Medicare GLP-1 Bridge at $50 a month is worth asking about first.

Q: What is the cheapest way to get a GLP-1 with GoodRx?
A: For branded semaglutide the floor GoodRx advertises is $149, which is the tablet at Novo's own price. Compounded semaglutide and tirzepatide through telehealth programs are cheaper again, though they are not FDA-approved. Our ranking shows the all-in monthly cost for every seller we verify.

### Mounjaro Dosage Chart (2026): 2.5 mg to 15 mg, From $499/mo
Source: https://pricetrackerglp1.com/guides/mounjaro-dosage-chart (updated 2026-10-08)
Q: What is the starting dose of Mounjaro?
A: 2.5 mg injected under the skin once a week. The label calls it the recommended starting dosage and says to increase in 2.5 mg steps only if more glycemic control is needed, after at least four weeks on the current dose.

Q: What is the maximum dose of Mounjaro?
A: 15 mg once weekly for adults and 10 mg once weekly for children 10 years and older with type 2 diabetes, per section 2.1 of the label.

Q: How fast does Mounjaro go up?
A: In 2.5 mg steps, each after at least four weeks on the current dose, and only if additional glycemic control is needed. At the four-week minimum for every step, an adult could reach 15 mg in week 21, but many people stay lower because their blood sugar target is met earlier.

Q: What happens if I miss a dose of Mounjaro?
A: Take it as soon as possible within four days (96 hours) of the missed dose. If more than four days have passed, skip it and take the next dose on your regular day. You can change your weekly day as long as two doses are at least three days apart.

Q: How many units is a Mounjaro dose?
A: Lilly's single-dose pens and vials hold 0.5 mL per dose and its multi-dose vials 0.6 mL, which are the 50 and 60 unit marks on a 1 mL U-100 insulin syringe. Compounded tirzepatide vials use other concentrations, so check your pharmacy label or use a dosing calculator with your vial's mg per mL.

Q: Does a higher Mounjaro dose cost more?
A: Not direct from Lilly: LillyDirect lists every strength starting at $499 a month. With commercial coverage and the savings card it can be as little as $25. Compounded tirzepatide sellers vary; some charge more at higher doses.

Q: Is Mounjaro approved for weight loss?
A: No. Mounjaro is approved for type 2 diabetes in adults and children 10 and older, and to reduce the risk of major cardiovascular events in adults with type 2 diabetes at high risk. The same molecule is approved for weight loss as Zepbound, with its own dosing schedule.

### Ozempic Dosage Chart (2026): 0.25 mg to 2 mg, $199 to $499/mo
Source: https://pricetrackerglp1.com/guides/ozempic-dosage-chart (updated 2026-10-08)
Q: What is the starting dose of Ozempic?
A: 0.25 mg injected under the skin once a week for 4 weeks, then 0.5 mg once a week. The 0.25 mg dose is for starting only; the label's maintenance doses are 0.5, 1 and 2 mg.

Q: What is the maximum dose of Ozempic?
A: 2 mg once weekly. The label allows 0.5 mg to rise to 1 mg, and 1 mg to rise to 2 mg, each after at least 4 weeks, if more glycemic control is needed.

Q: What happens if I miss a dose of Ozempic?
A: Take it as soon as possible within 5 days of the missed dose. If more than 5 days have passed, skip it and take the next dose on your regular day. You can move your weekly day as long as two doses are at least 2 days (more than 48 hours) apart.

Q: Can I take 1 mg with the 0.25/0.5 mg Ozempic pen?
A: No. The starter pen holds 2 mg in 3 mL and only dials 0.25 mg or 0.5 mg doses. The 1 mg and 2 mg doses come in their own pens (4 mg/3 mL and 8 mg/3 mL). The label also lists single-dose prefilled syringes of 0.25, 0.5 and 1 mg.

Q: How long does one Ozempic pen last?
A: The 1 mg and 2 mg pens each hold 4 weekly doses. The starter pen holds 4 doses of 0.25 mg plus 2 doses of 0.5 mg, or 4 doses of 0.5 mg, so during the start it usually lasts about 6 weeks.

Q: How much does Ozempic cost per dose without insurance?
A: Through NovoCare, new patients pay $199 a month for the first 2 fills of 0.25 or 0.5 mg (offer through December 31, 2026), then $349 a month for 0.25, 0.5 or 1 mg and $499 a month for 2 mg. A 1 mg pen holds four weekly doses, so a year takes 13 pens: a first year kept at 1 mg comes to $4,237 at those prices, and each year after to $4,537.

Q: What is the Ozempic dose for chronic kidney disease?
A: For adults with type 2 diabetes and chronic kidney disease, the label's maintenance dose is 1 mg once weekly, reached after at least 4 weeks on 0.5 mg.

### Is Hims Legit? Hims GLP-1 Cost, Reviews & Record (2026)
Source: https://pricetrackerglp1.com/guides/is-hims-legit (updated 2026-10-08)
Q: Is Hims legit?
A: Yes. Hims & Hers is a real, licensed telehealth company that prescribes through state-licensed providers. As of October 2026 its weight-loss pages sell FDA-approved brand-name GLP-1s: the Wegovy pill and pen, Zepbound, Foundayo and the Ozempic pill. FDA sent it a warning letter in September 2025 over claims about its compounded semaglutide; a warning letter is an allegation, not a court finding.

Q: How much does Hims weight loss cost per month?
A: On its own site in October 2026, the Wegovy pill and Foundayo start at $149 a month, the Wegovy pen at $199 and Zepbound at $299, each for the medication only. A membership of $39 for the first month and $149 a month after is required on top, so the Wegovy pill runs about $298 a month from month two. Prices may rise with the dose.

Q: Does Hims still sell compounded semaglutide?
A: We found no compounded GLP-1 on Hims's weight-loss pages on 5 October 2026, and its old compounded-semaglutide address opened the general weight-loss page. Its FAQ lists only FDA-approved brand-name medications.

Q: What is Hims's Trustpilot rating?
A: 2.9 out of 5 across 9,517 reviews on 8 October 2026. The profile covers all of Hims, not only weight loss, and Trustpilot notes that Hims invites its customers to review.

Q: Is there a cheaper alternative to Hims for GLP-1s?
A: Usually. The same brand-name drugs cost less all-in at several partner programs we track, and compounded semaglutide, which Hims no longer lists, costs much less but is not FDA-approved. Our cheapest semaglutide page ranks every option by its all-in monthly price. We do not partner with Hims, and partner programs pay us a commission.

### Is Noom Legit? Noom GLP-1Rx Cost & Reviews (2026)
Source: https://pricetrackerglp1.com/guides/is-noom-legit (updated 2026-10-08)
Q: Is Noom legit?
A: Yes. Noom is a real company, and its Noom Med arm prescribes GLP-1 medications through licensed clinicians and, by its own account, works with USP-compliant, state-regulated pharmacies. We found no FDA warning letter naming Noom on 5 October 2026. Its medication-included GLP-1 plans are compounded drugs, which are not FDA-approved.

Q: How much does Noom GLP-1Rx cost?
A: On Noom's own page in October 2026: $129 for the first four weeks, then $279 a month billed as $837 every 12 weeks, including the medication, clinician and app. The FAQ on the same page says $249 a month on the recurring plan, so confirm the figure at checkout. Noom Microdose starts at $79, then $179 a month.

Q: Is Noom GLP-1Rx compounded semaglutide?
A: Yes. Noom's footnote says its compounded semaglutide is produced in an FDA-registered facility but has not been reviewed by the FDA for safety, efficacy, or quality. Its GLP-1Rx Plus plan is compounded tirzepatide.

Q: What is Noom's Trustpilot rating?
A: 4.5 out of 5 across 67,088 reviews on 8 October 2026. The profile covers all of Noom, which is mainly a diet and food-logging app, so most of those reviews are not about the GLP-1 program.

Q: Is there a cheaper alternative to Noom for a GLP-1?
A: Usually. Compounded semaglutide costs well under Noom's $279 a month at several partner programs we track; our cheapest semaglutide page ranks them by all-in monthly price. They include less coaching than Noom. We do not partner with Noom, and partner programs pay us a commission.

### Is Henry Meds Legit? Cost, Reviews & FDA Record (2026)
Source: https://pricetrackerglp1.com/guides/is-henry-meds-legit (updated 2026-10-08)
Q: Is Henry Meds legit?
A: Yes. Henry Meds is a real telehealth company that prescribes through licensed providers and, by its own account, works only with licensed US compounding pharmacies. We found no FDA warning letter naming it on 5 October 2026. Everything it sells for weight loss is compounded, and compounded drugs are not FDA-approved.

Q: How much does Henry Meds semaglutide cost?
A: Henry's programs page lists compounded semaglutide injections at $297 a month, $1,482 for six months paid in full, or $2,364 for 12 months paid in full, which works out to $197 a month. Its under-the-tongue semaglutide starts at $179 a month. The page is dated 3 December 2025, so confirm at checkout.

Q: Why does Henry Meds say it starts at $179?
A: Because $179 a month is the price of its compounded liraglutide, a daily injection, and of its under-the-tongue semaglutide. The weekly semaglutide injection most people ask about is $297 a month on a monthly plan.

Q: What is Henry Meds' Trustpilot rating?
A: 4.4 out of 5 across 12,534 reviews on 8 October 2026. The profile covers all of Henry's treatments, not only weight loss, and Trustpilot notes that Henry invites its customers to leave reviews.

Q: Is there a cheaper alternative to Henry Meds?
A: For compounded semaglutide injections, usually yes: several partner programs we track charge well under Henry's $297 a month, and our cheapest semaglutide page ranks them by all-in monthly price. We do not partner with Henry Meds, and partner programs pay us a commission.

### Is Mochi Health legit? Cost, reviews and FDA record (2026)
Source: https://pricetrackerglp1.com/guides/is-mochi-health-legit (updated 2026-10-08)
Q: Is Mochi Health legit?
A: Yes, as of October 2026. Mochi Health is a telehealth platform whose affiliated licensed clinicians prescribe after a video visit. It publishes its prices, holds 4.5 on Trustpilot from 19,227 reviews, and FDA's warning-letter database listed no letter to Mochi Health when we searched on 5 October 2026. Being legitimate does not make it cheap: the membership and the medication are billed separately.

Q: How much does Mochi Health cost per month?
A: Two numbers. The membership is $79 a month on the monthly plan ($207 for 3 months, $354 for 6, $588 for 12), with a first-month-free promotion for new members on the monthly plan. Medication is extra: compounded semaglutide from $60 a month and compounded tirzepatide from $90 at the starting dose, Wegovy from $199 and Zepbound from $299. At the starting dose, the cheapest of those comes to about $139 a month all-in on the monthly plan.

Q: Has the FDA sent Mochi Health a warning letter?
A: None is listed. FDA's warning-letter database showed no letter to Mochi Health when we searched on 5 October 2026. A warning letter is an allegation by the agency rather than a court finding, and the FDA did send 30 letters to telehealth companies over compounded GLP-1 marketing in March 2026.

Q: Is Mochi Health's compounded semaglutide FDA-approved?
A: No. Mochi's own site says compounded medications are not approved or evaluated by the FDA for safety, effectiveness, or quality. That is true of every compounded GLP-1 from any seller. Mochi also sells branded, FDA-approved Wegovy, Zepbound and Foundayo at higher prices.

Q: Is Mochi Health cheaper than other GLP-1 programs?
A: Usually not on cash, because its $79 monthly membership is added to the drug. Compare the all-in monthly number: drug plus membership at your dose. Our cheapest compounded semaglutide and tirzepatide pages show the current all-in price at every program we track, re-checked weekly. We do not partner with Mochi, so it is not on those lists.

### Is Calibrate legit? Cost, reviews and catches (2026)
Source: https://pricetrackerglp1.com/guides/is-calibrate-legit (updated 2026-10-08)
Q: Is Calibrate legit?
A: Yes, as of October 2026. Calibrate is a GLP-1 program whose clinicians prescribe branded drugs such as Wegovy and Zepbound, paired with coaching and insurance navigation. Its homepage carries a LegitScript seal, it holds 4.5 on Trustpilot from 1,201 reviews, and FDA's warning-letter database listed no letter to Calibrate Health when we searched on 5 October 2026.

Q: How much does Calibrate cost?
A: $199 a month with an initial 3-month commitment, so $597 for the first three months. Medication and lab tests are not included: Calibrate works your commercial insurance and says copays are typically $25 a month or less after any deductible. It does not publish a cash price for the medication.

Q: Does Calibrate take Medicare?
A: No. Calibrate says it is not set up to accept members with any form of federal or government insurance, including Medicare, Medicaid and Tricare, even if they are willing to pay out of pocket or also have commercial insurance.

Q: Is Calibrate worth it without insurance?
A: Usually not on price. The program fee alone is $199 a month for at least three months, and the drug is extra at a self-pay price Calibrate does not publish. Cash programs we track sell branded and compounded GLP-1s with the medication included in one monthly price, which our board ranks and re-checks weekly. We do not partner with Calibrate.

Q: Can I cancel Calibrate?
A: After the initial 3-month commitment, Calibrate says the membership renews one month at a time and you can cancel at any time. During the first three months you are committed to the full $597.

### Mounjaro vs Rybelsus (2026): $499 Shot, a Pill Being Replaced
Source: https://pricetrackerglp1.com/guides/mounjaro-vs-rybelsus (updated 2026-10-08)
Q: Is Mounjaro better than Rybelsus?
A: No trial has compared them directly. In separate placebo-controlled trials, tirzepatide (Mounjaro) lowered A1C by 1.91 to 2.11 points beyond placebo over 40 weeks, and oral semaglutide (Rybelsus) by 0.6 to 1.1 points over 26 weeks. The trials differ in length and design, so that gap is a hint, not a head-to-head result. Which is better for you is a prescriber's decision.

Q: Is Rybelsus being discontinued?
A: Novo Nordisk's NovoCare page says Rybelsus is being replaced by the Ozempic pill. Novo says the Ozempic pill at 1.5, 4 and 9 mg works like Rybelsus at 3, 7 and 14 mg with the same efficacy and safety. Moving over needs a new prescription; coverage and an existing savings offer carry over.

Q: What is the difference between Mounjaro and Rybelsus?
A: Mounjaro is tirzepatide from Eli Lilly, injected once a week. Rybelsus is semaglutide from Novo Nordisk, taken as a tablet once a day on an empty stomach with no more than 4 ounces of water, 30 minutes before food, drink or other pills. Both are approved for type 2 diabetes and for heart-risk reduction in high-risk adults with type 2 diabetes.

Q: Can you take Mounjaro or Rybelsus for weight loss?
A: Both are approved for type 2 diabetes, not weight loss, so using either for weight is off-label and a prescriber's decision. The weight-loss brand of tirzepatide is Zepbound, and the semaglutide pill approved for weight is the Wegovy pill.

Q: How much do Mounjaro and Rybelsus cost without insurance?
A: LillyDirect sells Mounjaro from $499 a month. Novo publishes no cash price for Rybelsus; its NovoCare Pharmacy sells the Ozempic pill instead, at $149, $199 and $299 a month across its three strengths.

Q: Is there a savings card for Mounjaro or Rybelsus?
A: Yes, for people with commercial insurance. Lilly's Mounjaro card brings a covered fill to as little as $25, capped at $150 a month. Novo's offer brings the Ozempic pill to as little as $25, capped at $100 a month, and a Rybelsus offer you already hold keeps working on the Ozempic pill. Government beneficiaries are excluded from Novo's offer.

### Generic Tirzepatide (2026): None Before 2036, What to Buy
Source: https://pricetrackerglp1.com/guides/generic-tirzepatide (updated 2026-10-08)
Q: Is there a generic tirzepatide?
A: No. As of October 2026 FDA has approved no generic tirzepatide. The only approved tirzepatide products are Eli Lilly's Zepbound and Mounjaro, and the Orange Book lists Lilly's patent on the molecule as expiring May 13, 2036.

Q: Is there a generic Zepbound?
A: No. Zepbound's generic name is tirzepatide, but no generic drug version is approved. The cheapest FDA-approved route is Lilly's own self-pay price, from $299 a month at LillyDirect. Compounded tirzepatide, which is not FDA-approved, starts at $85 a month on our board.

Q: Is there a generic Mounjaro?
A: No. Mounjaro is tirzepatide, the same molecule as Zepbound, and it shares the same core patent, which runs to May 13, 2036; one Mounjaro use patent runs to December 30, 2041. Lilly sells Mounjaro self-pay starting at $499 a month against a list price of $1,112.16 per fill.

Q: When will tirzepatide be generic?
A: Not before May 13, 2036 on today's Orange Book listings, when the patent on the molecule (US 9,474,780) expires. Formulation and use patents run to June and July 2039. A successful patent challenge could bring that forward; pediatric exclusivity or new patents could push parts of it back.

Q: Does Zepbound's exclusivity ending in November 2026 mean a generic is coming?
A: No. Exclusivity and patents are separate protections. Zepbound's new-product exclusivity ends November 8, 2026 and the new chemical entity exclusivity on May 13, 2027, but the molecule patent still runs to May 2036, so no generic is expected in 2026 or 2027.

Q: Is compounded tirzepatide the same as generic tirzepatide?
A: No. A generic is FDA-approved as equivalent to the brand. Compounded tirzepatide is made by a pharmacy on a prescription and is not FDA-approved as a product. Since FDA declared the shortage resolved on December 19, 2024, pharmacies may compound it only under the per-patient rules.

Q: Is compounded tirzepatide legal in 2026?
A: Within limits. A state-licensed pharmacy may compound it for an individual patient on a prescription, and FDA expects a prescriber-documented clinical difference from the brand rather than routine copies. Outsourcing facilities cannot use bulk tirzepatide while it is off the shortage list and the 503B bulks list, and FDA proposed on April 30, 2026 to keep it off.

Q: What is the cheapest tirzepatide without a generic?
A: Compounded tirzepatide from $85 a month on our board, not FDA-approved. For the FDA-approved brand: $50 a month through the Medicare GLP-1 Bridge if you qualify, otherwise Zepbound self-pay from Lilly at $299 to $449 a month refilled on time.

### Generic Ozempic 2026: none in the US until 2031. Cheapest now
Source: https://pricetrackerglp1.com/guides/generic-ozempic (updated 2026-10-08)
Q: Is there a generic Ozempic?
A: Not in the US. The FDA Orange Book lists Novo Nordisk's semaglutide compound patent 8,129,343 until 5 December 2031, and no generic is approved. Generic semaglutide is sold in India (since 21 March 2026) and Canada (since 15 May 2026), but those products are not approved for US sale.

Q: When will Ozempic go generic?
A: Not before 5 December 2031 in the US, when compound patent 8,129,343 expires. Earlier is possible only if a generic maker wins a patent challenge: Cipla has filed one and Novo has sued, and Apotex already holds a tentative approval it cannot use until the patents allow.

Q: Is there a generic Wegovy?
A: Not in the US. Wegovy shares the 2031 compound patent and also lists formulation patents to 17 February 2041. Canada approved Apotex's Sevmia, the first generic Wegovy, on 29 June 2026. In the US, brand Wegovy is $349 a month for the pen from NovoCare, or from $208 a month through a partner program on our board.

Q: Is there a generic semaglutide in the US?
A: No FDA-approved one. What US sellers call generic semaglutide is compounded semaglutide: the same active ingredient, mixed by a licensed pharmacy for one patient, with no FDA review of the finished product. It starts at $69 a month on our board.

Q: Can I buy generic Ozempic from Canada or India?
A: Not legally. FDA says a drug approved abroad but unapproved in the US is illegal to import, and its personal-use allowance covers conditions with no treatment available at home, which semaglutide is not. US patent law also counts importing a patented drug as infringement until 5 December 2031.

Q: How much does generic Ozempic cost?
A: There is no US price because there is no US generic. In India the cheapest stated price is Rs 1,290 a month, against Rs 8,800 for Ozempic at its Indian launch. In the US, compounded semaglutide starts at $69 a month and Novo's Wegovy pill at $149 a month at 1.5 mg.

Q: Is compounded semaglutide the same as generic Ozempic?
A: No. A generic is FDA-approved as the same as the brand in dose, safety, strength, quality and the way it is taken. Compounded semaglutide has the same active ingredient but FDA does not review the finished product before it is sold, and pharmacies may make it only under FDA's compounding conditions.

Q: Why does Canada have generic Ozempic but the US does not?
A: Semaglutide's patent protection in Canada ended, so Health Canada could approve generics from 28 April 2026. The US compound patent runs to 5 December 2031, so FDA can only grant tentative approvals, which it did for Apotex in April 2026. Health Canada says most generics there cost 45 to 90% less than the brand.

### Retatrutide (2026): 28.3% Weight Loss, FDA Filing, Price
Source: https://pricetrackerglp1.com/guides/retatrutide (updated 2026-10-08)
Q: What is retatrutide?
A: Retatrutide is an investigational once-weekly injection from Eli Lilly that activates three hormone receptors: GIP, GLP-1 and glucagon. Tirzepatide (Zepbound) activates the first two and semaglutide (Wegovy) the second only. Its lab code was LY3437943. It is not approved for any use.

Q: Is retatrutide FDA approved?
A: No. As of October 2026 no regulator anywhere has approved it. Lilly says it plans to submit an application to FDA in the first quarter of 2027. FDA states retatrutide has not been found safe and effective for any condition.

Q: When will retatrutide be available?
A: Not before Lilly files with FDA, which it plans for Q1 2027. Neither Lilly nor FDA has given an approval date. FDA's general goal for a standard review of a new molecule is a decision within 10 months of the 60-day filing date, but that is a target, not a promise about this drug.

Q: How much will retatrutide cost?
A: No price exists. Lilly has not announced one and the drug has no brand name yet. The only legal access today, Lilly's single-patient expanded access program for people with severe, treatment-resistant obesity and serious complications, is provided at no cost.

Q: How much weight do people lose on retatrutide?
A: In the phase 3 TRIUMPH-1 trial, 12 mg produced 28.3% average weight loss at 80 weeks on Lilly's efficacy estimand and 25.0% on the intention-to-treat estimand reported in NEJM, against 2.2% and 3.9% on placebo. In people with type 2 diabetes (TRIUMPH-2) the figures were 20.8% and 18.8%.

Q: Retatrutide vs tirzepatide: which works better?
A: No published trial has compared them directly yet. Across separate trials, retatrutide 12 mg produced 25.0% weight loss at 80 weeks (TRIUMPH-1) and tirzepatide 15 mg 20.9% at 72 weeks (SURMOUNT-1), both counting everyone randomized. The head-to-head trial, TRIUMPH-5, lists an estimated primary completion of November 2026.

Q: Can I buy retatrutide online?
A: Not legally. FDA says retatrutide cannot be used in compounding and has warned companies selling it labelled "for research purposes" or "not for human consumption", calling those products of unknown quality and possibly harmful. Lilly says it cannot be sold to consumers and has sued sellers.

Q: Is research peptide retatrutide the same as Lilly's drug?
A: There is no way to know. Lilly calls black-market retatrutide entirely unverified and unapproved, and FDA says such products are of unknown quality. The trial results came from Lilly's manufactured drug given under medical supervision, so they say nothing about a vial bought online.

Q: What are the side effects of retatrutide?
A: Mostly gastrointestinal. In TRIUMPH-1, nausea affected 42.4% on 12 mg against 14.8% on placebo, with diarrhea, constipation and vomiting also more common. Dysesthesia, an abnormal skin sensation, appeared in 12.5% on 12 mg against 0.9% on placebo, and 11.3% on 12 mg stopped because of side effects.

Q: What can I take instead of retatrutide right now?
A: Tirzepatide, which beat semaglutide in a head-to-head trial and is the molecule retatrutide builds on. Zepbound self-pay starts at $299 a month at LillyDirect, and compounded tirzepatide, which is not FDA-approved, starts at $85 a month on our board.

### Tirzepatide Cost 2026: $85 Compounded, $299 Zepbound Direct
Source: https://pricetrackerglp1.com/guides/tirzepatide-cost (updated 2026-10-08)
Q: How much does tirzepatide cost?
A: It depends on the brand and who pays. Compounded tirzepatide runs $85 to $399 a month on our board. Zepbound from Lilly's self-pay programme is $299 at 2.5 mg, $399 at 5 mg and $449 from 7.5 mg with on-time refills ($499 to $699 otherwise). Mounjaro on LillyDirect is $499 at every strength. With commercial coverage and Lilly's card it can be $25; on Medicare's GLP-1 Bridge, $50 for the Zepbound KwikPen.

Q: How much is tirzepatide without insurance?
A: Paying cash, Zepbound is $299 to $699 a month direct from Lilly by dose, with $449 at 7.5 mg and above while every refill lands within 45 days. Mounjaro self-pay is $499 a month for an approved use. Compounded tirzepatide, which is not FDA-approved, starts at $85 a month on our board. Pharmacy list prices of $1,086.37 to $1,112.16 a fill apply only if you skip Lilly's programmes.

Q: What is the tirzepatide price per month?
A: A month in Lilly's pricing is a four-week fill of four weekly doses. Per fill: $299 (2.5 mg) and $399 (5 mg) for Zepbound self-pay, then $449 with on-time refills or $499 and $699 without; $499 for Mounjaro self-pay at any strength. Compounded sellers on our board charge $85 to $399 a month, median $174.

Q: How much does tirzepatide cost per mg?
A: Divide the four-week self-pay price by the milligrams in the fill: four doses, so 10 mg at the 2.5 mg step and 60 mg at 15 mg. For Zepbound, vial or KwikPen, that is $29.90 per mg at 2.5 mg and $7.48 per mg at 15 mg on the refill offer, or $11.65 at the regular price. For Mounjaro, at its flat $499, it is $49.90 per mg at 2.5 mg and $8.32 at 15 mg.

Q: How much does tirzepatide cost per year?
A: A year of weekly doses is 13 four-week fills. For Zepbound bought direct from Lilly, reaching 7.5 mg or higher with every refill on time, that is $5,637 in year one and $5,837 a year after; at the regular $699 from 10 mg it is $8,187 and $9,087. Mounjaro at its flat $499 self-pay price comes to $6,487 for 13 fills. Compounded at the board floor is about $1,000 over 12 monthly payments.

Q: How much is tirzepatide with insurance?
A: If your commercial plan covers the box you are prescribed, Lilly's card brings it to as little as $25 a fill. Card limits: for Zepbound, $100 a month and $1,300 a year; for Mounjaro, $150 a month and $1,950 a year. Above a plan copay of $125 or $175 respectively, you pay the difference. Government plans are excluded, and both cards expire on 12/31/2026 as currently written.

Q: Does Medicare cover tirzepatide?
A: Through the Medicare GLP-1 Bridge, yes, for one product: the Zepbound KwikPen prescribed for weight management, at $50 a month for eligible Part D members between July 1, 2026 and December 31, 2027. The vial, the single-dose pen and Mounjaro are not part of the Bridge. Mounjaro for type 2 diabetes may already be covered by your Part D plan.

Q: Is there a generic tirzepatide, and when will it be cheaper?
A: No generic exists. Zepbound and Mounjaro are Lilly's only approved tirzepatide products, and FDA's Orange Book lists the core patent as expiring on May 13, 2036, so no generic should be expected before then. Products sold as generic tirzepatide today are compounded or not legitimate.

Q: Why is compounded tirzepatide so much cheaper?
A: Compounding pharmacies prepare it without the cost of FDA approval, and FDA notes that unapproved versions do not undergo its review for safety, effectiveness and quality before they are marketed. Sellers on our board charge $85 to $399 a month. In April 2026 FDA proposed removing tirzepatide from the 503B bulks list, which could reduce supply if finalised.

Q: Is Zepbound or Mounjaro cheaper without insurance?
A: It depends on the dose. At 2.5 mg and 5 mg, Zepbound self-pay ($299 and $399) is below Mounjaro's flat $499. From 10 mg, Mounjaro's $499 is below Zepbound's regular $699, but above Zepbound's $449 refill price. Each programme requires a prescription for its own approved use: Mounjaro for type 2 diabetes, Zepbound for weight.

### Semaglutide cost 2026: $69 to $1,349 a month, every route
Source: https://pricetrackerglp1.com/guides/semaglutide-cost (updated 2026-10-08)
Q: How much does semaglutide cost per month?
A: Compounded semaglutide injection is $69 to $299 a month on our board today, not FDA-approved. From Novo directly, the Wegovy tablet is $149, $199 or $299 by strength, the Wegovy pen $349 at any dose from 0.25 to 2.4 mg ($199 for a new patient's first two fills), and the Ozempic pen $349 up to 1 mg and $499 at 2 mg. With a covering commercial plan and Novo's card it can be $25; on the Medicare GLP-1 Bridge, $50.

Q: How much is semaglutide without insurance?
A: Without insurance the cheapest FDA-approved semaglutide is Novo's Wegovy tablet at $149 a month for the 1.5 mg starting strength, rising to $299 at 9 and 25 mg. The Wegovy pen is $349 a box through NovoCare Pharmacy, and the Ozempic pen is $349 or $499. Compounded semaglutide starts at $69 a month on our board. The list price, $1,349.02 a box, is not what a self-pay patient needs to pay.

Q: What is the cheapest way to get semaglutide?
A: With coverage, Novo's $25 card on a commercial plan or the $50 Medicare GLP-1 Bridge. Without coverage, compounded semaglutide at $69 a month on our board is the lowest price, and Novo's Wegovy tablet at $149 a month is the cheapest FDA-approved option at the starting strength. Generic semaglutide is not approved in the US, and importing it from abroad for personal use is illegal.

Q: How much does semaglutide cost with insurance?
A: If a commercial plan covers Wegovy or Ozempic, Novo's savings card brings the copay to as little as $25 a month. Its cap is $100 off per 1-month fill, $200 per 2-month fill and $300 per 3-month fill, so a $200 copay becomes $100. Medicare, Medicaid, VA and TRICARE members cannot use the card. Ozempic is covered mainly for type 2 diabetes; Wegovy coverage for weight depends on the plan.

Q: How much does semaglutide cost on Medicare?
A: Through the Medicare GLP-1 Bridge, eligible Part D members pay a $50 copay for Wegovy, pen or pill, from 1 July 2026 to 31 December 2027. The Part D deductible does not apply, the $50 does not count toward the Part D out-of-pocket cap, and Extra Help does not reduce it. Ozempic for type 2 diabetes is covered by ordinary Part D plans at each plan's own copay.

Q: How much does semaglutide cost per year?
A: About $600 on the Medicare Bridge, from about $830 for the cheapest compounded semaglutide on our board, and $3,588 a year for the Wegovy tablet at 25 mg. With a covering commercial plan and the $25 card it is $300 to $325. A weekly pen at $349 a box costs $4,537 over 52 weeks, because each box is a 28-day supply and a year takes 13 of them; a new patient's first year is $4,237.

Q: How much is semaglutide per dose?
A: Novo sells the Wegovy pen at $349 for a box of four weekly pens and the tablet at $149 to $299 for a bottle of 30. At $349 a box, each weekly shot costs $87.25 at any strength to 2.4 mg, $49.75 during the two $199 intro fills, and $99.75 on the $399 HD pen. A 30-tablet bottle works out at $4.97 a day at 1.5 mg and $9.97 a day at 9 or 25 mg. The cheapest compounded semaglutide on our board works out at $17 a weekly dose if its month covers four doses.

Q: Is the semaglutide pill cheaper than the shot?
A: From Novo, yes at every strength: the Wegovy tablet is $149, $199 or $299 a month, and the pen is $349 at every standard dose. At the label's equivalent doses, 25 mg daily tablets against a 2.4 mg weekly injection, the tablet is about $69.77 a week and the pen $87.25. Both cost $25 with a covering commercial plan and the card, and $50 on the Medicare Bridge.

Q: Why is compounded semaglutide so much cheaper than Wegovy?
A: Compounded semaglutide is made by a licensed pharmacy from the raw ingredient, without the clinical trials, FDA review and branded pen that Wegovy's price pays for. FDA says compounded drugs are not FDA approved and the agency does not review them for safety, effectiveness or quality before they are marketed. That is the trade the $280 a month gap to Novo's $349 pen represents.

Q: Is there a generic semaglutide, and how much is it?
A: Not in the US: no generic is FDA-approved, and the Orange Book lists Novo's semaglutide compound patent until 5 December 2031. Abroad, generics launched in India in March 2026, from about 3,400 rupees a month for weekly injections and 1,250 rupees a month for a vial, according to CNBC, and Canada approved its first generic for weight loss in June 2026. FDA says importing a drug that is unapproved in the US is illegal.

### TrumpRx GLP-1 Prices (2026): Wegovy $149, Zepbound $299
Source: https://pricetrackerglp1.com/guides/trumprx-glp1 (updated 2026-10-08)
Q: What is TrumpRx?
A: TrumpRx.gov is a federal website, launched on 5 February 2026, that lists discounted cash prices for brand-name drugs whose makers signed most-favored-nation pricing deals with the administration, plus a separate list of generics added in May 2026. It does not sell or dispense anything. The Congressional Research Service describes it as connecting consumers with drug coupons and direct-to-consumer pharmacies rather than being one itself.

Q: Is TrumpRx cheaper than LillyDirect or NovoCare?
A: Not for GLP-1s. On 8 October 2026 every GLP-1 price on TrumpRx matched the maker's own self-pay price for the same dose: the Wegovy pill at $149, $199 and $299, the Wegovy pen at $199 for two new-patient fills then $349, Zepbound at $299, $399 and $449 with on-time refills, Foundayo at $149 to $299 and Mounjaro at $499. For Lilly's drugs TrumpRx links straight to LillyDirect.

Q: How much is Wegovy on TrumpRx?
A: The Wegovy pill is $149 a month at 1.5 mg, $199 at 4 mg and $299 at 9 and 25 mg. The Wegovy pen is $199 for each of the first two monthly fills at 0.25 or 0.5 mg for new patients (an offer that runs through 31 December 2026), then $349 at any standard dose, and $399 for the 7.2 mg Wegovy HD pen. TrumpRx shows a coupon you present at a retail pharmacy.

Q: What is the TrumpRx price for Zepbound?
A: Zepbound is listed at $299 a month for 2.5 mg and $399 for 5 mg. From 7.5 mg to 15 mg it is $449 as long as each refill is completed within 45 days of the last delivery; otherwise it is $499 at 7.5 mg and $699 at 10, 12.5 and 15 mg. The same prices apply to the vial and the KwikPen, and TrumpRx sends you to LillyDirect to buy.

Q: How much is Foundayo on TrumpRx?
A: Foundayo is $149 a month at 0.8 mg and 2.5 mg, $199 at 5.5 mg and $299 at 9 mg, 14.5 mg and 17.2 mg, with the top two strengths at $349 if a refill is late. The 2.5 mg and 5.5 mg prices are temporary reductions that Lilly says run through 31 December 2026; the regular prices are $199 and $299. Purchase is through LillyDirect.

Q: Is Ozempic on TrumpRx?
A: Yes. The Ozempic pen is $199 for each of the first two monthly fills at 0.25 or 0.5 mg for new self-pay patients, then $349 a month at 0.25, 0.5 or 1 mg and $499 at 2 mg. The Ozempic pill is listed at $149 to $299 a month by strength. Both use a Novo coupon at a retail pharmacy, and the prices match NovoCare's.

Q: Can I use TrumpRx with insurance?
A: The GLP-1 offers are for self-pay patients only, so your insurance is not billed. The site prints 'This is an out-of-pocket price' on each drug page and advises insured readers to check their copay first. If a commercial plan covers your GLP-1, a manufacturer savings card can bring it to as little as $25 a month, which is lower than any TrumpRx price.

Q: Can I use TrumpRx if I have Medicare or Medicaid?
A: Novo's Wegovy pill and Ozempic pill offers on TrumpRx state 'Government beneficiaries excluded.' The same offer terms also set conditions for people with Medicare, Medicaid, VA or TRICARE coverage, so ask the pharmacist before relying on the coupon. Separately, eligible Medicare Part D members can get Wegovy, Zepbound or Foundayo for $50 a month through their plan, which runs outside TrumpRx.

Q: Does a TrumpRx purchase count toward my deductible?
A: No. Novo's offer terms say you cannot count the cost toward your insurance deductible or out-of-pocket limit, Lilly's self-pay terms say you will not apply the cost toward any deductible or true out-of-pocket requirement, and NBC News reported that money spent on TrumpRx does not count toward a copay or deductible.

Q: Is compounded semaglutide or tirzepatide on TrumpRx?
A: No. TrumpRx lists FDA-approved branded drugs and generics, and compounded GLP-1s are not FDA-approved. Through telehealth programs, compounded semaglutide starts at $69 a month and compounded tirzepatide at $85 on our board, each checked on the seller's own page. They are the same molecules without FDA review of the finished product.

### CagriSema (2026): FDA Decision Q4, Price, vs Zepbound
Source: https://pricetrackerglp1.com/guides/cagrisema (updated 2026-10-08)
Q: Is CagriSema FDA approved?
A: No. As of October 2026 CagriSema is not approved in the US or the EU. Novo Nordisk submitted its New Drug Application to the FDA on December 18, 2025, for weight management at the 2.4 mg/2.4 mg dose, and says it expects the FDA's decision in the fourth quarter of 2026.

Q: When will CagriSema be available?
A: Not before an FDA approval. Novo Nordisk expects the FDA decision in Q4 2026 and, pending that decision, a full US launch during the start of 2027. Novo has not published a PDUFA date, so the exact timing is not public.

Q: How much will CagriSema cost?
A: No price has been published. Novo Nordisk has said only that it plans to sell CagriSema through NovoCare and partners. For context, NovoCare currently charges new patients $199 a month for the first two months of Wegovy, then $349 a month for the standard doses.

Q: Is CagriSema better than tirzepatide?
A: Not at the doses filed. In REDEFINE 4, an 84-week head-to-head trial, people on CagriSema 2.4 mg/2.4 mg lost 20.2% on average against 23.6% on tirzepatide 15 mg, counting everyone, and CagriSema failed to show non-inferiority. At lower doses in type 2 diabetes (REIMAGINE 5), CagriSema 1.0 mg/1.0 mg beat tirzepatide 5 mg, 12.4% against 9.1%.

Q: Is CagriSema better than Wegovy?
A: In trials, yes, for weight loss. REDEFINE 1 had a Wegovy-dose semaglutide arm: 14.9% average weight loss against 20.4% for CagriSema at 68 weeks, counting everyone. REDEFINE 5 found 18.4% against 11.9%. CagriSema also caused more stomach side effects than placebo, mainly nausea, constipation and vomiting.

Q: How much weight do people lose on CagriSema?
A: In REDEFINE 1, adults without diabetes lost 20.4% of body weight on average at 68 weeks counting everyone, or 22.7% if everyone had stayed on treatment. In REDEFINE 2, adults with type 2 diabetes lost 13.7%, or 15.7% on the same stay-on-treatment basis.

Q: What is in CagriSema?
A: Two drugs in one weekly injection: cagrilintide 2.4 mg, a long-acting amylin analogue, and semaglutide 2.4 mg, the same molecule and strength as Wegovy. Novo says the pair works by reducing hunger and increasing fullness.

Q: Can I buy cagrilintide or compounded CagriSema online?
A: Not legally. The FDA says cagrilintide cannot be used in compounding under federal law, is not a component of any FDA-approved drug and has not been found safe and effective for any condition. Vials sold as research chemicals are unapproved products of unknown quality.

Q: What can I take instead of CagriSema right now?
A: Its semaglutide half is already sold. Compounded semaglutide, not FDA-approved, starts at $69 a month on our board, and Wegovy at $208 a month through programs on our board. Zepbound, which beat CagriSema head to head, starts at $348 a month through programs on our board.

### Employer GLP-1 coverage in 2026: who covers it, who dropped it
Source: https://pricetrackerglp1.com/guides/glp1-employer-coverage (updated 2026-10-08)
Q: Does my employer cover Wegovy for weight loss?
A: Probably not if you work for a mid-sized company, and about even odds at a very large one. KFF's 2025 survey found 19% of employers with 200 or more workers cover GLP-1s for weight loss, and 43% of those with 5,000 or more. To know for certain, check your plan's Summary of Benefits and Coverage, search the formulary for Wegovy, and ask HR whether the weight-management GLP-1 benefit is included.

Q: Which employers cover Zepbound?
A: There is no public list of employers that cover it, because most plans do not publish their formularies outside the member portal. Of the public plans we could source, Colorado's state employee plan covers Zepbound for weight loss for Cigna members from 1 May 2026, and CVS Caremark said it would add Zepbound back to its commercial template formularies on 1 October 2026. Your own plan's formulary is the only answer that counts.

Q: What percentage of employers cover GLP-1s for weight loss in 2026?
A: It depends on the employer size the survey samples. Business Group on Health found 60% of the largest employers covered them in 2026, down from 72% in 2025. Mercer put employers with 500 or more staff at 44%. The IFEBP found 36% of corporate plans cover them for both diabetes and weight loss. KFF's broader 2025 figure for all employers with 200 or more workers was 19%.

Q: Which companies are dropping GLP-1 coverage?
A: Sourced examples include Cigna's own employee plan (from 1 July 2026), PwC in the US (diabetes only from July 2026), HCA Healthcare (2026), Ohio State University's health plan (1 January 2026) and the Massachusetts Group Insurance Commission (1 July 2026). Insurers including Blue Cross Blue Shield of Massachusetts, Harvard Pilgrim and Mass General Brigham Health Plan also removed weight-loss GLP-1s from many employer plans for 2026.

Q: Why are employers dropping GLP-1 coverage?
A: Cost. Business Group on Health found employers expect pharmacy costs to keep rising faster than overall health costs, with GLP-1 use for obesity a named driver, and the IFEBP found GLP-1s for weight loss made up 11.4% of total annual claims for corporate plans. HCA also told staff that the makers' discounts were, in many cases, less expensive than what group plans could negotiate, and pointed them there instead.

Q: Can I appeal if my employer plan excludes weight-loss drugs?
A: You can, but it rarely works, because an exclusion is a decision about the plan, not about you. Appeals succeed against prior authorization denials and step therapy, where documentation can change the answer. If your plan excludes weight loss, check whether you qualify under a covered condition such as type 2 diabetes, heart disease or sleep apnea, and ask your prescriber which applies.

Q: Can I use my HSA or FSA for a GLP-1 if my employer does not cover it?
A: Usually yes, when the drug is prescribed to treat a diagnosed disease. IRS Publication 502 lets you count amounts paid to lose weight as a medical expense if the weight loss treats a specific disease diagnosed by a physician, such as obesity, hypertension or heart disease. Keep the prescription and diagnosis on file in case your account administrator asks for them.

Q: Do manufacturer savings cards work if my employer excludes GLP-1s?
A: No. The copay cards require commercial insurance that covers the drug, so a plan exclusion rules them out. Your options are the makers' self-pay programs, telehealth programs selling brand-name Wegovy or Zepbound for cash, or compounded versions, which are cheaper but not FDA-approved. Our board ranks the cash options weekly.

Q: Will my employer cover the Wegovy pill or Foundayo?
A: Only if it covers weight-loss GLP-1s at all, and even then not always. Some benefits consultants expect employers may leave the pills off their drug lists because they cost about the same as injections for plans. CVS Caremark lifted its new-to-market block on Foundayo on 1 June 2026, where a plan approves coverage. Search your formulary for each drug by name.

Q: If my employer drops weight-loss coverage, is my diabetes GLP-1 affected?
A: Not in any of the changes we tracked. The plans that address it, including Blue Cross Blue Shield of Massachusetts, Ohio State University and the Massachusetts Group Insurance Commission, say coverage of GLP-1s for type 2 diabetes continues, usually still with prior authorization that requires a documented diabetes diagnosis.

### Rybelsus coupon (2026): it now moves to the Ozempic pill
Source: https://pricetrackerglp1.com/guides/rybelsus-coupon (updated 2026-10-07)
Q: Is there still a Rybelsus coupon?
A: In effect, yes, but it now applies to the Ozempic pill. Novo Nordisk says Rybelsus is being replaced by the Ozempic pill and that patients with a Rybelsus savings offer can keep using it on Ozempic without signing up again. The terms: pay as little as $25, with a maximum saving of $100 a month, government beneficiaries excluded.

Q: Is Rybelsus being discontinued?
A: Novo Nordisk's NovoCare page says Rybelsus is being replaced by the Ozempic pill and that your health care provider will guide you through the change. Moving over needs a new prescription. Novo says the Ozempic pill at 1.5, 4 and 9 mg works similarly to Rybelsus at 3, 7 and 14 mg, with the same efficacy and safety, and has the same coverage.

Q: How much does the Rybelsus replacement cost without insurance?
A: NovoCare Pharmacy lists self-pay options for the Ozempic pill starting at $149 a month, with the price set by dose. A self-pay fill is processed outside your insurance and does not count toward a deductible or out-of-pocket maximum.

Q: Can I use the Rybelsus or Ozempic coupon with Medicare?
A: Not the savings card: government beneficiaries are excluded. Novo says government-insured patients may use its self-pay program if they pay themselves outside their insurance, and that purchase must not be counted toward Medicare Part D out-of-pocket totals. For type 2 diabetes, Part D coverage is usually the route to try first.

### Is LifeMD legit? Weight-loss cost and reviews (2026)
Source: https://pricetrackerglp1.com/guides/is-lifemd-legit (updated 2026-10-05)
Q: Is LifeMD legit?
A: Yes, as of October 2026. LifeMD is a telehealth company whose affiliated licensed providers prescribe branded GLP-1s such as Wegovy and Zepbound. Its pages carry a LegitScript seal, it holds 3.9 on Trustpilot from 4,270 reviews, and FDA's warning-letter database listed no letter to LifeMD when we searched on 5 October 2026.

Q: How much does LifeMD weight loss cost?
A: The program is $39 for the first month and $149 a month after that, and medication is extra. LifeMD's page lists the Wegovy pen from $199 a month and the Zepbound vial from $299. Add the program fee and the starting all-in cost is about $348 a month for the pen and $448 for the vial. With commercial insurance that covers the drug, LifeMD advertises copays as low as $25.

Q: Does LifeMD take insurance or Medicare?
A: LifeMD does not accept insurance for the program fee, but its team works with commercial insurance on the medication. Anyone with government coverage, including Medicare, Medicaid and TRICARE, is not eligible for its GLP-1 programs, even as secondary coverage.

Q: Can I get a refund from LifeMD if insurance denies my GLP-1?
A: Not for fees already paid. LifeMD says that if insurance will not cover the medication you can pay for it yourself or cancel, but it is unable to refund previously incurred monthly membership fees. Separately, it offers a refund if you do not lose 10% of your body weight in a year in the program, subject to its terms.

Q: Does LifeMD sell compounded semaglutide?
A: Not on its weight-management page, which we read on 5 October 2026: every GLP-1 listed there is a branded drug. Compounded semaglutide and tirzepatide are sold by other telehealth programs at lower prices, and they are not FDA-approved.

### Embody vs SnagRx (2026): Price, Plans & Which Is Cheaper
Source: https://pricetrackerglp1.com/guides/embody-vs-snagrx (updated 2026-10-05)
Q: Embody vs SnagRx: what is the difference?
A: The advertised prices are the same: SnagRx $69 a month for semaglutide and $119 for tirzepatide, Embody $69 and $119, with no membership fee at either. The difference is the plan term: Embody's $69 is a 12-month rate paid up front ($828) and its month-to-month price is $79, while SnagRx advertises $69 without naming a term before the intake quiz.

Q: Is Embody or SnagRx cheaper?
A: Month to month, SnagRx: $69 for semaglutide and $119 for tirzepatide against Embody's $79 and $129, as long as SnagRx's checkout confirms a monthly plan. On a 12-month plan they tie, at $69 and $119 a month, which at Embody is $828 or $1,428 paid up front.

Q: Do I have to pay a year up front for Embody's $69 price?
A: Yes. Embody's product page lists $69 a month for a 12-month supply of semaglutide, $828 at checkout. One month at a time it is $79.

Q: What billing term is SnagRx's $69 price?
A: Its site does not say before the intake quiz. The signup steps say you pay for the first month of your prescription, and the FAQ mentions subscribe-and-save discounts for longer commitments without pricing them. Our board records the $69 as month to month; confirm it on the checkout screen.

Q: Do Embody or SnagRx charge a membership fee?
A: No. Both FAQs say pricing has no hidden costs or monthly fees, and the price does not change with your dose.

Q: Which states do Embody and SnagRx serve?
A: Both FAQs say every state except Louisiana, and only patients 19 or older in Nebraska.

Q: What are Embody's and SnagRx's Trustpilot ratings?
A: When we read them on October 5, 2026, Embody had 3.8 from 9,145 reviews. SnagRx had 8 reviews, fewer than the 25 we need before we print a score.

### Hims vs Ro (2026): GLP-1 Prices, Membership & Which Is Cheaper
Source: https://pricetrackerglp1.com/guides/hims-vs-ro (updated 2026-10-05)
Q: Hims vs Ro: which is better for GLP-1s?
A: On price they match month to month: both charge a $149 monthly membership after a discounted first month, plus the drug at the same starting prices. Ro is cheaper if you prepay its membership for a year at $74 a month, and it runs a free insurance check for Ozempic, Wegovy and Zepbound pens. Hims says its medication fee is FSA/HSA eligible.

Q: Is Hims or Ro cheaper?
A: Month to month, neither: the starting Wegovy pill is $149 plus a $149 membership at both. Ro is cheaper on its 12-month prepaid membership, $74 a month or $888 up front, which brings the starting Wegovy pill to $223 a month all in. Hims shows no prepaid membership on its pages.

Q: How much is the Hims weight loss membership?
A: Hims's weight-loss page, read October 5, 2026, says the membership is $39 for the first month and then auto-renews at $149 a month, billed separately from the medication. The medication is not available without it.

Q: How much is the Ro Body membership?
A: Ro's pricing page, read October 5, 2026, says $39 for the first month, then $149 a month on a monthly plan, or less on a prepaid plan of 3, 6 or 12 months, down to $74 a month when you prepay a year ($888). Medication is billed separately.

Q: Do Hims and Ro accept insurance?
A: Ro checks your coverage for Ozempic, Wegovy and Zepbound pens and handles the paperwork. Hims says insurance is not required and describes no insurance check on its weight-loss pages.

Q: Does PriceTracker partner with Hims or Ro?
A: No. Ro is a program we track but keep off our board because it is not a partner right now, and Hims is not tracked. We quote both from their own pages and send readers to partner programs, ranked by price.

Q: Is there a cheaper way to get Wegovy or Zepbound than Hims or Ro?
A: Yes. Partner programs on our board sell the Wegovy pill and Zepbound for less than either program's month-to-month total once the membership is counted, and compounded semaglutide and tirzepatide cost less again. The live prices are on our cheapest Wegovy and cheapest Zepbound pages.

### Foundayo (orforglipron) in 2026: cost, doses, what it does
Source: https://pricetrackerglp1.com/guides/foundayo (updated 2026-10-04)
Q: What is Foundayo?
A: Eli Lilly's once-daily oral GLP-1 for weight management, brand name for orforglipron, approved by the FDA on 1 April 2026 for adults with obesity or overweight with a weight-related condition. Unlike the semaglutide pills it is taken with or without food at any time of day.

Q: How much does Foundayo cost?
A: Lilly's self-pay price starts at $149 a month for the lowest dose, rising through their published ladder as you titrate. With commercial coverage the savings card advertises as little as $25 a month, and eligible Medicare Part D beneficiaries may get it for $50 through the Medicare GLP-1 Bridge. Sesame Care, the telehealth program on our board that sells it, charges $208 all-in, its $59 membership included.

Q: Is Foundayo cheaper through a telehealth program?
A: No, and that is unusual for this category. Lilly direct at $149 undercuts Sesame Care, the one program on our board that sells it, at $208 once its membership fee is counted. There is no compounded orforglipron because it is a new small molecule under patent, so nothing exists to undercut the brand. The cheap compounded prices elsewhere on this site are semaglutide and tirzepatide only.

Q: How much weight do you lose on Foundayo?
A: In the ATTAIN-1 trial, people on the highest dose who stayed on treatment lost an average of 27.3 pounds, or 12.4% of body weight, compared with 2.2 pounds and 0.9% on placebo. Both qualifiers matter: that is the highest dose, among those who continued.

Q: Foundayo or Wegovy?
A: Different trade-offs rather than a ranking. Foundayo is a tablet with no food or timing rules; Wegovy is a weekly injection with a longer track record and higher average weight loss in trials, and it also has a Wegovy tablet now. On cost, Lilly self-pay starts at $149 and Novo's Wegovy pen is $349 flat, so the pill is the cheaper brand at entry.

Q: Does insurance cover Foundayo?
A: It appears on commercial formularies already: Anthem lists it at Tier 2 with prior authorisation, quantity limits and a benefit-exclusion flag, meaning your employer's plan design decides whether it is covered for you. Medicare Part D beneficiaries have a route through the GLP-1 Bridge at $50 a month, where Foundayo is named first among covered drugs.

Q: Do you have to fast before taking Foundayo?
A: No. Lilly's instruction is to take it by mouth once each day, with or without food, swallowing the tablet whole. That is the practical difference from oral semaglutide, which has to be taken on an empty stomach with a small amount of water followed by a wait before eating or drinking.

### Zepbound Alternatives (2026): 6 Cheaper Routes, Priced
Source: https://pricetrackerglp1.com/guides/zepbound-alternatives (updated 2026-10-04)
Q: What is the cheapest alternative to Zepbound?
A: Compounded tirzepatide, the same active ingredient as Zepbound made by a licensed compounding pharmacy and sold through telehealth programs. Our board ranks every partner program's current price, read from the seller's own page. It is not FDA-approved: FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed.

Q: Is there a cheaper FDA-approved alternative to Zepbound?
A: Yes, depending on the dose. Wegovy from NovoCare Pharmacy is $199 a month for the first two fills for new self-pay patients, then $349 a month up to 2.4 mg. The Wegovy pill starts at $149 a month at 1.5 mg, and Lilly's Foundayo pill starts at $149 a month at its lowest dose. Zepbound itself is $299 to $699 by dose from Lilly self-pay, or $449 on the KwikPen from 7.5 mg with on-time refills.

Q: Is Wegovy as effective as Zepbound?
A: Not in the head-to-head trial. In SURMOUNT-5, a 72-week trial of 751 adults with obesity, tirzepatide (Zepbound's molecule) reduced body weight by 20.2% and semaglutide (Wegovy's molecule) by 13.7%.

Q: Is Mounjaro an alternative to Zepbound?
A: It is the same drug, tirzepatide, from the same maker, but its label is for type 2 diabetes, not weight loss. For someone with type 2 diabetes whose plan covers Mounjaro it can be the cheapest route to tirzepatide. Plans that refuse Zepbound for weight loss generally do not cover Mounjaro for it either.

Q: Is there a pill alternative to Zepbound?
A: Two. The Wegovy pill is oral semaglutide, $149 to $299 a month by dose through NovoCare Pharmacy. Foundayo is Lilly's orforglipron pill, from $149 a month at the lowest dose on self-pay. In Lilly's ATTAIN-1 trial, people on the highest Foundayo dose who stayed on treatment lost 12.4% of their body weight on average.

### Mounjaro Side Effects (2026): Nausea 12 to 18% by Dose
Source: https://pricetrackerglp1.com/guides/mounjaro-side-effects (updated 2026-10-03)
Q: What are the most common side effects of Mounjaro?
A: On the label's pooled placebo-controlled trials, nausea (12 to 18% across the 5, 10 and 15 mg doses vs 4% on placebo), diarrhea (12 to 17% vs 9%), decreased appetite (5 to 11% vs 1%), vomiting (5 to 9% vs 2%), constipation (6 to 7% vs 1%), indigestion and abdominal pain. All are stomach effects, and most happen while the dose is being increased.

Q: How long do Mounjaro side effects last?
A: The label says the majority of reports of nausea, vomiting and diarrhea occurred during dose escalation and decreased over time. It does not give a set number of days. Persistent or severe vomiting or diarrhea is worth a call, because the label links dehydration from them to kidney injury.

Q: Does Mounjaro cause low blood sugar?
A: Rarely on its own: in the 40-week trial of Mounjaro alone, no one on any dose went below 54 mg/dL. The risk is real when it is added to insulin (13 to 19% below 54 mg/dL in the insulin trial) or a sulfonylurea (9.9 to 13.8%), which is why those drugs' doses may be adjusted.

Q: Are Mounjaro and Zepbound side effects the same?
A: Same molecule, same kind of side effects, but different numbers on the two labels: nausea is 12 to 18% on Mounjaro's diabetes trials and 25 to 29% on Zepbound's weight-loss trials. The trials enrolled different people and counted differently, and the label warns that rates cannot be directly compared between trials.

Q: Does Mounjaro affect birth control?
A: It can affect the pill. The label advises people on oral hormonal contraceptives to switch to a non-oral method or add a barrier method for 4 weeks after starting and for 4 weeks after each dose increase. Contraceptives that are not taken by mouth should not be affected.

Q: What Mounjaro side effects need urgent attention?
A: The label's warnings name persistent or severe abdominal pain that may spread to the back (possible pancreatitis), vomiting or diarrhea severe enough to dehydrate you (kidney injury), signs of a serious allergic reaction, gallbladder pain, and a lump in the neck, trouble swallowing or persistent hoarseness (thyroid). It also asks you to tell any team doing surgery or sedation that you take it.

### What Is GLP-1? How It Works and 7 Drugs That Use It (2026)
Source: https://pricetrackerglp1.com/guides/what-is-glp1 (updated 2026-10-03)
Q: What does GLP-1 stand for?
A: Glucagon-like peptide-1. It is a hormone released by the gut after eating, and the drug labels describe it as a physiological regulator of appetite and caloric intake.

Q: How do GLP-1 drugs work?
A: They bind the same receptor as your own GLP-1. That raises insulin only when blood sugar is high, lowers glucagon, slows how fast the stomach empties, and acts on brain areas that regulate appetite. The drugs are built to last much longer than the natural hormone: a week for the injections, a day for the pills.

Q: Which drugs are GLP-1 medications?
A: On the US market: Ozempic, Rybelsus and Ozempic tablets, and Wegovy (semaglutide); Mounjaro and Zepbound (tirzepatide, which also activates the GIP receptor); Foundayo (orforglipron); and Trulicity (dulaglutide). Older daily injections such as liraglutide also exist.

Q: Is Ozempic a GLP-1?
A: Yes. Ozempic is semaglutide, a GLP-1 analogue with 94% sequence homology to human GLP-1, and it is labelled for type 2 diabetes and for heart and kidney risk reduction in people with type 2 diabetes. Wegovy is the same molecule labelled for weight loss.

Q: Is Mounjaro a GLP-1?
A: It is a GLP-1 receptor agonist and also a GIP receptor agonist: its label says tirzepatide activates both receptors. Mounjaro is labelled for type 2 diabetes; Zepbound is the same molecule labelled for weight loss and sleep apnea.

Q: Are there GLP-1 pills?
A: Yes: Rybelsus and Ozempic tablets for type 2 diabetes, and the Wegovy pill and Foundayo for weight loss. They are taken daily rather than weekly, and the semaglutide pills are not interchangeable dose for dose.

### Ozempic Lawsuit Status (2026): MDL 3094, 2,400+ Cases
Source: https://pricetrackerglp1.com/guides/ozempic-lawsuit (updated 2026-10-03)
Q: Is there an Ozempic class action lawsuit?
A: Not in the usual sense. The federal cases are individual personal injury lawsuits grouped as MDL No. 3094 in the Eastern District of Pennsylvania, transferred there for coordinated or consolidated pretrial proceedings. Each case remains its own lawsuit.

Q: How many Ozempic lawsuits are there?
A: In its memorandum of 15 August 2025 the court wrote that there were more than 2,400 cases in MDL 3094. The court pages we read on 3 October 2026 do not publish a newer total.

Q: Which drugs are included in the GLP-1 lawsuit?
A: The court's August 2025 memorandum lists eight: Ozempic, Wegovy, Rybelsus, Victoza and Saxenda (Novo Nordisk) and Trulicity, Mounjaro and Zepbound (Eli Lilly). The vision-loss MDL 3163 lists Ozempic, Wegovy, Saxenda and Trulicity.

Q: Has the Ozempic lawsuit settled?
A: None of the court pages or orders we read on 3 October 2026 announce a settlement or a trial date. The next step on the court's schedule was a Rule 702 hearing on Cross Cutting Issues 2 and 3, set for 14 to 18 September 2026.

Q: What did the court decide about gastroparesis?
A: On 15 August 2025 it ruled that any plaintiff claiming drug-induced gastroparesis must have had a gastric emptying study (scintigraphy, breath test or WMC) properly performed at the time of diagnosis, confirming delayed emptying.

Q: Is the NAION vision-loss lawsuit part of the same case?
A: No. NAION claims are in a separate MDL, No. 3163, also before Judge Marston in the Eastern District of Pennsylvania. MDL 3094 covers gastrointestinal injuries.

Q: Who is the judge in the Ozempic lawsuit?
A: Judge Karen S. Marston of the U.S. District Court for the Eastern District of Pennsylvania presides over both GLP-1 MDLs, No. 3094 (gastrointestinal injuries) and No. 3163 (NAION). The panel's original transfer order assigned MDL 3094 to Judge Gene E. K. Pratter.

Q: Can the public watch the Ozempic MDL hearings?
A: Yes. The court's MDL page says members of the public may watch the monthly status conferences and the hearing remotely, but may not participate without the court's approval.

### What Is Zepbound (Tirzepatide)? Uses, Forms, Cost (2026)
Source: https://pricetrackerglp1.com/guides/what-is-zepbound (updated 2026-10-03)
Q: What is Zepbound?
A: Zepbound is Eli Lilly's brand of tirzepatide, a once-weekly injection that acts on the GIP and GLP-1 receptors. Its label approves it, with diet and exercise, for weight reduction in adults with obesity or overweight with a weight-related condition, and for moderate to severe obstructive sleep apnea in adults with obesity.

Q: What is tirzepatide?
A: Tirzepatide is the active ingredient in Zepbound and Mounjaro. The label describes it as a GIP receptor and GLP-1 receptor agonist that binds albumin, which lets it be injected once a week.

Q: Is Zepbound the same as Mounjaro?
A: They contain the same molecule, tirzepatide. Mounjaro is approved for type 2 diabetes; Zepbound is approved for weight reduction and obstructive sleep apnea. The Zepbound label says not to combine it with other tirzepatide-containing products.

Q: Is Zepbound better than Wegovy?
A: In the head-to-head SURMOUNT-5 trial, average weight loss at 72 weeks was 20.2% with tirzepatide and 13.7% with semaglutide (Wegovy's molecule). Averages do not predict any one person's result, and the trial was funded by Lilly.

Q: How much does Zepbound cost without insurance?
A: Lilly's self-pay price is $299 a month at 2.5 mg, $399 at 5 mg, $499 at 7.5 mg and $699 at 10, 12.5 and 15 mg, for the vial or KwikPen bought direct; the KwikPen is $449 from 7.5 mg while each refill is within 45 days. Compounded tirzepatide from the programs we track costs less and is not FDA-approved.

Q: What forms does Zepbound come in?
A: The label lists pre-filled single-dose pens, single-dose vials, multi-dose vials and single-patient-use KwikPens. The multi-dose vial and KwikPen each hold four weekly doses.

Q: Does Zepbound treat sleep apnea?
A: Yes. Its label approves it, with diet and exercise, to treat moderate to severe obstructive sleep apnea in adults with obesity. The recommended maintenance dose for that use is 10 mg or 15 mg once a week.

Q: Is Zepbound a GLP-1?
A: Partly. The label calls tirzepatide a GIP receptor and GLP-1 receptor agonist, so it acts on the GLP-1 receptor like Wegovy and Ozempic, and on the GIP receptor as well.

### GLP-1 Diet (2026): What to Eat and Avoid, per 4 Medical Groups
Source: https://pricetrackerglp1.com/guides/glp1-diet (updated 2026-10-03)
Q: Is there an official GLP-1 diet?
A: No branded diet, but there is a 2025 joint advisory from four medical societies (ACLM, ASN, the Obesity Medicine Association and The Obesity Society). It recommends nutrient-dense, minimally processed food (fruits, vegetables, whole grains, legumes, lean proteins, nuts and seeds) and limiting refined carbohydrates, sugary drinks, red and processed meats, fast food and ultra-processed snacks. Every GLP-1 weight-loss label pairs the drug with a reduced-calorie diet and more physical activity.

Q: What foods should I avoid on Ozempic or Wegovy?
A: The advisory lists refined carbohydrates, sugar-sweetened drinks, red and processed meats, most fast food and ultra-processed sweets and snacks as things to limit, and says alcohol should be minimised because it can worsen nausea and reflux. During the first days after a dose increase, it suggests avoiding fatty or high-fibre foods and large meals, which make nausea and vomiting more likely.

Q: How much protein should I eat on a GLP-1?
A: The advisory quotes the general adult allowance of 0.8 g per kg of body weight per day and notes that higher targets have been proposed during active weight loss; your prescriber or a dietitian should set your number. It suggests eating protein first in a meal and choosing dense sources such as fish, eggs, Greek yogurt, cottage cheese and nut butters, and says protein alone does not preserve muscle without strength training.

Q: Do I need to time meals around my GLP-1 injection?
A: No. The Wegovy and Zepbound labels say to inject once weekly at any time of day, with or without meals.

Q: What should I eat when I feel nauseous on a GLP-1?
A: The advisory suggests smaller, more frequent meals, avoiding fatty or high-fibre foods during the first few days of treatment, not skipping meals (nausea is often worse after long gaps), enough fluids, and ginger or peppermint tea. Persistent nausea or vomiting is a reason to call your prescriber, because dehydration is how the kidney injury the labels warn about happens.

### Zepbound for Sleep Apnea (2026): Trial, Dose, 4 Ways to Pay
Source: https://pricetrackerglp1.com/guides/zepbound-sleep-apnea (updated 2026-10-03)
Q: Is Zepbound approved for sleep apnea?
A: Yes. The Zepbound label approves it to treat moderate to severe obstructive sleep apnea in adults with obesity, in combination with a reduced-calorie diet and increased physical activity. It is the only GLP-1 with that indication.

Q: How well does Zepbound work for sleep apnea?
A: In the two 52-week SURMOUNT-OSA trials, the apnea-hypopnea index fell by 25.3 events an hour on Zepbound against 5.3 on placebo in people not using CPAP, and by 29.3 against 5.5 in people on CPAP, from a starting point of about 50 events an hour. These are averages; individual results vary.

Q: What dose of Zepbound is used for sleep apnea?
A: The label starts everyone at 2.5 mg a week for 4 weeks and steps up in 2.5 mg increments after at least 4 weeks on each dose. For sleep apnea the recommended maintenance dose is 10 mg or 15 mg once a week. Your prescriber sets your dose.

Q: Does Medicare cover Zepbound for sleep apnea?
A: Not through the $50 GLP-1 Bridge: medicare.gov lists moderate-to-severe sleep apnea as a reason you are not eligible for the Bridge, and adds that your Part D plan might cover your GLP-1. Coverage and prior authorization are decided by your Part D plan.

Q: Can Zepbound replace my CPAP?
A: The trials do not answer that. One trial enrolled people already on CPAP and kept them on it; the other enrolled people who could not or would not use CPAP. Any change to CPAP is a decision for your sleep physician.

Q: How much does Zepbound cost for sleep apnea without insurance?
A: At Lilly's self-pay prices, the 10 mg and 15 mg KwikPens are $699 a month at the regular price, with a $449 purchase offer on those doses that requires refilling within 45 days. Telehealth programs that sell brand Zepbound are compared on this page with their current prices.

### How Long Does Ozempic, Wegovy or Zepbound Take to Work? (2026)
Source: https://pricetrackerglp1.com/guides/how-long-glp1-takes-to-work (updated 2026-10-03)
Q: How long does Wegovy take to work?
A: Wegovy starts at 0.25 mg and steps up every 4 weeks, reaching the 2.4 mg maintenance dose at week 17 on the label's schedule. In the STEP 4 trial, people who completed the 20-week escalation had lost 10.6% of their weight on average; in STEP 1, average loss at week 68 was 14.9% against 2.4% on placebo. These are averages, not predictions.

Q: How long does Zepbound take to work?
A: Zepbound starts at 2.5 mg for 4 weeks and rises in 2.5 mg steps at least 4 weeks apart, so 10 mg arrives at week 13 at the earliest and 15 mg at week 21. In SURMOUNT-4, people who completed a 36-week lead-in averaged 20.9% weight loss; in SURMOUNT-1, average loss at week 72 was 15.0% to 20.9% depending on dose.

Q: How long does Ozempic take to work?
A: Ozempic starts at 0.25 mg for 4 weeks, then 0.5 mg, with 1 mg or 2 mg if more glucose control is needed. Semaglutide reaches steady levels in the blood after 4 to 5 weeks. In the label's 30-week monotherapy trial, A1C fell 1.4 points on 0.5 mg and 1.6 on 1 mg, against 0.1 on placebo.

Q: Why is there no weight loss in my first month?
A: The first month is a starting dose meant to let your body adjust, not the dose the trials tested. Each new dose takes about 4 weeks to reach steady levels, and the trial averages build over months. If you are worried, talk to your prescriber rather than raising the dose yourself.

Q: How long does a GLP-1 stay in your body after you stop?
A: Semaglutide has a half-life of about a week and, per the Ozempic label, is present in the circulation for about 5 weeks after the last dose. Tirzepatide's half-life is about 5 to 6 days.

### GLP-1 Pills (2026): All 4 Compared, $149 to $349/mo Self-Pay
Source: https://pricetrackerglp1.com/guides/glp1-pill (updated 2026-10-02)
Q: Is there a GLP-1 in pill form?
A: Four of them. Rybelsus, the Wegovy pill and the Ozempic pill are all semaglutide tablets, and Foundayo is orforglipron, a different molecule. Three of the four went on sale during 2026. The Wegovy pill and Foundayo are approved for weight; Rybelsus and the Ozempic pill are approved for type 2 diabetes.

Q: Which GLP-1 pill is best for weight loss?
A: Only two are approved for it: the Wegovy pill and Foundayo. Foundayo is the only GLP-1 pill with no food or timing restrictions, so it wins on practicality. The Wegovy pill is semaglutide, the same molecule as the injection with the longer track record. Both start at $149 a month on the manufacturer's own self-pay price.

Q: How much does a GLP-1 pill cost?
A: Novo's published self-pay ladder for its tablets is $149 a month at 1.5 mg, $199 at 4 mg and $299 at 9 and 25 mg. Lilly's Foundayo self-pay also starts at $149. Telehealth programs selling compounded oral semaglutide can be cheaper, but that is a different, non-FDA-approved product rather than a discount on the branded pill.

Q: Do you have to take GLP-1 pills on an empty stomach?
A: For the three semaglutide tablets, yes: empty stomach, a small amount of plain water, and a wait of roughly half an hour before eating, drinking or taking anything else. Foundayo is the exception and is taken once daily with or without food, because it is a small molecule and does not rely on the same absorption mechanism.

Q: Is the GLP-1 pill as effective as the injection?
A: Generally not. Every pill currently available lands below what injectable tirzepatide achieves in trials, and choosing a tablet is a convenience trade rather than a free upgrade. For a meaningful number of people who would never start an injection, that trade is clearly worth making.

Q: What is the difference between Rybelsus and the Wegovy pill?
A: Both are semaglutide tablets from Novo, but they are different products with different strengths and different approvals. Rybelsus is 3, 7 and 14 mg and approved for type 2 diabetes, on sale since September 2019. The Wegovy pill is 1.5, 4, 9 and 25 mg, approved for obesity, and launched in January 2026. Novo publishes a cash price for the Wegovy pill and none for Rybelsus.

Q: How much weight do people lose on GLP-1 pills?
A: In their main trials, oral semaglutide 25 mg (the Wegovy pill) produced a mean -13.6% body-weight change at 64 weeks against -2.2% on placebo (OASIS 4), and orforglipron at its highest dose (Foundayo) produced -12.4% at 72 weeks against -0.9% (ATTAIN-1). The trials ran for different lengths and were not head to head.

Q: What does the Wegovy pill cost at the maintenance dose?
A: The tablet label's maintenance dose is 25 mg once daily, and Novo's self-pay price for 25 mg is $299 a month, about $3,588 a year paying Novo directly. With commercial insurance that covers it, the savings card brings it to as little as $25 a month.

Q: Does Medicare cover GLP-1 pills?
A: For weight loss, through the Medicare GLP-1 Bridge, which covers Foundayo and the Wegovy injection or tablet at a $50 copayment per 30-day supply. Standard Part D does not cover a GLP-1 for weight loss alone. For type 2 diabetes, Rybelsus and the Ozempic pill go through ordinary Part D coverage instead.

### Wegovy or Zepbound denied by insurance? What works in 2026
Source: https://pricetrackerglp1.com/guides/glp1-insurance-denial-appeal (updated 2026-10-02)
Q: What do I do if my insurance denies Wegovy?
A: Find out which kind of denial it is before you write anything. If weight-loss drugs are excluded from your plan's benefit, no clinical documentation will change it and an appeal is the wrong tool. If it is step therapy or unmet criteria, both are answerable, usually with documentation rather than argument. One call to member services asking whether the drug is excluded or failed the criteria tells you which.

Q: Can I appeal a weight-loss drug exclusion?
A: Generally no, because an exclusion is a plan-design decision your employer made rather than a clinical decision about you, so there is no medical judgement to overturn. What can work is asking HR whether the benefit will be added at renewal, asking whether a different indication such as obstructive sleep apnea has its own criteria, or moving to the cash market.

Q: What is a formulary exception?
A: A request to cover a drug that is not preferred on your plan's formulary, usually filed by your prescriber and usually supported by evidence that the preferred alternative failed, was not tolerated, or is contraindicated. It is a different process from an appeal, and asking for the right one gets you to the right queue faster.

Q: Do I have to try Wegovy before Zepbound?
A: On some plans yes. CVS Caremark told members that all of them, regardless of indication, would need to have tried and failed Wegovy before accessing tirzepatide. That is step therapy rather than a refusal, so a documented trial is the route through. Caremark also said it would add Zepbound back as a preferred option on 1 October 2026, which may change the answer on your plan, so check it.

Q: Does a denial ever expire?
A: Effectively yes, because formularies are revised at least annually and sometimes mid-year. Caremark removed Zepbound from its commercial formularies in July 2025 and said it would return it as a preferred option on 1 October 2026, so a denial from that window is worth re-running against your plan's current formulary rather than re-appealing.

Q: Is an appeal letter template worth using?
A: Less than people expect. Reviewers check specific documented items against a written criteria document your plan will give you on request: baseline weight and BMI, a named weight-related condition, and a dated period of lifestyle change. Supplying those beats persuasive prose, and if the denial was a benefit exclusion, no letter of any quality will help.

### Wegovy Pill Cost (2026): $149 to $299/mo by Dose, NovoCare
Source: https://pricetrackerglp1.com/guides/wegovy-weight-loss-pills (updated 2026-10-02)
Q: How much does the Wegovy pill cost?
A: Novo's published self-pay prices are $149 a month at 1.5 mg, $199 at 4 mg, and $299 at 9 mg and 25 mg, with one month defined as a bottle of 30 tablets. The earlier $149 offer on 4 mg ended on 31 August 2026.

Q: Is the Wegovy pill cheaper than the injection?
A: Yes, at self-pay prices. The tablet starts at $149 a month while the pen is $349 a month across every standard dose from 0.25 mg to 2.4 mg, and $399 for the 7.2 mg high-dose pen. Which form is appropriate for you is a clinical decision, not a pricing one.

Q: Is the Wegovy pill the same as Rybelsus?
A: No. They are both oral semaglutide but they are different products. Rybelsus has been sold since September 2019 at 3, 7 and 14 mg and is approved for type 2 diabetes. The Wegovy pill went on sale in January 2026 at 1.5, 4, 9 and 25 mg and is indicated for obesity. There is now also an Ozempic pill, on sale since April 2026.

Q: Did the Wegovy pill price change in 2026?
A: Yes, at 4 mg. It was $149 until 31 August 2026, when Novo's offer on that dose ended. Since then both of Novo's pages list 4 mg at $199 per month. Confirm the figure at checkout.

Q: Can I buy the Wegovy pill cheaper through a telehealth program?
A: Not always, and often not. Several programs resell the branded Wegovy pill, but once their membership fees are counted the all-in monthly cost commonly exceeds Novo's own $149 self-pay price. Our ranking shows the all-in figure for each, checked weekly.

### GLP-1 Patient Assistance (2026): Lilly Cares and Novo PAP
Source: https://pricetrackerglp1.com/guides/glp1-patient-assistance-programs (updated 2026-10-02)
Q: Can I get Wegovy or Zepbound free through a patient assistance program?
A: Not through the manufacturers' programs as of 2 October 2026. Novo Nordisk's Patient Assistance Program lists Ozempic injections as its only GLP-1, and Lilly Cares lists Trulicity as its only GLP-1. Wegovy, Zepbound, Mounjaro, Foundayo and the GLP-1 pills are not on either list.

Q: Who qualifies for free Ozempic from Novo Nordisk?
A: Uninsured US citizens or legal residents with total household income at or below 200% of the federal poverty level, who are not enrolled in or eligible for Medicaid, Medicare Extra Help or VA benefits. Medicare beneficiaries with prescription drug coverage are no longer eligible to receive Ozempic through the program, and commercial insurance disqualifies you.

Q: What is the income limit for Lilly Cares?
A: It depends on the drug's group. Trulicity is a Group 1 medication, capped at 300% of the 2026 federal poverty guidelines: $47,880 for one person, $64,920 for two, $81,960 for three and $99,000 for four. You must have no insurance or Medicare Part D.

Q: Does Lilly Cares cover Mounjaro?
A: No. Lilly Cares' published medication list includes Trulicity as its only GLP-1 receptor agonist. Mounjaro, Zepbound and Foundayo do not appear on it.

Q: What is the cheapest way to get a GLP-1 for weight loss if I cannot get it free?
A: On Medicare, the GLP-1 Bridge covers Foundayo, Wegovy and the Zepbound KwikPen at $50 a month if you qualify. Otherwise, the makers sell direct for cash: Zepbound KwikPen or vial from $299 a month, the Wegovy pill from $149. Compounded GLP-1s through telehealth programs are often cheaper still but are not FDA-approved.

### GLP-1 vs GLP-2 vs GLP-3 (2026): What Each Is, and the Prices
Source: https://pricetrackerglp1.com/guides/glp1-vs-glp2-vs-glp3 (updated 2026-10-02)
Q: What is the difference between GLP-1, GLP-2 and GLP-3?
A: Online, the numbers usually count receptors. GLP-1 drugs such as semaglutide act on the GLP-1 receptor. "GLP-2" is used for tirzepatide, which acts on GIP and GLP-1. "GLP-3" is used for retatrutide, which acts on GIP, GLP-1 and glucagon. Properly, GLP-2 is a separate gut hormone; its drug, Gattex, treats short bowel syndrome.

Q: Is tirzepatide a GLP-2?
A: No. Tirzepatide is a dual GIP and GLP-1 receptor agonist. It is sometimes called a "GLP-2" because it has two targets, but it does not act on the GLP-2 receptor. It is sold as Zepbound for weight and Mounjaro for type 2 diabetes.

Q: Is retatrutide FDA approved?
A: No. Retatrutide is investigational. Lilly reported phase 3 results in 2026 and plans to submit it to the FDA in the first quarter of 2027. The FDA says retatrutide cannot be used in compounding under federal law and has not been found safe and effective for any condition.

Q: How much weight do people lose on retatrutide?
A: In the phase 3 TRIUMPH-1 trial, people without diabetes on the 12 mg dose lost an average of 28.3% of body weight at 80 weeks. In TRIUMPH-2, with type 2 diabetes, the top result was 20.8%; in TRIUMPH-3, with severe obesity and heart disease, 22.6%.

Q: Can I buy retatrutide online?
A: Not legally as a medicine. It is not approved, the FDA says it cannot be used in compounding, and the agency has warned sellers marketing it online. Anything sold as retatrutide or "GLP-3" today is an unapproved product.

Q: What is the strongest weight-loss drug I can get now?
A: Of approved drugs, tirzepatide (Zepbound) has the strongest head-to-head result: -20.2% mean body weight at 72 weeks against -13.7% for semaglutide in SURMOUNT-5. Lilly sells the Zepbound KwikPen or vial from $299 a month self-pay.

### Do GLP-1 Patches Work? The FTC Says No (2026). Pills From $149
Source: https://pricetrackerglp1.com/guides/do-glp1-patches-work (updated 2026-10-02)
Q: Do GLP-1 patches work for weight loss?
A: No. No GLP-1 patch is FDA-approved, and the FTC's consumer guidance says "Nothing you can wear or apply to your skin will cause you to lose weight. Period." Its guidance to media calls weight-loss claims for patches false.

Q: Is there an FDA-approved GLP-1 patch?
A: No. Every FDA-approved GLP-1 for weight loss is an injection (Wegovy, Zepbound) or a tablet (the Wegovy pill, Foundayo). A product sold over the counter as a GLP-1 patch is not semaglutide or tirzepatide.

Q: What is the closest real alternative to a GLP-1 patch?
A: A GLP-1 pill. The Wegovy pill starts at $149 a month self-pay from Novo at 1.5 mg, and Foundayo starts at $149 a month from Lilly at 0.8 mg. Both are FDA-approved for weight and need a prescription.

Q: Are GLP-1 patches safe?
A: The FTC warns that products in this category "could even hurt your health", and the FDA advises getting GLP-1 treatment by prescription from a state-licensed pharmacy. Talk to a clinician before using any product marketed as a GLP-1 that is not a prescription drug.

### GLP-1 constipation, nausea, diarrhea (2026): rates + fixes
Source: https://pricetrackerglp1.com/guides/glp1-constipation-nausea-diarrhea (updated 2026-09-03)
Q: How common is constipation on GLP-1s?
A: The Wegovy label reports constipation in 24% of people on 2.4 mg against 11% on placebo. The Zepbound label reports 17% at 5 mg, 14% at 10 mg and 11% at 15 mg against 5% on placebo, the only gut effect that becomes less common as the dose rises. Both labels say a slower dose escalation reduces gastrointestinal effects.

Q: How long does GLP-1 nausea last?
A: The trials show it peaking with each dose increase and settling within the four-week step, which is why both labels are built around a four-week climb. Nausea affected 44% of people on Wegovy 2.4 mg and 25% to 29% on Zepbound, and it is among the most common reasons the 6.8% of Wegovy patients who stopped for side effects did so.

Q: Is diarrhoea or constipation more common on GLP-1s?
A: Diarrhoea, on both drugs: 30% against 24% for constipation on Wegovy, and 19% to 23% against 11% to 17% on Zepbound. Many people experience both at different points. The labels connect persistent diarrhoea or vomiting to a serious consequence, dehydration leading to acute kidney injury, which is why versions you cannot keep ahead of with fluids warrant a call.

Q: Why do GLP-1s cause fatigue?
A: The labels report it (11% on Wegovy, 5% to 7% on Zepbound, roughly double placebo) but do not explain it. The likely contributors are the ones that follow from eating much less: fewer calories, less fluid, and in people also on diabetes medication, low blood sugar, which both labels flag separately. Fatigue that outlasts the dose climb is the kind to raise with a prescriber.

Q: When is GLP-1 stomach pain serious?
A: When it is severe or persistent rather than tied to a dose step. Both labels separate ordinary gut effects from pancreatitis (severe pain, sometimes radiating to the back) and gallbladder disease (upper-right pain, fever, jaundice). Ordinary nausea and loose stools that ease within a dose step are the drug working; pain with those features is what the warnings section is for.

### Wegovy 7.2 mg (HD) in 2026: 18.7% in STEP UP, $399 a month
Source: https://pricetrackerglp1.com/guides/wegovy-7-2-mg (updated 2026-09-03)
Q: What is Wegovy 7.2 mg?
A: Wegovy HD, semaglutide at 7.2 mg once weekly, three times the standard 2.4 mg maximum, in its own pen. It is the same molecule and mechanism as every other Wegovy dose, positioned as a further step above the normal ladder rather than a replacement for it.

Q: How much weight do you lose on Wegovy 7.2 mg?
A: In the STEP UP trial of 1,407 adults with obesity over 72 weeks, 7.2 mg reduced body weight by 18.7%, against 15.6% for the standard 2.4 mg dose and 3.9% for placebo. The trial's authors report it as superior to both while retaining a favourable risk-benefit profile.

Q: How much does Wegovy HD cost?
A: $399 a month direct from Novo's pharmacy for cash patients, $50 above the $349 charged for every standard-dose Wegovy pen. Through commercial insurance that covers Wegovy, the maker's savings card applies as it does to the standard pens.

Q: Is Wegovy 7.2 mg as good as Zepbound?
A: Close, but not directly tested. Wegovy 7.2 mg lost 18.7% in STEP UP; tirzepatide lost 20.2% in SURMOUNT-5, a different trial. Read side by side that is a gap of about 1.5 points, but no trial has run the two against each other. In cash terms the 18.7% dose is $399 a month and the 20.2% dose is $699.

Q: Does the higher dose have more side effects?
A: Not more serious ones, in the trial: serious adverse events were 6.8% on 7.2 mg, 10.9% on 2.4 mg and 5.5% on placebo, with the caveat that the 2.4 mg group was small. The ordinary gut effects are dose-related on every GLP-1, so expect them and follow the label's advice to climb slowly.

### Is compounded semaglutide safe? FDA's concerns (2026)
Source: https://pricetrackerglp1.com/guides/is-compounded-semaglutide-safe (updated 2026-09-03)
Q: Is compounded semaglutide the same as Ozempic or Wegovy?
A: The same molecule, made by a licensed compounding pharmacy rather than Novo Nordisk. What differs is oversight: Wegovy and Ozempic went through FDA's review for safety, effectiveness and quality, and a compounded vial did not. Novo's own line is that only it makes FDA-approved semaglutide, which is true and does not mean the compounded molecule is different.

Q: Is compounded semaglutide legal?
A: Yes. Compounding by a licensed pharmacist in a state-licensed pharmacy, or an FDA-registered outsourcing facility, is lawful with a prescription. FDA's position is that compounded drugs should be used only when an approved drug cannot meet a patient's medical need or is not commercially available, and it does not treat price as such a need.

Q: What does FDA say about compounded semaglutide?
A: That it does not review compounded drugs for safety, effectiveness or quality before they are sold, and that it has received reports of dosing errors from self-measured vials, doses beyond the approved label, products shipped warm, and fraudulent products naming pharmacies that never made them. Its advice on multi-dose vials is to discard them 28 days after first use regardless of the compounder's instructions.

Q: What is the difference between a 503A and 503B compounder?
A: A 503A pharmacy compounds per patient and is overseen by its state board of pharmacy, without FDA's manufacturing rules. A 503B outsourcing facility compounds in batches, is registered with and inspected by FDA, and must meet current good manufacturing practice, the same standard as a drug factory. Neither is FDA-approved, but 503B is the higher standard.

Q: How do I check a compounded semaglutide seller?
A: Ask which pharmacy fills the prescription and look it up in that state's licence register; confirm the vial's concentration in mg per mL and your dose in both mg and units in writing; compare the escalation schedule to the Wegovy label's four weeks per step; refuse anything that arrives warm; and discard vials 28 days after first use. Our seller guide walks through it in about ten minutes.

### Zepbound (tirzepatide) side effects by dose (2026), per label
Source: https://pricetrackerglp1.com/guides/zepbound-side-effects (updated 2026-09-03)
Q: What are the most common side effects of Zepbound?
A: From the label's pooled trials, at 5, 10 and 15 mg respectively: nausea 25, 29 and 28 percent (8 on placebo); diarrhoea 19, 21 and 23 (8); vomiting 8, 11 and 13 (2); constipation 17, 14 and 11 (5). Any gastrointestinal effect was reported by 56 percent at each dose against 30 percent on placebo, mostly during dose escalation and fading with time.

Q: How many people stop Zepbound because of side effects?
A: In the two approval trials, 4.8 percent at 5 mg, 6.3 percent at 10 mg and 6.7 percent at 15 mg permanently stopped because of adverse reactions, against 3.4 percent on placebo. The label says most who quit did so in the first few months, from gastrointestinal effects. Between 1.9 and 4.3 percent stopped specifically for gut effects, against 0.5 percent on placebo.

Q: Does Zepbound cause hair loss?
A: Hair loss was reported by 4 to 5 percent of people on Zepbound against 1 percent on placebo, and the label attributes it to the weight loss rather than the drug. It fell almost entirely on women: 7.1 percent of women versus 0.5 percent of men on Zepbound. No one in the trials stopped the drug because of it.

Q: Is Zepbound's thyroid cancer warning serious?
A: It is a boxed warning carried by every GLP-1 drug, based on thyroid C-cell tumours seen in preclinical studies at clinically relevant exposures. The label states it is unknown whether Zepbound causes them in humans. Practically it is a screening rule: Zepbound is contraindicated with a personal or family history of medullary thyroid carcinoma or MEN 2.

Q: Does Zepbound have worse side effects than Ozempic?
A: Zepbound's label rates are higher: nausea 28 percent at 15 mg versus 20.3 percent at Ozempic 1 mg, diarrhoea 23 versus 8.8. But Ozempic's table comes from shorter diabetes trials at lower doses with a different placebo group, so the labels are not directly comparable. In the one head-to-head weight trial, gut effects were similar between the two molecules.

### Semaglutide for weight loss (2026): approved vs compounded
Source: https://pricetrackerglp1.com/guides/semaglutide-for-weight-loss (updated 2026-09-02)
Q: Is semaglutide good for weight loss?
A: Semaglutide is the molecule in Wegovy, which is FDA-approved for weight management, so the approved answer is yes for people who meet the criteria a prescriber applies. It is also the molecule in Ozempic, approved for type 2 diabetes, where using it for weight is off-label.

Q: What is the difference between Wegovy, Ozempic and compounded semaglutide?
A: They are the same molecule. Wegovy is Novo Nordisk's version approved for weight management and dosed higher. Ozempic is Novo Nordisk's version approved for type 2 diabetes with a lower dose ceiling. Compounded semaglutide is made by a compounding pharmacy and is not FDA-approved, so the finished product has not been reviewed for safety, effectiveness or manufacturing quality.

Q: Is compounded semaglutide the same as Wegovy?
A: The active molecule is the same and the side effects are the same. The oversight is not: a compounded product is not FDA-approved, and the FDA has stated that the enforcement discretion allowing 503A pharmacies to compound semaglutide has ended. The pharmacy's own licensing is doing the work an approval would otherwise do.

Q: Can I take Ozempic for weight loss?
A: People do, and it is off-label because Ozempic is approved for type 2 diabetes rather than weight management. It is a decision for a prescriber. One practical difference is that Ozempic's dose range tops out lower than Wegovy's, so the two are not interchangeable at the upper doses despite being the same molecule.

Q: How much does semaglutide cost for weight loss?
A: It depends entirely on which version. Novo publishes self-pay prices for Wegovy, and compounded programs are typically a fraction of that. Our ranking shows the all-in monthly cost for every seller we can verify, re-checked weekly and dated.

### Ozempic for weight loss (2026): off-label, the dose ceiling
Source: https://pricetrackerglp1.com/guides/ozempic-for-weight-loss (updated 2026-09-02)
Q: Is Ozempic approved for weight loss?
A: No. Ozempic is approved for adults with type 2 diabetes to improve blood sugar. Using it for weight loss is off-label, which is legal and common but is a prescriber's decision. Wegovy is the same molecule approved for weight management.

Q: What is the maximum dose of Ozempic for weight loss?
A: Ozempic's dose range runs 0.25 mg, 0.5 mg, 1 mg and 2 mg. Wegovy, the same molecule approved for weight management, goes to 2.4 mg with a 7.2 mg high-dose strength above it. Your dose is set by your prescriber.

Q: Should I switch from Ozempic to Wegovy for weight loss?
A: That is a clinical decision, but it is a common one once someone reaches the top of Ozempic's range, because Wegovy continues higher with the same molecule. Cost is also relevant: Novo's published self-pay price is $499 a month for Ozempic 2 mg against $349 for Wegovy at any standard dose.

Q: Is Ozempic or Wegovy cheaper?
A: On Novo's published self-pay prices, Wegovy is cheaper at the top: $349 a month at every standard pen dose, against $349 for Ozempic up to 1 mg and $499 at 2 mg. Both are far above the compounded market, which is where most cash buyers end up.

Q: Why do doctors prescribe Ozempic instead of Wegovy for weight?
A: Often coverage: plans that pay for a diabetes medicine frequently will not pay for a weight-management one. Supply has also moved around. It is worth asking your prescriber directly, and worth checking what your own insurer publishes about each drug.

### Ozempic for type 2 diabetes (2026): cost, doses, coverage
Source: https://pricetrackerglp1.com/guides/ozempic-for-type-2-diabetes (updated 2026-09-02)
Q: Is Ozempic approved for type 2 diabetes?
A: Yes. Novo Nordisk states it is for adults with type 2 diabetes, along with diet and exercise, to improve blood sugar. This is its on-label indication, unlike its use for weight loss, which is off-label.

Q: What doses does Ozempic come in?
A: 0.25 mg, 0.5 mg, 1 mg and 2 mg, climbed in steps over months. It tops out at 2 mg, lower than Wegovy's range, because it is dosed for blood sugar rather than for maximum weight loss.

Q: How much does Ozempic cost for diabetes?
A: It depends on coverage. Novo publishes self-pay prices of $349 a month up to 1 mg and $499 at 2 mg, with $199 for a new patient's first two fills through 31 December 2026. The savings card can bring an insured copay to as little as $25, subject to a maximum saving of $100 a month.

Q: Why does the savings card not get me to $25?
A: Because it is capped. Novo's terms say pay as little as $25 subject to a maximum saving of $100 per month, so the card reduces your copay by up to $100. If your copay is $110 you reach $25. If it is $400 you reach $300.

Q: Should I use compounded semaglutide if I have type 2 diabetes?
A: That is a question for your prescriber, and the calculation is different from someone using it off-label for weight. Compounded semaglutide is not FDA-approved, telehealth weight programs are not managing your diabetes, and coverage for a diabetes indication is generally much better than for a weight one, so the cash market may not be your cheapest route at all.

### Mounjaro for weight loss (2026): off-label, the cheaper twin
Source: https://pricetrackerglp1.com/guides/mounjaro-for-weight-loss (updated 2026-09-02)
Q: Is Mounjaro approved for weight loss?
A: No. Mounjaro is tirzepatide approved for type 2 diabetes. Zepbound is the same molecule from the same manufacturer, approved for weight management. Using Mounjaro for weight loss is off-label and is a prescriber's decision.

Q: What is the difference between Mounjaro and Zepbound?
A: The indication and the label, not the molecule or the strengths. Both are tirzepatide from Eli Lilly and both reach 15 mg. Mounjaro is indicated for type 2 diabetes and Zepbound for weight management, and they are typically treated differently by insurance formularies.

Q: Do I need to switch from Mounjaro to Zepbound to keep losing weight?
A: Not for dose reasons. Both reach 15 mg, so unlike the Ozempic-to-Wegovy situation there is no strength available on one and not the other. People switch for coverage or cash price rather than because they have run out of ladder.

Q: Is Mounjaro better than Ozempic for weight loss?
A: In the one head-to-head trial, tirzepatide produced 20.2% mean body-weight loss at 72 weeks against semaglutide's 13.7%. That trial used doses corresponding to Zepbound and Wegovy in people without diabetes, so it compares the molecules rather than those two specific brands.

Q: Where do you inject Mounjaro?
A: The tirzepatide label says to inject subcutaneously in the abdomen or thigh, and that another person should inject in the back of the upper arm, rotating sites with each dose. That last part differs from the semaglutide label, which lists the upper arm without that qualifier.

### Is this GLP-1 seller legit? Five checks to run (2026)
Source: https://pricetrackerglp1.com/guides/is-a-glp1-seller-legit (updated 2026-09-02)
Q: How do I know if an online GLP-1 provider is legitimate?
A: Run five checks: look the company up on LegitScript, ask which pharmacy dispenses your medication and verify that licence with the state board of pharmacy, confirm there is a licensed prescriber and a real prescription, find a physical address and a way to reach someone, and check the price against the verified market floor. A price far below the floor is a claim about the supply chain rather than a bargain.

Q: What is LegitScript certification?
A: LegitScript certifies online pharmacies and telehealth providers, and it is the accreditation most commonly cited in this market. It is free to search. Certification is a positive signal rather than a guarantee, and its absence does not by itself prove a company is illegitimate, so treat it as one input among several.

Q: Is compounded semaglutide legitimate?
A: Compounding is legal and long-established, but a compounded drug is not FDA-approved, so the finished product has not been reviewed for safety, effectiveness or manufacturing quality. The FDA has also stated that the enforcement discretion for 503A pharmacies compounding semaglutide has ended. The dispensing pharmacy's own licensing carries the weight, which is why verifying it matters more here than anywhere else.

Q: Is a GLP-1 seller that does not require a prescription safe?
A: No. GLP-1 medicines are prescription drugs. A seller that does not require a prescription is not offering a cheaper tier or a loophole; it is the clearest single indication that the product is not being handled the way a prescription medicine must be.

Q: Do you check that these providers are safe?
A: No, and we will not imply otherwise. We verify advertised prices, membership and consultation fees, state coverage, plan terms and third-party review scores, re-checked weekly and dated. We do not audit pharmacies, inspect facilities or test product. Those checks are yours to run, and this page explains how.

### How to get prescribed a GLP-1 in 2026: what qualifies you
Source: https://pricetrackerglp1.com/guides/how-to-get-prescribed-a-glp1 (updated 2026-09-02)
Q: What BMI do you need to be prescribed a GLP-1?
A: The label does not state a BMI number in its indication. Wegovy's indications describe adults with obesity, and adults with overweight in the presence of at least one weight-related comorbid condition. The commonly quoted figures of 30, or 27 with a comorbidity, are the standard clinical definitions of those terms rather than text from the indication. Whether you qualify is a clinical judgement.

Q: Can I get a GLP-1 without being obese?
A: There are indications that are not about weight at all. The same label covers reducing the risk of major adverse cardiovascular events in adults with established cardiovascular disease and either obesity or overweight, and treating MASH with moderate to advanced liver fibrosis. Semaglutide is separately approved as Ozempic for type 2 diabetes.

Q: How do I get prescribed Ozempic?
A: Ozempic is approved for adults with type 2 diabetes to improve blood sugar, so the on-label route is a diabetes diagnosis assessed by a clinician. Being prescribed it for weight loss instead is off-label, which is legal and common but remains a prescriber's decision.

Q: Is a telehealth prescription legitimate?
A: Yes, provided there is a licensed clinician doing a genuine assessment of your history and you can reach them afterwards. Telehealth is where most cash-pay GLP-1 prescriptions originate. A seller that does not require an assessment at all is not offering a faster route; it is skipping the step that makes it a prescription.

Q: What will a prescriber ask me?
A: Generally your height and weight, your other diagnoses and medicines, your personal and family history including thyroid cancer and pancreatitis, and whether you are pregnant or planning to be. These drugs carry a boxed warning for thyroid C-cell tumour risk and must not be combined with another GLP-1, so an assessment that does not ask about history is not an assessment.

# 7. PAGE INDEX

## Rankings
- https://pricetrackerglp1.com/cheapest/glp-1
- https://pricetrackerglp1.com/cheapest/semaglutide
- https://pricetrackerglp1.com/cheapest/tirzepatide
- https://pricetrackerglp1.com/cheapest/oral-semaglutide
- https://pricetrackerglp1.com/cheapest/wegovy
- https://pricetrackerglp1.com/cheapest/zepbound

## Guides (114)
### What it costs
- GLP-1 coupons and copay cards: the $25 headline and the $100 cap: https://pricetrackerglp1.com/guides/glp1-copay-cards
- Wegovy and Ozempic alternatives: every cheaper route, ranked by what it costs: https://pricetrackerglp1.com/guides/wegovy-alternatives
- The Ozempic coupon: $25 for up to 3 months, and why your copay decides the rest: https://pricetrackerglp1.com/guides/ozempic-coupon
- The Wegovy coupon: what $25 turns into at the counter: https://pricetrackerglp1.com/guides/wegovy-coupon
- Costco GLP-1 prices in 2026: Sesame, Wegovy, Ozempic, and what CVS, Walgreens and Walmart charge: https://pricetrackerglp1.com/guides/costco-glp1
- LillyDirect vs NovoCare Pharmacy: every self-pay price by dose, the refill rules, and who can use them: https://pricetrackerglp1.com/guides/lillydirect-vs-novocare
- What Ozempic, Wegovy, Zepbound and Mounjaro cost with insurance: copays, coinsurance and the deductible, worked out: https://pricetrackerglp1.com/guides/glp1-cost-with-insurance
- Can you use an HSA or FSA for a GLP-1? What the IRS text says: https://pricetrackerglp1.com/guides/glp1-hsa-fsa
- Embody vs Trimi: which compounded GLP-1 program costs less, plan by plan: https://pricetrackerglp1.com/guides/embody-vs-trimi
- Mounjaro cost: the list price, the $25 card, and the $499 self-pay price: https://pricetrackerglp1.com/guides/mounjaro-cost
- Ro, Hims, Noom, WeightWatchers, Found, Calibrate: what each GLP-1 program actually charges: https://pricetrackerglp1.com/guides/glp1-program-prices
- Zepbound without insurance: every dose priced, and what the vial changes: https://pricetrackerglp1.com/guides/zepbound-cost-without-insurance
- The Zepbound savings card: two programs, not one: https://pricetrackerglp1.com/guides/zepbound-savings-card
- The Mounjaro savings card, and why its cap beats Zepbound's: https://pricetrackerglp1.com/guides/mounjaro-savings-card
- GLP-1s without insurance: what each route actually costs: https://pricetrackerglp1.com/guides/glp1-without-insurance
- Does Medicare cover GLP-1s? Ozempic, Wegovy and Zepbound, route by route: https://pricetrackerglp1.com/guides/does-medicare-cover-glp1
- Does Medicaid cover GLP-1s? It depends which state, and on why: https://pricetrackerglp1.com/guides/does-medicaid-cover-glp1
- GoodRx for GLP-1s: what the discount actually is: https://pricetrackerglp1.com/guides/goodrx-glp1
- Generic tirzepatide: there is none, the patent runs to 2036, and here is what costs less today: https://pricetrackerglp1.com/guides/generic-tirzepatide
- Tirzepatide cost: every price for the molecule, per month, per mg and per year: https://pricetrackerglp1.com/guides/tirzepatide-cost
- TrumpRx GLP-1 prices: what Wegovy, Zepbound, Ozempic and Foundayo cost there: https://pricetrackerglp1.com/guides/trumprx-glp1
- Does your employer cover GLP-1s for weight loss? The 2026 numbers, who dropped it, and what to do: https://pricetrackerglp1.com/guides/glp1-employer-coverage
- The Rybelsus coupon now works on the Ozempic pill: https://pricetrackerglp1.com/guides/rybelsus-coupon
- Embody vs SnagRx: same advertised price, different plan terms: https://pricetrackerglp1.com/guides/embody-vs-snagrx
- Hims vs Ro: what each GLP-1 membership costs once the drug is added: https://pricetrackerglp1.com/guides/hims-vs-ro
- Zepbound alternatives: every cheaper route, ranked by what it costs: https://pricetrackerglp1.com/guides/zepbound-alternatives
- The Wegovy pill: what each dose costs, and how it compares with the pen: https://pricetrackerglp1.com/guides/wegovy-weight-loss-pills
- GLP-1 patient assistance programs: what Lilly Cares and Novo's PAP actually cover: https://pricetrackerglp1.com/guides/glp1-patient-assistance-programs

### Side effects
- Ozempic teeth: can semaglutide or tirzepatide damage your teeth?: https://pricetrackerglp1.com/guides/ozempic-teeth
- GLP-1s before surgery: do you stop Ozempic, Wegovy or Zepbound, and for how long?: https://pricetrackerglp1.com/guides/glp1-before-surgery
- GLP-1s and birth control: which ones weaken the pill, for how long, and what to use instead: https://pricetrackerglp1.com/guides/glp1-birth-control
- GLP-1 muscle loss: how much of the weight is muscle, and what protects it: https://pricetrackerglp1.com/guides/glp1-muscle-loss
- What is “Ozempic face”? What the studies show, who gets it, and what fixing it costs: https://pricetrackerglp1.com/guides/ozempic-face
- Ozempic side effects, and the ones that actually make people stop: https://pricetrackerglp1.com/guides/ozempic-side-effects
- Wegovy side effects, and why the top of the ladder is different: https://pricetrackerglp1.com/guides/wegovy-side-effects
- Semaglutide side effects, and what compounding does and does not change: https://pricetrackerglp1.com/guides/semaglutide-side-effects
- “Ozempic butt” is not a side effect either: https://pricetrackerglp1.com/guides/ozempic-butt
- GLP-1 hair loss: what is actually going on: https://pricetrackerglp1.com/guides/glp1-hair-loss
- GLP-1s and alcohol: what is known and what is not: https://pricetrackerglp1.com/guides/glp1-and-alcohol
- Mounjaro side effects: the label's numbers by dose, the low blood sugar risk, and how tirzepatide compares at weight-loss doses: https://pricetrackerglp1.com/guides/mounjaro-side-effects
- The GLP-1 diet: what to eat on Ozempic, Wegovy or Zepbound, and what to limit, from the 2025 joint advisory: https://pricetrackerglp1.com/guides/glp1-diet
- GLP-1 constipation, nausea, diarrhoea and fatigue: the label numbers, and what the labels say to do: https://pricetrackerglp1.com/guides/glp1-constipation-nausea-diarrhea
- Zepbound side effects: the label's table by dose, who actually quits, and how it compares to semaglutide: https://pricetrackerglp1.com/guides/zepbound-side-effects

### Doses and injecting
- Ozempic 6 week results: what the label and the studies say to expect: https://pricetrackerglp1.com/guides/ozempic-6-week-results
- Microdosing GLP-1s: what it saves you, and what it doesn't: https://pricetrackerglp1.com/guides/microdosing-glp1
- Tirzepatide dosage chart: the 2.5 to 15 mg ladder, week by week, and what each step costs: https://pricetrackerglp1.com/guides/tirzepatide-dosage-chart
- GLP-1 dosage chart: every brand's starting dose, step-ups and top dose, straight from the FDA labels: https://pricetrackerglp1.com/guides/glp1-dosage-chart
- Stopping a GLP-1: what the withdrawal trials found, and what a maintenance dose actually is: https://pricetrackerglp1.com/guides/stopping-glp1-weight-regain
- Zepbound dosage chart: every tirzepatide dose, the escalation rule, what each rung lost in the trial, and what it costs: https://pricetrackerglp1.com/guides/zepbound-dosage-chart
- The semaglutide dose ladder, and what each step costs: https://pricetrackerglp1.com/guides/semaglutide-dosage-chart
- Where to inject a GLP-1, and the one thing the labels disagree about: https://pricetrackerglp1.com/guides/glp1-injection-sites
- The Wegovy dosing chart, and what year one actually costs: https://pricetrackerglp1.com/guides/wegovy-dosing-chart
- Mounjaro dosage chart: the label's schedule, every pen and vial, and what each dose costs: https://pricetrackerglp1.com/guides/mounjaro-dosage-chart
- Ozempic dosage chart: 0.25 mg to 2 mg, every pen, the missed-dose rule, and what each dose costs: https://pricetrackerglp1.com/guides/ozempic-dosage-chart
- How long do Ozempic, Wegovy and Zepbound take to work? The label calendar and the trial timepoints: https://pricetrackerglp1.com/guides/how-long-glp1-takes-to-work
- Wegovy 7.2 mg (Wegovy HD): what the higher dose adds, and what it costs: https://pricetrackerglp1.com/guides/wegovy-7-2-mg

### The drugs
- GLP-1s for fatty liver disease (MASH): what Wegovy and tirzepatide do for the liver: https://pricetrackerglp1.com/guides/glp1-liver-disease
- GLP-1 heart benefits: which drugs are proven to cut heart attack and stroke risk: https://pricetrackerglp1.com/guides/glp1-heart-benefits
- GLP-1s for binge eating: what semaglutide, liraglutide and tirzepatide trials show: https://pricetrackerglp1.com/guides/glp1-binge-eating
- Generic liraglutide in 2026: every approved Victoza and Saxenda generic, what it costs, and how it compares: https://pricetrackerglp1.com/guides/generic-liraglutide
- GLP-1s for PCOS: what the guideline allows, what the trials show, and what it costs: https://pricetrackerglp1.com/guides/glp1-pcos
- What is food noise, and do GLP-1 medicines quiet it? What the studies show: https://pricetrackerglp1.com/guides/food-noise
- Wegovy pill vs injection: the same semaglutide, two schedules, two price lists: https://pricetrackerglp1.com/guides/wegovy-pill-vs-injection
- Wegovy vs Ozempic: the same drug, and why the box still decides what you pay: https://pricetrackerglp1.com/guides/wegovy-vs-ozempic
- Ozempic vs Zepbound: a diabetes drug and a weight-loss drug, compared on label, dose and price: https://pricetrackerglp1.com/guides/ozempic-vs-zepbound
- The best GLP-1 for weight loss, ranked by the evidence and then by the bill: https://pricetrackerglp1.com/guides/best-glp1-for-weight-loss
- Compounded semaglutide vs Wegovy: same molecule, different rules, and what the price gap buys: https://pricetrackerglp1.com/guides/compounded-semaglutide-vs-wegovy
- Foundayo vs Wegovy pill: two weight-loss tablets, two molecules, the same $149 start: https://pricetrackerglp1.com/guides/foundayo-vs-wegovy-pill
- Tirzepatide vs semaglutide: the head-to-head result, and what the better one costs: https://pricetrackerglp1.com/guides/tirzepatide-vs-semaglutide
- Zepbound vs Wegovy: the two weight-loss brands, priced every way you can buy them: https://pricetrackerglp1.com/guides/zepbound-vs-wegovy
- Zepbound vs Mounjaro: one molecule, two labels, and why the label sets your price: https://pricetrackerglp1.com/guides/zepbound-vs-mounjaro
- Switching between Wegovy and Zepbound, and who is really deciding: https://pricetrackerglp1.com/guides/switching-wegovy-to-zepbound
- Mounjaro vs Ozempic, and the trial everyone quotes about it: https://pricetrackerglp1.com/guides/mounjaro-vs-ozempic
- Rybelsus for type 2 diabetes, and the Ozempic pill replacing it: https://pricetrackerglp1.com/guides/rybelsus-for-type-2-diabetes
- Mounjaro vs Rybelsus: a weekly shot against a pill Novo is replacing: https://pricetrackerglp1.com/guides/mounjaro-vs-rybelsus
- Retatrutide: up to 28.3% weight loss in trials, no FDA approval yet, and no legal way to buy it today: https://pricetrackerglp1.com/guides/retatrutide
- CagriSema: FDA decision due by the end of 2026, no price yet, and how it compares with Zepbound and Wegovy: https://pricetrackerglp1.com/guides/cagrisema
- Foundayo: the GLP-1 pill where buying direct is the cheap route: https://pricetrackerglp1.com/guides/foundayo
- What is GLP-1? The hormone, how the drugs work, and every GLP-1 medication on the market: https://pricetrackerglp1.com/guides/what-is-glp1
- What is Zepbound? Tirzepatide explained: what it treats, how it works, and what it costs: https://pricetrackerglp1.com/guides/what-is-zepbound
- Zepbound for sleep apnea: what the label approves, what SURMOUNT-OSA found, and who pays for it: https://pricetrackerglp1.com/guides/zepbound-sleep-apnea
- Every GLP-1 pill you can actually get, and what each one costs: https://pricetrackerglp1.com/guides/glp1-pill
- GLP-1 vs GLP-2 vs GLP-3: what the names mean, and which ones you can actually buy: https://pricetrackerglp1.com/guides/glp1-vs-glp2-vs-glp3
- Semaglutide for weight loss: which version, and what each costs: https://pricetrackerglp1.com/guides/semaglutide-for-weight-loss
- Ozempic for weight loss, and where the ladder runs out: https://pricetrackerglp1.com/guides/ozempic-for-weight-loss
- Ozempic for type 2 diabetes: the on-label one, and what it costs: https://pricetrackerglp1.com/guides/ozempic-for-type-2-diabetes
- Mounjaro for weight loss, and why Zepbound exists: https://pricetrackerglp1.com/guides/mounjaro-for-weight-loss

### Buying safely
- How to get Ozempic online: the prescription, the pen or the pill, and what each route costs: https://pricetrackerglp1.com/guides/get-ozempic-online
- Who qualifies for Wegovy and Zepbound? The BMI rules, the conditions, and what your plan adds: https://pricetrackerglp1.com/guides/wegovy-zepbound-eligibility
- 503A vs 503B pharmacies: who makes compounded semaglutide and tirzepatide, and how to check yours: https://pricetrackerglp1.com/guides/503a-vs-503b-pharmacies
- How much does Wegovy cost: the pen, the pill, insured, cash, Medicare and compounded, in one table: https://pricetrackerglp1.com/guides/wegovy-cost
- How much does Ozempic cost: $25 covered, $199 to $499 cash, and why the weight-loss version of the same drug is cheaper: https://pricetrackerglp1.com/guides/ozempic-cost
- How to get Wegovy, online or in person: the criteria, the prescriber, the tablet, and what each route costs: https://pricetrackerglp1.com/guides/how-to-get-wegovy
- Buying a GLP-1 in Mexico or Canada: what the import rules say, where the fakes turn up, and the legal US price to beat: https://pricetrackerglp1.com/guides/buy-glp1-abroad
- Semaglutide online: the six versions you can be prescribed, what the rules now allow, and what each costs: https://pricetrackerglp1.com/guides/semaglutide-online
- Telehealth weight loss programs: how they work, what the monthly price covers, and the red flags: https://pricetrackerglp1.com/guides/telehealth-weight-loss
- How to get Zepbound: who qualifies, who prescribes it, and the four ways to pay: https://pricetrackerglp1.com/guides/how-to-get-zepbound
- How to get Mounjaro: the diabetes route, and why the weight route is a different box: https://pricetrackerglp1.com/guides/how-to-get-mounjaro
- Compounded tirzepatide: what it is, what FDA says now the shortage is over, and what it costs against Zepbound: https://pricetrackerglp1.com/guides/compounded-tirzepatide
- How to get a GLP-1 covered by insurance, in the order it actually works: https://pricetrackerglp1.com/guides/how-to-get-a-glp1-covered-by-insurance
- Is Hims legit? What its GLP-1 program costs, what reviews say, and its FDA record: https://pricetrackerglp1.com/guides/is-hims-legit
- Is Noom legit? What Noom's GLP-1 program costs, its reviews, and its record: https://pricetrackerglp1.com/guides/is-noom-legit
- Is Henry Meds legit? What it charges, what reviews say, and its FDA record: https://pricetrackerglp1.com/guides/is-henry-meds-legit
- Is Mochi Health legit? What it costs, what reviewers say, and its FDA record: https://pricetrackerglp1.com/guides/is-mochi-health-legit
- Is Calibrate legit? What the program costs, who it takes, and what reviewers say: https://pricetrackerglp1.com/guides/is-calibrate-legit
- Generic Ozempic: none in the US until December 2031, where generics already sell, and what to buy instead: https://pricetrackerglp1.com/guides/generic-ozempic
- How much semaglutide costs: $69 compounded, $149 to $499 from Novo, $25 or $50 covered, by dose and by year: https://pricetrackerglp1.com/guides/semaglutide-cost
- Is LifeMD legit for weight loss? The program fee, the drug prices, and the reviews: https://pricetrackerglp1.com/guides/is-lifemd-legit
- Your GLP-1 was denied. Which kind of no was it?: https://pricetrackerglp1.com/guides/glp1-insurance-denial-appeal
- Do GLP-1 patches work? What the FTC and FDA say, and the real needle-free option: https://pricetrackerglp1.com/guides/do-glp1-patches-work
- Is compounded semaglutide safe? What FDA actually says, and what it does not: https://pricetrackerglp1.com/guides/is-compounded-semaglutide-safe
- How to check a GLP-1 seller is legitimate, in about ten minutes: https://pricetrackerglp1.com/guides/is-a-glp1-seller-legit
- How to get prescribed a GLP-1, and what the label actually requires: https://pricetrackerglp1.com/guides/how-to-get-prescribed-a-glp1

### News
- The Ozempic lawsuit: what the court has actually decided, and what happens next: https://pricetrackerglp1.com/guides/ozempic-lawsuit

## Seller verification (22)
- Is SnagRx legit: https://pricetrackerglp1.com/is-snagrx-legit
- Is Embody legit: https://pricetrackerglp1.com/is-embody-legit
- Is Collective legit: https://pricetrackerglp1.com/is-collective-legit
- Is CoreAge Rx legit: https://pricetrackerglp1.com/is-coreage-rx-legit
- Is Sprout Health legit: https://pricetrackerglp1.com/is-sprout-health-legit
- Is bmiMD legit: https://pricetrackerglp1.com/is-bmimd-legit
- Is Strut Health legit: https://pricetrackerglp1.com/is-strut-health-legit
- Is Bodybuilding.com Health+ legit: https://pricetrackerglp1.com/is-bodybuilding-glp1-legit
- Is Wellorithm legit: https://pricetrackerglp1.com/is-wellorithm-legit
- Is DudeMeds legit: https://pricetrackerglp1.com/is-dudemeds-legit
- Is TMates legit: https://pricetrackerglp1.com/is-tmates-legit
- Is ShedRx legit: https://pricetrackerglp1.com/is-shedrx-legit
- Is Enhance MD legit: https://pricetrackerglp1.com/is-enhance-md-legit
- Is Found legit: https://pricetrackerglp1.com/is-found-legit
- Is Gala Health legit: https://pricetrackerglp1.com/is-gala-health-legit
- Is Oak Longevity legit: https://pricetrackerglp1.com/is-oak-longevity-legit
- Is SkinnyRx legit: https://pricetrackerglp1.com/is-skinnyrx-legit
- Is Sesame Care legit: https://pricetrackerglp1.com/is-sesame-care-legit
- Is Lemonaid Health legit: https://pricetrackerglp1.com/is-lemonaid-health-legit
- Is Direct Meds GLP-1 legit: https://pricetrackerglp1.com/is-direct-meds-legit
- Is MangoRx legit: https://pricetrackerglp1.com/is-mango-rx-legit
- Is Willow legit: https://pricetrackerglp1.com/is-willow-legit

## Provider price pages (22)
- SnagRx: https://pricetrackerglp1.com/p/snagrx
- Embody: https://pricetrackerglp1.com/p/embody
- Collective: https://pricetrackerglp1.com/p/collective
- CoreAge Rx: https://pricetrackerglp1.com/p/coreage-rx
- Sprout Health: https://pricetrackerglp1.com/p/sprout-health
- bmiMD: https://pricetrackerglp1.com/p/bmimd
- Strut Health: https://pricetrackerglp1.com/p/strut-health
- Bodybuilding.com Health+: https://pricetrackerglp1.com/p/bodybuilding-glp1
- Wellorithm: https://pricetrackerglp1.com/p/wellorithm
- DudeMeds: https://pricetrackerglp1.com/p/dudemeds
- TMates: https://pricetrackerglp1.com/p/tmates
- ShedRx: https://pricetrackerglp1.com/p/shedrx
- Enhance MD: https://pricetrackerglp1.com/p/enhance-md
- Found: https://pricetrackerglp1.com/p/found
- Gala Health: https://pricetrackerglp1.com/p/gala-health
- Oak Longevity: https://pricetrackerglp1.com/p/oak-longevity
- SkinnyRx: https://pricetrackerglp1.com/p/skinnyrx
- Sesame Care: https://pricetrackerglp1.com/p/sesame-care
- Lemonaid Health: https://pricetrackerglp1.com/p/lemonaid-health
- Direct Meds GLP-1: https://pricetrackerglp1.com/p/direct-meds
- MangoRx: https://pricetrackerglp1.com/p/mango-rx
- Willow: https://pricetrackerglp1.com/p/willow

## Savings cards, comparisons and reference pages
Manufacturer savings cards (each cell quoted from the maker's own terms, dated):
- Zepbound savings card: as little as $25 with covering commercial insurance, self-pay from $299 (read 2026-10-02): https://pricetrackerglp1.com/guides/zepbound-savings-card
- Mounjaro savings card: as little as $25 with covering commercial insurance, self-pay from $499 (read 2026-10-02): https://pricetrackerglp1.com/guides/mounjaro-savings-card
- Wegovy savings card: as little as $25 with covering commercial insurance, self-pay from $199 (read 2026-10-02): https://pricetrackerglp1.com/guides/wegovy-coupon
- Wegovy pill savings card: as little as $25 with covering commercial insurance, self-pay from $149 (read 2026-10-02): https://pricetrackerglp1.com/savings/wegovy-pill
- Ozempic savings card: as little as $25 with covering commercial insurance, self-pay from $149 (read 2026-10-04): https://pricetrackerglp1.com/guides/ozempic-coupon
- Foundayo savings card: as little as $25 with covering commercial insurance, self-pay from $149 (read 2026-10-04): https://pricetrackerglp1.com/savings/foundayo

Comparisons (verified prices on both sides; clinical facts quoted from trials and labels):
- Tirzepatide vs Semaglutide: https://pricetrackerglp1.com/guides/tirzepatide-vs-semaglutide
- Zepbound vs Wegovy: https://pricetrackerglp1.com/guides/zepbound-vs-wegovy
- Mounjaro vs Ozempic: https://pricetrackerglp1.com/guides/mounjaro-vs-ozempic
- Wegovy vs Ozempic: https://pricetrackerglp1.com/guides/wegovy-vs-ozempic
- Zepbound vs Mounjaro: https://pricetrackerglp1.com/guides/zepbound-vs-mounjaro
- Compounded Semaglutide vs Wegovy: https://pricetrackerglp1.com/guides/compounded-semaglutide-vs-wegovy
- Compounded Tirzepatide vs Zepbound: https://pricetrackerglp1.com/compare/compounded-tirzepatide-vs-zepbound
- Wegovy Pill vs Injection: https://pricetrackerglp1.com/guides/wegovy-pill-vs-injection

Program vs program (every plan of two live partner programs side by side, all in; the cheaper one computed from the board):
- Embody vs SnagRx: From $69 vs $69 a month. SnagRx costs less on every plan both sell. https://pricetrackerglp1.com/guides/embody-vs-snagrx
- Embody vs Sprout Health: From $69 vs $99 a month. Embody costs less on every plan both sell. https://pricetrackerglp1.com/compare/embody-vs-sprout-health
- Embody vs CoreAge Rx: From $69 vs $79 a month. The same price on every plan both sell. https://pricetrackerglp1.com/compare/embody-vs-coreage-rx
- Embody vs bmiMD: From $69 vs $119 a month. Embody costs less on every plan both sell. https://pricetrackerglp1.com/compare/embody-vs-bmimd
- Embody vs Strut Health: From $69 vs $129 a month. Embody costs less on every plan both sell. https://pricetrackerglp1.com/compare/embody-vs-strut-health
- Embody vs Bodybuilding.com Health+: From $69 vs $141 a month. Embody costs less on every plan both sell. https://pricetrackerglp1.com/compare/embody-vs-bodybuilding-glp1
- SnagRx vs Sprout Health: From $69 vs $99 a month. SnagRx costs less on every plan both sell. https://pricetrackerglp1.com/compare/snagrx-vs-sprout-health
- SnagRx vs CoreAge Rx: From $69 vs $79 a month. SnagRx costs less on every plan both sell. https://pricetrackerglp1.com/compare/snagrx-vs-coreage-rx
- SnagRx vs bmiMD: From $69 vs $119 a month. SnagRx costs less on every plan both sell. https://pricetrackerglp1.com/compare/snagrx-vs-bmimd
- SnagRx vs Strut Health: From $69 vs $129 a month. SnagRx costs less on every plan both sell. https://pricetrackerglp1.com/compare/snagrx-vs-strut-health
- SnagRx vs Bodybuilding.com Health+: From $69 vs $141 a month. SnagRx costs less on every plan both sell. https://pricetrackerglp1.com/compare/snagrx-vs-bodybuilding-glp1
- Sprout Health vs CoreAge Rx: From $99 vs $79 a month. CoreAge Rx costs less on every plan both sell. https://pricetrackerglp1.com/compare/sprout-health-vs-coreage-rx
- Sprout Health vs bmiMD: From $99 vs $119 a month. Sprout Health costs less on every plan both sell. https://pricetrackerglp1.com/compare/sprout-health-vs-bmimd
- Sprout Health vs Strut Health: From $99 vs $129 a month. Strut Health costs less on every plan both sell. https://pricetrackerglp1.com/compare/sprout-health-vs-strut-health
- Sprout Health vs Bodybuilding.com Health+: From $99 vs $141 a month. Sprout Health costs less on every plan both sell. https://pricetrackerglp1.com/compare/sprout-health-vs-bodybuilding-glp1
- CoreAge Rx vs bmiMD: From $79 vs $119 a month. CoreAge Rx costs less on every plan both sell. https://pricetrackerglp1.com/compare/coreage-rx-vs-bmimd
- CoreAge Rx vs Strut Health: From $79 vs $129 a month. CoreAge Rx costs less on every plan both sell. https://pricetrackerglp1.com/compare/coreage-rx-vs-strut-health
- CoreAge Rx vs Bodybuilding.com Health+: From $79 vs $141 a month. CoreAge Rx costs less on every plan both sell. https://pricetrackerglp1.com/compare/coreage-rx-vs-bodybuilding-glp1
- bmiMD vs Strut Health: From $119 vs $129 a month. Strut Health costs less on every plan both sell. https://pricetrackerglp1.com/compare/bmimd-vs-strut-health
- bmiMD vs Bodybuilding.com Health+: From $119 vs $141 a month. Which costs less depends on the drug and the plan. https://pricetrackerglp1.com/compare/bmimd-vs-bodybuilding-glp1
- Strut Health vs Bodybuilding.com Health+: From $129 vs $141 a month. Strut Health costs less on every plan both sell. https://pricetrackerglp1.com/compare/strut-health-vs-bodybuilding-glp1
- Embody vs SkinnyRx: From $69 vs $199 a month. Embody costs less on every plan both sell. https://pricetrackerglp1.com/compare/embody-vs-skinnyrx
- Embody vs Direct Meds GLP-1: From $69 vs $249 a month. Embody costs less on every plan both sell. https://pricetrackerglp1.com/compare/embody-vs-direct-meds
- Embody vs ShedRx: From $69 vs $159 a month. Embody costs less on every plan both sell. https://pricetrackerglp1.com/compare/embody-vs-shedrx
- Embody vs Gala Health: From $69 vs $179 a month. Embody costs less to start. https://pricetrackerglp1.com/compare/embody-vs-gala-health
- Embody vs Collective: From $69 vs $75 a month. Collective costs less on every plan both sell. https://pricetrackerglp1.com/compare/embody-vs-collective
- SnagRx vs Collective: From $69 vs $75 a month. Which costs less depends on the drug and the plan. https://pricetrackerglp1.com/compare/snagrx-vs-collective
- Collective vs Sprout Health: From $75 vs $99 a month. Collective costs less on every plan both sell. https://pricetrackerglp1.com/compare/collective-vs-sprout-health
- Collective vs CoreAge Rx: From $75 vs $79 a month. Collective costs less on every plan both sell. https://pricetrackerglp1.com/compare/collective-vs-coreage-rx
- Gala Health vs Sprout Health: From $179 vs $99 a month. Sprout Health costs less to start. https://pricetrackerglp1.com/compare/gala-health-vs-sprout-health
- Sprout Health vs SkinnyRx: From $99 vs $199 a month. Sprout Health costs less on every plan both sell. https://pricetrackerglp1.com/compare/sprout-health-vs-skinnyrx
- ShedRx vs Sprout Health: From $159 vs $99 a month. Sprout Health costs less on every plan both sell. https://pricetrackerglp1.com/compare/shedrx-vs-sprout-health
- Sesame Care vs MangoRx: From $208 vs $299 a month. Sesame Care costs less to start. https://pricetrackerglp1.com/compare/sesame-care-vs-mango-rx
- SkinnyRx vs TMates: From $199 vs $158 a month. Which costs less depends on the drug and the plan. https://pricetrackerglp1.com/compare/skinnyrx-vs-tmates

Reference pages:
- Every GLP-1 pill, approval status and price: https://pricetrackerglp1.com/guides/glp1-pill
- What every GLP-1 costs, three ways to pay: https://pricetrackerglp1.com/cost/glp-1
- Citable GLP-1 price statistics (CC BY 4.0): https://pricetrackerglp1.com/stats

Status, dated answers in the regulator's own words (re-checked monthly):
- Is compounded semaglutide still legal? As of October 2026, FDA says semaglutide is not on its drug shortage list or the 503B bulks list, so pharmacies may compound it only under the ordinary limits of sections 503A and 503B; the shortage-era grace periods ended in 2025. https://pricetrackerglp1.com/status/compounded-semaglutide-legal
- Is compounded tirzepatide still legal? As of October 2026, FDA says tirzepatide is not on its drug shortage list or the 503B bulks list, so pharmacies may compound it only under the ordinary limits of sections 503A and 503B; the shortage-era grace periods ended in March 2025. https://pricetrackerglp1.com/status/compounded-tirzepatide-legal
- Is there a GLP-1 shortage? As of October 2026, FDA's drug shortage database lists both semaglutide injection and tirzepatide injection as resolved; FDA declared the tirzepatide shortage over on Dec 19, 2024 and the semaglutide shortage over on Feb 21, 2025. https://pricetrackerglp1.com/status/glp1-shortage
- Does Medicare cover GLP-1s for weight loss? As of October 2026, Medicare covers Wegovy (injection or tablet), Foundayo and the Zepbound KwikPen for weight loss through the temporary Medicare GLP-1 Bridge, for eligible people with Part D, at a $50 monthly copayment. https://pricetrackerglp1.com/status/medicare-glp1-coverage
- Is the Wegovy pill available? As of October 2026, the Wegovy pill (oral semaglutide) is sold with a prescription through NovoCare Pharmacy at $149 a month for 1.5 mg, $199 for 4 mg and $299 for 9 mg and 25 mg self-pay, and Medicare's GLP-1 Bridge covers the tablet. https://pricetrackerglp1.com/status/wegovy-pill-availability

Citable statistics (H1 = the statistic, every program behind it listed, CC BY 4.0):
- Index of statistics: https://pricetrackerglp1.com/stats
- Programs shipping to all 50 states: https://pricetrackerglp1.com/stats/all-50-states
- Headline prices that need a prepaid plan: https://pricetrackerglp1.com/stats/headline-prepay
- Price changes in the last 30 days: https://pricetrackerglp1.com/stats/price-changes
- Every genuine price change, week by week (RSS at /changes/feed.xml): https://pricetrackerglp1.com/changes
- GLP-1 glossary, 25 terms with primary sources: https://pricetrackerglp1.com/glossary

FDA records (regulator facts only, quoted from fda.gov with the read date; no recommendation, no affiliate link):
- 163 FDA warning letters whose text names a GLP-1 drug (149 semaglutide, 113 tirzepatide), one record page each with recipient, date, subject, MARCS-CMS number, closeout status and a verbatim excerpt: https://pricetrackerglp1.com/safety/warning-letters
- 98 FDA-registered 503B outsourcing facilities (41 marked "Not yet inspected"), one page each with registration and inspection dates as FDA lists them: https://pricetrackerglp1.com/safety/outsourcing-facilities
- How to read them: a warning letter is FDA's allegation of violations, not a court finding; "open" means FDA has not published a closeout letter; 503B registration is a filing, not an approval of any drug.

Free tools (no sign-up; every answer server-rendered with its sources):
- Insurance coverage checker: plan type, insurer and drug, answered in the insurer's own published words: https://pricetrackerglp1.com/coverage
- Medicare GLP-1 Bridge checker: Part D plus the BMI and condition rules quoted from medicare.gov; $50 a month for Wegovy, Foundayo and the Zepbound KwikPen: https://pricetrackerglp1.com/tools/medicare-bridge
- BMI for Wegovy and Zepbound: the labels name obesity, or overweight with a weight-related condition; BMI 30, or 27 with a condition, are the trials' enrollment cutoffs: https://pricetrackerglp1.com/tools/bmi-glp1
- GLP-1 programs by state: which partner programs ship to each state, cheapest first, all 50 states on one page: https://pricetrackerglp1.com/tools/by-state
- GLP-1 by state, one page per state and DC (https://pricetrackerglp1.com/states/<state>, e.g. /states/ohio): the partner programs that ship there ranked by all-in price, the state Medicaid answer for weight loss quoted from KFF's January 2026 map (13 states covered GLP-1s for obesity under fee-for-service; diabetes coverage is required everywhere), and the state's own CMS 2025 Medicaid GLP-1 prescription and spending figures: https://pricetrackerglp1.com/states
- Dosing calculator, mg to syringe units, with microdosing unit tables (arithmetic only; the prescriber sets the dose): https://pricetrackerglp1.com/tools/dosage-chart
- Titration schedule with the cost of each monthly fill and the first-year total: https://pricetrackerglp1.com/tools/titration-cost
- Weight loss calculator from trial averages (SURMOUNT-1 20.9% at 15 mg, STEP 1 14.9%, OASIS 4 13.6%, ATTAIN-1 11.2%; averages, not predictions): https://pricetrackerglp1.com/tools/weight-loss-projection
- Patient assistance checker: income against the 2026 limits for Lilly Cares and Novo Nordisk PAP; neither program lists Wegovy, Zepbound, Mounjaro, Foundayo or any GLP-1 pill: https://pricetrackerglp1.com/tools/patient-assistance

## GLP-1 TV (video library)
1548 public YouTube videos about GLP-1 medications, chosen by view count and relevance, sorted by drug and topic: journeys week by week, side effects, how to inject, injection-site reactions, dosing up, food noise and mood, stopping, cost. Clinicians and news are labelled; nothing sponsored; videos selling grey-market drugs, miracle claims or scam/fear bait are left out. Personal experiences, not medical advice. Each video page carries our own summary, key moments with timestamps and the facts as stated in the video; transcripts are not published.
- Hub: https://pricetrackerglp1.com/tv
- Ozempic: 332 videos: https://pricetrackerglp1.com/tv/ozempic
- Wegovy pen: 278 videos: https://pricetrackerglp1.com/tv/wegovy
- Wegovy pill: 96 videos: https://pricetrackerglp1.com/tv/wegovy-pill
- Rybelsus and the Ozempic pill: 44 videos: https://pricetrackerglp1.com/tv/rybelsus
- Compounded semaglutide: 44 videos: https://pricetrackerglp1.com/tv/compounded-semaglutide
- Zepbound: 295 videos: https://pricetrackerglp1.com/tv/zepbound
- Mounjaro: 338 videos: https://pricetrackerglp1.com/tv/mounjaro
- Compounded tirzepatide: 62 videos: https://pricetrackerglp1.com/tv/compounded-tirzepatide
- Foundayo: 74 videos: https://pricetrackerglp1.com/tv/foundayo
- Every GLP-1: 327 videos: https://pricetrackerglp1.com/tv/glp-1
- Retatrutide: 24 videos: https://pricetrackerglp1.com/tv/retatrutide
- CagriSema: 9 videos: https://pricetrackerglp1.com/tv/cagrisema
- Program reviews on video (independent reviewers; company channels and affiliate-code reviews excluded): https://pricetrackerglp1.com/tv/providers

## Reference
- Methodology: https://pricetrackerglp1.com/methodology
- How we verify prices: https://pricetrackerglp1.com/methodology
- Editorial policy: https://pricetrackerglp1.com/editorial-policy
- Affiliate disclosure: https://pricetrackerglp1.com/affiliate-disclosure
- Price index: https://pricetrackerglp1.com/price-index
- Press and data: https://pricetrackerglp1.com/press
- Sources: https://pricetrackerglp1.com/sources
- Corrections: https://pricetrackerglp1.com/corrections